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Summary
The protozoan parasite, Theileria cimmlatci, is a tick transmitted intracellular 
pathogen of domestic cattle in tropical regions of Africa and Asia. The parasite life cycle 
within the bovine host involves proliferative phases within the host lymphocytes and 
erythrocytes. As a means of characterising cdc2-related kinases (CRKs) involved in these 
stages which would control the parasite division cycle, pl3sucl affinity columns have been 
used to show binding and activity of parasite proteins which are likely to have a role in 
the cell cycle. Further experiments showed the existence of at least two pl38UCl binding 
kinases in T. cinnulata, together with possible substrate specificities of these 
polypeptides. Another gene involved in replication and division has been isolated, namely 
the large subunit of ribonucleotide reductase (Rl) which encodes a unique N terminal 
extension to the predicted amino acid sequence compared to higher eukaryotes. The role 
of this extension is unknown but could serve in the allosteric regulation of the parasite 
enzyme. It is also feasible that this region could be used as a target for peptidomimetic 
inhibitors specific for the parasite enzyme. The Rl polypeptide immunolocalises to the 
parasite nuclei whereas the host Rl remains in the cytoplasm.
Using anti-sera generated against a range of host and parasite cell cycle 
associated proteins it was possible to gain a picture of changes occuring during the 
intracellular differentiation of the parasite within the lymphocyte. These results show that 
the intracellular differentiation initially involves both host and parasite cell cycles but 
there is an early decline in the amounts of two polypeptide markers of the host cell cycle 
whilst the parasite continues to undergo repeated nuclear division prior to the 
differentiation into the merozoite stage. Attempts were made to synchronise infected 
cells using aphidicolin and the effects of this drug on the expression of cell cycle 
associated genes in T. cinmdcita was also examined.
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Chapter One
Introduction
1.1 Theileria annulata
The protozoan parasite Theileria annulata is the causative agent of tropical 
theileriosis, a debilitating and frequently fatal disease of cattle. It has been estimated 
that there are more than 250 million cattle across the globe that are at risk from this 
disease (Tait & Hall, 1990). Endemic regions stretch from the Moroccan Atlantic coast 
to the Pacific in a broad band encompassing Saharan North Africa, India, Byelorussia 
and into China (Dolan, 1992).
1.1.2 History
Theileriosis was first described as tropical bovine piroplasmosis by 
Dschunkowsky & Luhs in 1904 in Transcaucasia in southern Russia. The haemo- 
protozoan parasite responsible was named Piroplasma annulatum by Bettencourt in 
1907 (cited in Irvin, 1987).
Experimental evidence showing P. annulatum to be similar to the Theileria 
parva parasite was published by Theiler in 1904 and the presence of a schizont stage 
resulted in P. annulatum being re-assigned as Theileria and hence its name today as 
Theileria annulata.
1.1.3 Classification of the Theileria Genus
Traditionally the taxonomic classification of protozoa depended upon criteria 
such as ecology, morphology, pathology and immunology. With the advent of 
molecular biology, more detailed studies at a genetic and biochemical level have 
resolved long standing disputes over certain Theileria species and sub-species 
designations.
1.1.4 Taxonomic Hierarchy
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The currently accepted Theileria classification is as given below: (Levine,
1980).
Sub-kingdom Protozoa
Phylum
Class
Order
Family
Genus
Apicomplexa
Aconoidasida
Piroplasmorida
Theileriidae
Theileria
1.1.5 Theilerial Parasites of Domestic Animals
There are six species of Theileria infectious for bovine hosts: T. annulata, T. 
parva, T. sergenti, T. mutans, T. taurotragi and T. velifera (Irvin, 1987). Of the six, 
the first two are the most serious pathogens. There are other Theileria species of 
ruminants which are not pathogenic but which could confuse a correct diagnosis - 
these are T. ovis, T recondita and Tseparata (Dolan, 1989, Papadopoulos etal., 
1996).
1.1.5.1 Theileria annulata
T. annulata causes tropical theileriosis in domestic cattle {Bos taurus and Bos 
indicus) and Asian water buffalo (Bubalus bubalis). It has been shown that the host 
range of T. annulata is limited to bovids since sporozoites were unable to infect 
peripheral blood mononuclear cells (PBMs) from other mammals in an experimental 
situation (Steuber, 1986).
The transmission vectors of T. annulata are ixodid ticks of the Hyalomma 
species. The natural disease vector in the Middle East and India is H. anatolicum but 
other vector species include H. asiaticum, H. detritum and H. dromedarii (Irvin, 
1987). Ticks may feed on different hosts as adults, nymphs and larvae. H. anatolicum
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is a three host tick, H. detritum is a two host tick whereby larvae and nymph feed from 
the same host (Sergent et al.t 1945). Ticks acquire T. annulata infection during a 
blood meal and transmit the parasite transtadially at the next stage of development 
when feeding on another bovine host
The disease is restricted to areas where the tick vectors can survive and an 
endemic belt of tropical theileriosis ranges from Morocco to China. Indigenous cattle 
in endemic areas (Bos indicus) are relatively resistant to theileriosis with the mortality 
rate being less than 5% (Neitz, 1957). However, attempts to increase productivity and 
yields in these indigenous cattle by cross breeding with European breeds (Bos taurus) 
has led to increased mortality rates due to the higher susceptibility of these exotic and 
crossbreeds to theileriosis. Indigenous animals in endemic areas are exposed early to 
the parasite and if they survive then the immune protection is maintained through 
constant challenge. For newly introduced animals in endemic areas, rates of mortality 
reach up to 60% (Singh, 1991). There appears to be no inherent calf resistance and no 
maternal transfer of factors mediating resistance from mother to progeny. The number 
of animals at risk worldwide from theileriosis makes assessment of economic damage 
very difficult Moreover, cattle which recover from infection suffer diminished milk 
yields, weight loss and fertility problems. This loss of productivity is a further 
constraint to the growth of local economies in endemic areas. Estimated losses to the 
Indian economy as a result of theileriosis is thought to be 10% of the livestock 
contribution to the gross national product (GNP) which places the dollar value of this 
loss in the range of tens of millions of dollars per annum (Singh, 1991).
1.1.5.2 Theileria parva
This species is the causative agent of East Coast Fever (ECF) in Bos taurus 
and African buffalo (Syncerus caffer). It has a higher pathogenicity than T. annulata 
and is prevalent throughout Central and Eastern Africa. Transmission is by the three 
host tick species, Rhipicephalus appendiculatus and R. zambeziensus.
Like T. annulata, exotic cattle have a higher susceptibility to T. parva than do 
the cattle indigenous to endemic regions. However, indigenous cattle originating from
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non - endemic areas are severely affected by ECF. Once infected, mortality rates can 
be 80-100% for all age groups. Even for indigenous cattle in endemic areas the 
mortality rates can be as high as 50% with calves accounting for most of this figure 
(Irvin & Morrison, 1987).
Mukhebi et al. (1992) estimated the economical impact of ECF in 1989 to be of 
the order of $168 million with 1.1 million cattle killed by ECF. It is probable that the 
high rates of mortality stem from T. parva infecting T-cells which interferes with the 
effector response in the immune system (Morrison et al., 1987). The cause of death in 
ECF is leucopenia.
Infections by T. parva and T. annulata can be distinguished morphologically 
between piroplasm stages. In T. annulata the piroplasms are predominantly round and 
oval shaped but in T. parva piroplasms are rod and comma shaped (Melhom & Schein, 
1984). There is no clinical need for this distinction given the lack of geographical 
overlap between these two species.
There is a trinomial nomenclature for the 3 subspecies of T. parva\ - T.p. 
parva (East Coast Fever), T.p. bovis (Rhodesian theileriosis) and T.p. lawrencei 
(Corridor disease). From immunofluorescence using monoclonal antibodies generated 
against sporozoite surface antigens the three subspecies are indistinguishable from one 
another but the sporozoites differ in their ultrastructure (Fawcett, 1985).
1.1.5.3 Theileria sergenti
This species is endemic in areas of Eastern Asia and is transmitted by ticks of 
the Haemophysalis genus. The pathogenicity of infection is much milder than either T. 
annulata or T. parva. However when T. sergenti infection combines with other 
haemoprotozoic infections, mild pyrexia and anaemia can develop resulting in a large 
decrease in cattle productivity. It is the most common protozoan disease of grazing 
cattle in Japan.
Until most recently the two other benign species of Theileria which cause 
anaemia but not leucopenia have been linked taxonomically with T. sergenti in a group 
of T. sergenti/orientalis and T. buffeli. Based on differences in vector ticks at the sub
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genus level, Fujisaki (1992) proposed that the classification triplet of T. 
sergenti!orientalisIbuffeli be divided into two groups - T. sergenti and T. 
orientalist buffeli. This has been confirmed by two dimensional PAGE protein analysis 
of piroplasm stages and by characterisation of genes encoding immunodominant 
proteins (Fujisaki et al., 1994).
1.1.5.4. Theileria mutans
This species infects cattle (Bos taurus and B. indicus) and buffalo CSyncerus 
coffer) in sub-Saharan Africa and also in the Caribbean (Uilenberg et al, 1983). Its 
tick vector belongs to the Amblyomma genus and the infection caused is benign 
theileriosis being only mildly pathogenic.
1.1.5.5. Theileria taurotragi
T. taurotragi infects cattle and other bovidae, being transmitted by ixodid ticks 
of the Rhipicephalus genus. It also occurs naturally in antelopes (Taurotragus oryx) 
(Stagg, 1983). It is widely found in Africa and can occasionally be pathogenic in cattle.
1.1.5.6. Theileria velifera
This is infectious for cattle and buffalo being transmitted by ticks of the 
Amblyomma genus. It is found in sub-Saharan Africa and the Carribean and is 
apathogenic.
1.1.5.7. Other species of Theileria
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T hirci (Dschunowsky & Uridschevich (1924), cited in Irvin 1987) infects 
sheep and goats via the Hyalomma vector. It has a similar geographical distribution to 
that of T. annulata and is highly pathogenic.
T camelensis infects camels but the vector and pathogenesis of the disease is 
unknown. It is found in Africa and parts of the former USSR.
A previously unidentified species of Theileria has been reported (Ngumi et al, 
1994). This parasite was isolated from cattle in Kenya and was shown to be 
antigenically distinct from other Theileria species by use of species specific 
monoclonal antibodies.
1.1.6 The Life Cycle of Theileria annulata
See Figure 1.1
1.1.6.1 Bovine Stages
Infection of the bovine host is initiated by an infected adult tick. Sporozoites 
contained within the tick vector salivary glands are injected into the bovine host when 
the tick begins to feed. Sporozoites then rapidly invade leucocytes (Jura et a l, 1983). 
Leucocytes susceptible to invasion by T. annulata sporozoites are those displaying 
major histocompatability complex (MHC) class II molecules - primarily B cells and 
monocytes/ macrophages (Glass et al, 1989).
After leucocyte invasion the parasite develops into a uninucleate trophozoite 
stage which then undergoes a series of nuclear divisions to produce the multinucleated 
schizont composed of parasite membrane containing an average of 15 - 20 nuclei. As 
this development proceeds, the host cell divides in synchrony with the schizont by the 
schizont attaching to the host spindle apparatus (Carrington et al, 1995). The 
mechanism of this transformation has still to be fully elucidated and is discussed in 
more detail in section 1.1.11. After a finite number of cell divisions the enlarged 
macroschizont differentiates into microschizonts through the asexual stage of
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merogony. Uninucleate merozoites are formed by nuclei migrating to the perimeter of 
the macroschizont and rhoptries appear in the schizont cytoplasm. The internal 
organelles then associate with the nucleus in the order found in the mature merozoite. 
Merozoites then bud out from the surface of the schizont and are liberated from the 
infected cell by breakdown of the host cell plasma membrane (Shaw & Tilney, 1992).
Merozoites then invade erythrocytes and undergo a further 2 rounds of division 
by schizogony to give the piroplasm stage (Conrad et al., 1985). It has been proposed 
that piroplasms may be able to form merozoites which re-invade erythrocytes, as 
happens in T. sergenti but this has not been confirmed in any experimental studies. 
Piroplasms and infected erythrocytes are taken up by feeding ticks to complete the 
bovine stages of the life cycle.
I.I.6.2. The Tick Vector Stages
Ingested erythrocytes containing piroplasms are lysed in the tick gut. A 
proportion of the piroplasms undergo a sexual cycle (Cowdry & Ham, 1932, Melhom 
& Schein, 1984). The free piroplasms differentiate into ray bodies and spherical forms 
which are the micro and macrogametes respectively. Syngamy of this pair forms a 
zygote. This and the succeeding kinete are believed to be the only diploid stages during 
the entire life cycle of the parasite. Morzaria et al. (1992) showed that recombinant 
parasites of mixed parental genotypes can be obtained from ticks fed on animals 
infected with two distinct parental stocks confirming sexual reproduction in T. parva. 
The motile kinete then passes through the haemolymph to the immature salivary gland 
cells where it transforms into a sporoblast undergoing multiple rounds of division. This 
stage remains dormant until the tick moults and resumes feeding (Schein et al, 1975). 
The sporoblast then enlarges dramatically to give a multinucleate syncytium and 
uninucleate sporozoites form by cytoplasmic fission (Fawcett, Buscher & Doxsey,
1982). The sporoblast is probably the stage where meiosis occurs. Measurements of 
the DNA contents of the stages found in the tick gut showed that the gamete stages 
had half the DNA content of the zygote. This implies that fusion of the gametes 
occured in the gut of the tick, however in T. parva, the zygotes underwent a two step
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meiotic division but a comparable division could not be detected in T. annulata (Gauer 
et al., 1995). Sporozoites, merozoites and gametes are haploid while the multi­
nucleated macroschizonts are polyploid. The sporozoites are released into the salivary 
gland and infection of the bovine host then occurs with the next blood meal (Purnell & 
Joyner, 1968, Reid & Bell, 1984).
1.1.7. Pathogenesis
The progress of the disease is charted by the destruction of lymphoid cells (as a 
result of parasite induced lymphoproliferation) and subsequent anaemia after the 
development of the piroplasm stages (reviewed in Irvin & Morrison, 1987).
In experimentally infected animals, the first manifestation of the disease is a 
swelling of the lymph nodes draining the site of sporozoite inoculation. As the 
parasitised cells proliferate and the macroschizont infected cell expand in number there 
is a marked fall in peripheral blood leucocytes (Preston et al, 1992). This coincides 
with a fever of ~42°C occuring about 10 days after infection. By this point there is 
extensive destruction of both infected and non-infected cells in the lymphoid tissue 
which is probably linked to the expression of host matrix metalloproteinases in infected 
cells (Baylis et al., 1992) which has been postulated to aid the dissemination of 
infected cells throughout the body (Adamson & Hall, 1996).
A second peak of fever after about 15 days can be correlated with the detection 
of piroplasms in blood smears. Fatalities occur ~20 days post infection from severe 
panleucopenia, anaemia and liver failure. Early autopsies showed several organs to be 
penetrated by lymphoblastoid cells - particularly liver, spleen, lungs, kidneys and gut 
(Sergent e ta l,  1945).
Total elimination of the parasite from surviving animals is rare, thus 
maintaining a reservoir of infection. Low levels of parasitised erythrocytes are 
detectable in recovered animals (Neitz, 1957) hence a reservoir of infection is 
maintained. PCR is now the most sensitive means of determining the presence of the 
parasite in carrier cattle (D’Olivera et al, 1995). Cattle used for these experiments
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carried the infection for 12 and 15 months and could be shown, by PCR, to be 
diagnosed specifically for T. annulata even at parasitaemias as low as 0.00005%.
1.1.8. Chemotherapy and Control Measures
The three control measures currently available for tropical theileriosis are:-
a) Acaricides for tick vector control.
b) Chemotherapy
c) Vaccination/Immunisation using attenuated cell lines
1.1.8.1. Tick Vector Control
Acaricides provide a means of controlling tick vector populations. Due to 
expense and logistical problems they tend only to be used in areas suffering from a 
heavy tick infestation. All cattle must be treated in a comprehensive acaricide dipping 
programme. The disadvantage here is that if the programme is interrupted then cattle 
are again exposed to ticks and hence the disease. Furthermore, because this means of 
control does not provide natural immunity, cattle can become susceptible to theileriosis 
at a lower level of parasite challenge. There are also risks of ticks developing 
resistance to acaricides over long periods of treatment together with possible health 
risks to personnel from exposure to the acaricides together with the residues found in 
meat and milk (Drummond, 1976).
The major advantage of acaricides is that simultaneous control of all tick borne 
diseases is achieved, hence different control measures for different diseases become 
unnecessary.
1.1.8.2. Chemotherapy
Drugs currently available for the control of theileriosis include oxytetracyclin 
(Terramycin, Pfizer), halofuginone (Terit, Hoechst), parvaquone (Clexon, Coopers
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Animal Health), buparvaquone (Butalex, Coopers Pitman Moore) and primaquin 
phosphate.
Oxytetracyclin, by inhibition of protein synthesis, suppresses macroschizont 
development if administered shortly after sporozoite innoculation. It preferentially 
affects parasite protein synthesis, probably through its effects on mitochondria. Host 
protein synthesis is only affected after long periods of treatment and at high doses 
(Spooner, 1990). It is ineffective against piroplasm or sporozoite stages and thus 
cannot be given therapeutically at the peak of parasitaemia and fever. It has been 
shown to be more effective against T. parva infections (Hashemi - Fesharki, 1992).
Halofuginone also targets macroschizonts but is more effective than 
oxytetracyclin at low dose rates. In an in vitro experiment, halofuginone was shown to 
reduce the numbers of schizont infected cells from 82% to 42% at a concentration of
0.025ppm (Schein, 1986). In vivo trials of the drug resulted in the complete elimination 
of schizonts four days post treatment (Schein & Voight, 1981).
Parvaquone and buparvaquone are both napthoquinone analogues of 
menoctone. They are potent against macroschizonts and are effective also against 
piroplasms. Parvaquone is more effective against T. parva infections (McHardy et al,
1983), whereas buparvaquone is equally effective against both T. annulata and T. 
parva. It is believed to act as a specific inhibitor of the parasite mitochondrial electron 
transport pathway (Fry et al, 1984). Large scale trials using buparvaquone and 
parvaquone have shown the efficacy of these drugs with cure rates ranging from 85 - 
100% from a single dose (McHardy, 1992).
However the expense of chemotherapy remains a stumbling block but treated 
animals are often resistant to further infection. The drugs must be administered early in 
the course of infection to be of use.
1.1.9. Immunisation
Two methods are currently used for immunising cattle against theileriosis:-
a) Infection and treatment
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b) Attenuated infected cell lines
1.L9.1. Infection and Treatment
Infection is initiated by innoculation with sporozoites and concurrent 
tetracycline therapy. This method is currently used against T. parva (Radley et al., 
1975, Young et al, 1992). For T. annulata the use of buparvaquone together with 
attenuated schizonts protects the cow against any likely tick exposure and provides 
appreciable immunity, probably by allowing an immune response against the schizonts 
to develop with the presence of the drug limiting any new infected cells developing 
(Grewal, 1992).
1.1.9.2 Attenuated Cell Lines
Cell line vaccines have been used successfully for a number of years to 
immunise cattle against theileriosis. The attenuated lines are derived from 
macroschizont infected cell lines, which through repeated passage have lost virulence 
(Pipano, 1981). By hybridisation with two polymorphic DNA probes Sutherland et al. 
(1996) showed that after 50-100 passages, in vitro selection of particular parasite 
genotypes occurs. This indicates clonal selection may contribute to loss of virulence. 
The same authors showed that continued passage of cloned cell lines derived from a 
virulent line led to the loss of reactivity with a monoclonal antibody which recognised 
the parental virulent line. This indicates that alteration of parasite gene expression 
takes place during attenuation, in addition to clonal selection.
Work by Baylis et al. (1992) showed that long-term cell culture caused a 
reduction in metalloproteinase activity when compared to newly infected cells. One of 
the attenuated cell lines (ODE) had reduced protease activity coupled with a decrease 
in the ability to produce merozoites. This may suggest that the proteases are also 
needed for merozoite production in addition to aiding the spread of infected cells. The 
reduction of these proteins and differences in gene expression may contribute to the
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decreased pathogenesis seen with the attenuated vaccine lines which allows a 
protective immune response to develop.
Schizont vaccines are cryopreserved prior to administration. The need for 
refrigeration poses problems in endemic areas. One vaccine dose contains about 106 
cells and is enough to give immunity to both natural and artificially heterologous 
infective challenges.
It has been much easier to immunise against T. annulata than T. parva using 
attenuated cell lines. This is probably because the transfer of macroschizonts from 
infected cell line to host cells is more efficient in 7! annulata (Spooner et a l, 1989). 
Large scale vaccination programmes have been undertaken in many developing 
countries with considerable success.
Total eradication of the disease probably will depend on a successful subunit 
vaccine directed against the sporozoite stage as there is a known humoral immune 
response against this stage of the parasite. However, more must be learnt about the 
roles of the humoral and cell mediated immunity to the parasite before such an 
approach would yield results.
1.1.10. The Immune Response to Theileria annulata
Knowledge of the basis of immunity to theileriosis would greatly aid a rational 
approach to a subunit vaccine design. Some progress has been made on this front with 
the expression of the major 30kDa surface antigen of the merozoite stage (D’Olivera et 
al, 1996) which could form part of a live subunit vaccine. The two arms of the 
immune system involved are the humoral and the cell mediated immune responses.
1.1.10.1 Humoral Immunity
Humoral immunity does not appear to play a primary role in immune 
protection. Antibodies directed against the sporozoite, macroschizont and piroplasm 
stages are produced but there is no evidence for immune sera reacting against the 
surfaces of infected host cells - either infected monocytes or erythrocytes (Hall,1988).
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Recognition of the infected cell by sera would be the first step of antibody mediated 
cellular lysis. Antibodies that neutralise the infectivity of sporozoites have been 
detected in the serum of hyperimmunised cattle. This sporozoite neutralising activity 
was mainly present in sera from immune animals after a primary challenge (Preston & 
Brown, 1988).
Work with sporozoites has led to certain antibodies being shown to be able to 
block invasion (Williamson et al, 1989). One antigen, SPAG-1 (sporozoite antigen 1), 
was identified by an inhibitory MAb. Western blots using this MAb recognise a series 
of polypeptides in sporozoite extracts which are thought to be the result of the 
proteolytic processing of a single gene product. The gene encoding SPAG-1 was 
found to contain regions with a high degree of homology to a bovine elastin repeat 
sequence (Hall et al, 1992). Thus, it was proposed that sporozoites may be using 
mimicry to bind to the bovine elastin receptors as a means of invading cells. However, 
this region has since been found to be highly polymorphic (Katzer et al, 1994) and in 
vitro sporozoite infection targeted elastin receptor positive and negative cell 
populations with an equal frequency, thus making the elastin receptor an unlikely 
binding ligand for the parasite (Campbell et al, 1994). This molecule, though, is a 
candidate for inclusion in a subunit vaccine and has been analysed to determine the 
neutralising B- cell epitopes which lie towards the C- terminus (Boulter et al, 1994)
1.1.10.2 Cell Mediated Immunity
The finding that immunity to T. parva could be transferred by innoculation of T 
cells from an immune calf into its naive twin (Emery, 1981) suggests that the 
mechanisms responsible for protective immunity are cell mediated. Work by McKeever 
et a l  (1994) showed that the adoptive transfer of immunity was due to the CD8(+) 
fraction of class IMHC restricted cytotoxic T lymphocytes that recognise schizont 
infected cells. In T. annulata, Preston et a l (1983) showed there were two peaks of 
cytotoxic cells generated after challenge. The first peak appeared two weeks into the 
infection and was BoLA restricted (bovine MHC Class 1 antigens). The second peak, 
four weeks after challenge was not genetically restricted and was likely to be Natural
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Killer (NK) cells. The second peak is associated with recovery from theileriosis since it 
is not detected in lethal infections. Attempts have been made to further characterise the 
BoLA restriction markers of the cytotoxic lymphocytes (reviewed in Morrison, 1996). 
More recent work (Oliver & Williams, 1996) has shown that BoLA class I antigens are 
modified on the cell surface of T. annulata transformed lymphoblastoid cells. This 
could explain the long term persistance of the parasite by modification of presented 
peptides thus providing a possible explanation for the avoidance of immune detection, 
since infection is controlled by the MHC class I restricted cytotoxic T cell killing of the 
infected cells.
Shiels et al. (1986) showed that one monoclonal antibody (4H5) recognised a 
polypeptide on the surface of schizont infected lymphocyte and that this antibody could 
mediate complement lysis of the infected cells (Preston et al., 1986). It is unclear as to 
whether this antigen is host or parasite derived, although recent work indicates it to be 
host derived (C.Dando, unpublished work).
Mechanisms of immunity to the merozoite and piroplasm stages are still largely 
unknown, although antibodies in immune serum strongly recognise antigens from these 
stages such as the 30kDa merozoite surface antigen and the 117kDa rhoptry protein 
antigen (Dickson & Shiels 1993). These antigens are of considerable interest since a 
response to the merozoites would effectively limit the pathogenicity of the disease and 
the response to piroplasms could block the transmission of the parasite. Work in 
Plasmodium using a monoclonal against free gametes reduces the infectivity of the 
parasite to the mosquito vector (Carter et al, 1990).
1.1.11. Activation of the host cell upon infection
Much work has focused on the ability of Theileria infections to induce 
lymphocytic proliferation in that infected monocytes can stimulate naive autologous T 
cells to proliferate. It has been shown that different T. annulata infected cell lines 
expressed different but constant levels of MHC class II but that there was no 
correlation between levels of MHC class II expression and levels of induced T cell 
proliferation (Brown et al., 1995). Infected cells were shown to produce specific
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mRNAs for IL-la, IL-1[3, IL-6, IL-10 and TNFa but not IL-2 or IL-4. One cloned 
line was found not to produce TNFa mRNA. The degree of proliferation of T cells 
stimulated by the infected cells paralled the amounts of IL -la and IL-6 mRNA which 
are T -cell stimulatory cytokines.
However with T. parva infected cells, the mRNAs produced differ from the 
above in that IL-2, IL-4 and IFNy mRNAs are produced together with IL -la  and IL- 
10. It is believed that IL -la  production by either T. parva or T. annulata infected cells 
acts as a major signal for the induction of non-specific T cell proliferation (Brown et 
al, 1995).
1.1.12. The Cell Cyde in Theileria annulata
There are several proliferative stages during the life cycle of Theileria that 
undoubtably account for the pathogenesis seen during the course of the disease. These 
stages must involve the parasite’s own cell cycle and in the bovine lymphocytes, it 
involves the host cell cycle also. The cell cycle has been extensively studied in higher 
eukaryotes and in yeasts but little is currently known about the cell cycle in protozoan 
parasites in terms of the degree of conservation of constituent molecules or the 
adaptions used to accommodate the complex parasite life cycles.
An introduction to the cell cycle follows and the aims of the project are given 
at the end of the cell cycle introduction.
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Figure 1.1 The life cycle of Theileria annulata.
Diagram adapted from Tait & Hall, 1990. Infection starts upon inoculation 
of sporozoites into the bovine host upon feeding by the tick. These 
sporozoites then invade and transform leukocytes. The parasite then 
develops into a macroschizont which breaks down into merozoites. 
Merozoites invade erythrocytes and develop into piroplasms. This completes 
the life cycle within the bovine host. There are two main stages within the 
tick - gametogony and sporogony.
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1.2.1 The Eukaryotic Cell Cycle
The cell cycle is a series of events that are necessary for a cell to replicate its 
DNA and then undergo mitosis. There are 4 stages to each cell cycle although 
processes such as meiosis or embryonic cell division may miss stages.
The 4 stages are S - replication of DNA 
G2 - gap prior to mitosis 
M - mitotic division
G1 - gap open to influence from external signals
Progress through the four stages is controlled by a family of serine/threonine 
kinases known as the cyclin dependent kinases (CDKs). The first isolated and best 
characterised CDK is p34cdc2 encoded by the cdc2 gene (Cell Division Cycle 2) named 
from a temperature sensitive mutant of the fission yeast Schizosaccharomyces pombe 
(Nurse & Bisset, 1981). Homologues of cdc2 have been cloned from the budding yeast 
Saccharomyces cerevisiae (CDC28) and higher eukaryotes by exploiting the high 
degree of conservation of this gene between species. For example the cloning of the 
human p34cdc2 homologue was achieved by complementation of the S. pombe 
temperature sensitive mutant (Lee & Nurse, 1987). p34cdc2 is also known as CDK1 in 
higher eukaryotes.
1.2.2. CDC2
The cdc2 gene of S. pombe encodes a 34kD serine/threonine kinase. Together 
with cyclin B, p34cdc2 induces the G2 to M transition in response to a signal monitoring 
the completion of DNA replication (reviewed by Forsberg & Nurse, 1991). Certain 
residues conserved in other protein kinases are crucial for p34cdc2 function (Booher & 
Beach, 1986). Threonine 167 (Thr 161 in higher eukaryotes) is phosphorylated for the 
kinase to gain activity. Mutations at this site render the enzyme inactive and it cannot 
bind cyclin partners stabily (reviewed in Krek & Nigg, 1992). The cyclins bind a 
conserved PSTAIRE motif inducing a conformational change that allows Thr 161/167
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to be phosphorylated. A final step of activation occurs by the dephosphorylation of a 
phosphorylated tyrosine residue Tyr 15 which is located in the ATP binding domain of 
the kinase. This reaction is mediated by CDC25 phosphatase. Arrest of DNA 
replication inhibits p34cdc2 by preventing this dephosphorylation step (Enoch &
Nurse,1991).
S. pombe has only one CDK - p34cdc2 responsible for controlling progess 
through the cell cycle. When p34cdc2 is complexed with cyclin B the cell is in G2 and 
enters M phase after the kinase is activated. When cyclin B is destroyed upon exit from 
M phase, the yeast cells are then in G1 and can enter S phase once past the ‘start’ 
checkpoint. A temporal order is established due to a balance between the cyclin 
binding partners of cdc2 and its state of activation (reviewed in Nurse, 1994). 
Homologues of p34cdc2 are present in all eukaryotes and some have been designated as 
functional homologues. Figure 1.2 shows the conserved domains of cdc2- related 
kinases compared with human cdc2 (Hscdc2). The Trypanosoma brucei TbCRK3 and 
Theileria annulata ThaCRK2 have not been shown conclusively to be the cdc2 
homologues in the protozoa but they are related to the CDK family based on the 
homology in the domains illustrated.
1.2.3 Cell Cycle Regulation in Aspergillus is by two Protein Kinases
In Aspergillus nidulans a second class of cell-cycle regulated protein kinases is 
required for progression into mitosis. These kinases are the NIMA kinases named from 
the mutant phenotype “never in mitosis” (reviewed in Osmani & Ye, 1996). Both 
cdc2/cyclin B and NIMA must be activated prior to mitosis in Aspergillus and both 
kinases must be proteolytically destroyed before completion of mitosis. There are a 
number of parallels between the NIMA and cdc2 kinases - their levels of the active 
kinase complexes fluctuate during the cell cycle, peaking in G2 and being inactivated 
upon mitotic exit. The regulation of these two kinases is very similar in order to 
achieve identical patterns of activity during the cell cycle - being regulated by cell cycle 
specific phosphorylation and being irreversibly inactivated during mitosis by 
proteolysis. With the NIMA kinase, the whole protein is destroyed unlike the p34cdc2
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kinase which is inactivated by the destruction of the cyclin B subunit. One mitosis 
specific role of NIMA could be to promote chromatin condensation whilst the cdc2 
complex induces spindle formation. A number of NIMA related kinases {nrk) have 
been isolated in higher eukaryotes but the only identified functional homologue is from 
Neurospora crassa, another filamentous ascomycete. Nrk genes have been isolated 
from T. brucei (Gale & Parsons, 1993). Further work is needed to identify binding 
partners of NIMA in order to fully understand how NIMA and cdc2 co-operate in 
regulating the cell cycle in Aspergillus.
1.2.4. Other Members of the CDK family
In higher eukaryotes and certain protozoans there is a family of cyclin 
dependent kinases. Evidence for these first came about from work done with 
temperature sensitive cdc2 mutant mouse cell lines. These cells were found only to 
arrest at the G2/M transition at the restrictive temperature. If the cells were 
immunodepleted of p34cdc2 they are unable to enter mitosis but showed no defect in 
DNA replication. The G1 cyclins were found to co-immunoprecipitate with a 34kDa 
protein which contained the PSTAIRE motif but differed from p34cdc2. Using PCR, a 
total of twelve cdc2-related cDNAs were isolated from human cells (Meyerson et al,
1992), two from Drosophila (Lehner & O’ Farrell, 1990), two from Xenopus (Paris et 
a l, 1991), three from T. brucei (Mottram & Smith, 1995) and two from Leishmania 
mexicana (Mottram et al, 1993 & Mottram, pers. comm.). The twelve cdc2 related 
genes are listed in Table 1.1 and three of these molecules were able to complement a 
CDC28 deficient yeast mutant (CDK1-3). To date no protozoan CRK has been shown 
to complement the CDC28 yeast mutant.
1.2.5. The Cyclin Family
These proteins serve as regulatory partners of the CDKs. Certain cyclins bind 
specific CDKs but others such as cyclin D can bind multiple CDKs (see table 1.1). The
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cyclins are expressed at specific points of the cell cycle as shown in figure 1.4. Human 
cells contain at least fourteen cyclins with eight partner CDKs isolated to date 
(reviewed in Pines, 1996). Although the main role of the cyclin/CDK complex is in the 
regulation of the cell cycle, some other roles have been defined outwith the cell cycle: 
these include response to phosphate starvation in yeast (Kaffman et al, 1994) and 
neurofilament phosphorylation in post-mitotic neurons (Lew et al, 1992). There is 
now evidence that the binding of an alternative cyclin partner can lead to the 
expression of a different function. For example, expression of a specific subclass of 
cyclin A (cyclin Al) is restricted to germ cells in mouse and is found associated with 
cdc2/CDK2 indicating a probable functional role in meiosis (Sweeney et al, 1996). 
Also the localisation of different cyclin subclasses suggests direction of different 
functions - cyclin B1 is localised to microtubules whereas cyclin B2 associates with the 
Golgi apparatus (Jackman et al, 1995). The mechanism of activation of the cyclin 
dependent kinase subunit upon cyclin binding to the PSTAIRE box has been solved by 
X-ray crystallography - cyclin binding induces a conformational change in the CDK 
catalytic subunit which brings the bound ATP into the appropriate position to allow 
catalysis of the phospho-transfer reaction to the substrate (Jeffrey et al, 1995).
The cyclins can be divided into two major classes - the mitotic cyclins and the 
G1 or START cyclins. Both classes share a common cyclin box - a region of -100 
amino acids involved in binding to the CDK partner. This is shown in Figure 1.3. The 
START cyclins include D and E and the mitotic cyclins are A and B1/B2. Cyclins A 
and B are specifically destroyed at mitosis through ubiquitination of a partially 
conserved ‘destruction box’ at the N-terminus. The START cyclins are inherently 
unstable and rapidly turned over due to the presence of a conserved PEST sequence in 
the C-terminal region of the proteins. However, yeast G1 cyclin destruction involves 
ubiquitin. So the sequential destruction of cyclins could be achieved by the specific 
induction of the ubiquitin turnover pathway at particular points of the cell cycle. More 
recent work has shed light on the nature of cyclin turnover (Jackson 1996). There is a 
family of proteins homologous to the yeast Cdc53 known as “cullins” which may be 
responsible for the targeting of cell cycle regulators, including cyclins, for destruction 
by ubiquitin-dependent proteolysis. Only the cyclin B/cdc2 complex has been defined 
as the primary mitotic complex responsible for the phosphorylation of components of
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cellular architecture that are changed during mitosis (reviewed in Pines, 1995). Many 
proteins which have been shown to be in vivo substrates for the p34cdc2 kinase contain 
the substrate consensus sequence of S/T P X K/R (Kamijo et al, 1992). These include 
many of the cytoskeletal proteins together with a number of protein kinases. Work 
with Xenopus egg extracts showed that the dynamics of spindle microtubules can be 
regulated by p34cdc2 kinase by phosphorylation of the microtubule associated protein 
p220 (Verde et al., 1990). Immunofluorescence has shown some of the cellular p34cdc2 
to be localised to the centrosome in Hela cells at the G2/M boundary which indicate a 
possible role for p34cdc2 in chromatin condensation and contraction of the spindle poles 
at mitosis (Bailly et al, 1989, Riabowol et al, 1989). The significance of histone HI 
phosphorylation by the p34cdc2 kinase may be induction of changes in nucleosome 
packing allowing chromatin condensation but this has not been proven in vivo. The 
finding of the p34cdc2 substrate consensus motif in many DNA binding proteins has led 
to suggestions that the phosphorylation of the motif would abolish the DNA binding 
abilities of these proteins allowing the chromatin condensation to proceed - members 
of this group include the HMG (high mobility group) of transcription factors (Meijer et 
al, 1991).
1.2.6. External controls and CKIs
In all eukaryotic cells, once a point in late G1 is passed, known as START in 
yeast, the cell cycle is closed to external influences such as mitogens which can control 
the commitment to S phase (Pardee, 1989). In higher eukaryotes, key regulators which 
link the cell cycle to external factors include the three D type cyclins which are 
produced only as long as growth factor persists and are rapidly degraded once the 
mitogenic stimulus stops (Matsushime et al, 1991). The regulatory pathways 
converging on Gl/S border are as shown in figure 1.5.
Key regulators of G1 progression in mammalian cells are the three D-type cyclins 
which assemble with CDK4 or CDK6 and cyclin E which combines with CDK2 later in 
G1 (reviewed in Sherr, 1993). The three D type cyclins are induced in a cell lineage 
specific manner as part of the delayed early response to mitogens. They persist
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throughout the cell cycle but are rapidly degraded if mitogenic signals cease. However, 
this will only regulate the cell cycle if the cells are in Gl.
Cyclin E is expressed periodically with maximal levels at the Gl/S border - 
associating in a complex with CDK2. Once cells enter S phase, cyclin E degrades and 
CDK2 associates with cyclin A. Like cdc2-cyclin B, both cyclin E - CDK2 and cyclin 
D - CDK4 complexes undergo phosphorylation on a single threonine residue to 
achieve activation. This phosphorylation is done by a CDK activating kinase (CAK) 
which may be composed of cyclin H and CDK7 (Fisher & Morgan, 1994), although 
this remains a matter of controversy as the cyclin H/CDK7 complex is also found 
associated with transcription factor TFHH and is believed to phosphorylate RNA 
polymerase II and hence regulate transcription (Serizawa et al, 1995).
The D type cyclins alone can bind retinoblastoma protein, pRb, which is 
believed to be an important point in the switch between proliferation and 
differentiation. Rb may act in cell cycle arrest by sequestering positive regulators of the 
cell cycle - transcription factors such as E2F. The cyclin D/CDK4 complex has been 
shown to phosphorylate members of the E2F transcription factor family (Fagan et al, 
1994) which are believed to regulate the cell cycle linked transcription of proteins 
required for S phase such as DNA polymerase a  and ribonucleotide reductase.
1.2.7. Cyclin dependent kinase inhibitors
The cyclin dependent kinase inhibitors (CKIs) are a further class of control 
molecules in the cell cycle. These proteins co- purify with the CDKs isolated from 
mammalian cells (Xiong et al, 1993). There are five distinct inhibitors which have 
been well studied so far and their inhibitory effects on different CDK/cyclin complexes 
is illustrated in figure 1.6.
The recent publication of the crystal structure of CDK2/cyclin A complexed 
with the p27 inhibitory subunit has done much to clarify the mode of action of CDK 
inhibitors (Russo et al, 1996). The amino terminal of p27 binds to cyclin A and the 
carboxy region binds to the kinase small lobe, acting both to disrupt the conformation 
and to block ATP binding within the active site.
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p21 is a universal CDK inhibitor in mammalian cells (Harper et a l, 1993). Its 
expression is directly regulated by p53 and is part of p53 induced G1 checkpoint 
control (reviewed in Sherr 1994). p53 is a tumour suppressor gene and levels of the 
p53 protein transiently increase in response to DNA damage (Kastan et al, 1992) 
acting as a transcription factor activating the transcription of genes involved in arrest 
of the cell cycle such as p21. p21 forms a ternary complex with PCNA (proliferating 
cell nuclear antigen), a subunit of DNA polymerase 6 and various CDK/cyclin 
combinations. The exact significance of the PCNA/CDK/cyclin complex is unclear 
although both p21 and p27 are implicated in linking mitogenic signals to the G1 phase 
of the cell cycle (Xiong et al., 1993, Kato et al, 1994). Recently it has been shown that 
specific removal of p27 by anti-sense DNA, prevented cell cycle arrest in response to 
mitogen depletion (Coats et al, 1996).
The other main CKIs range from 15- 20kD and are specific inhibitors of CDK4. 
These may be differentially expressed as a response to a variety of anti- proliferative 
signals.
1.2.8. p l3"“1
The sucl gene of Schizosaccharomyces pombe encodes a small protein p i3 
whose role in the cell cycle is still largely unknown. It was originally identified as a 
gene capable of rescuing certain temperature sensitive mutants of cdc2 in S. pombe 
(Hayles et al, 1986b), whereas deletion of sucl causes cells to arrest in mitosis 
(Moreno et al, 1989). Homologous genes have been identified in budding yeast and 
other eukaryotes including human (Richardson et al., 1990) and Leishmania (Mottram 
& Grant, 1996).
The ability of pl3 to bind strongly with p34cdc2 and p33cdk2 in vitro (Arison et 
al, 1988; Azzi et al., 1992; Brizuela et al., 1987; Draetta et al, 1987, Duncommun et 
al., 1991; Hadwiger et al., 1989; Hayles et al., 1986a; Meijer eta l, 1989) led to the 
development of a rapid affinity purification technique for p34cdo2/cyclin B complexes 
from cell extracts (Labbe et al., 1989; Pondaven et al, 1990). Although in vivo only a
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small porportion of the total cellular p34cdc2 is found complexed with pl3 (Brizuela et 
al, 1987).
Until quite recently the role of pl3 in the cell cycle was largely undefined and 
simply portrayed as an oscillating factor in the mathematical models put forward for 
p34cdc2 activation and turnover (Thron, 1992). Using fluorescently labelled p i 3 protein 
injected into stamen cells of Transcantia, Hepler et al, (1994) showed that the protein 
is rapidly targeted to the nucleus. When the nuclear envelope breaks down the labelled 
protein is dispersed throughout the cell with no evident specific association with 
spindle elements. After division, pl3 reconcentrates in daughter nuclei. In S. pombe 
pl3 regulates two distinct forms of the mitotic cdc2 kinase, each binding different B 
type cyclins (Basi & Draetta, 1995). They also showed that it is required for M phase 
progression. Simon et a l, (1995) have shown that transcript levels of Ckshsl (one 
human homologue of sucl) are down regulated in certain cells after exposure to 
transforming growth factor |3 (TGF-J3) which may suggest a role in growth arrest 
responses.
The structures of pl3 and its human homologue, p9 Ckshslt have been 
determined (reviewed in Endicott & Nurse, 1995). The p9 protein can oligomerise to a 
hexameric ring structure. It has been proposed that p9 can influence p34cdc2 localisation 
and activity by this oligomerisation process (Parge et al, 1993). However, p i3 cannot 
form a hexamer and exists either as a monomer or dimer. Recently the crystal structure 
of human sucl homologue {Ckshsl) complexed with CDK2 has been determined 
(Bourne et al, 1996) and combined with mutational analysis, it has been shown that 
Ckshsl only bound directly to the C-terminal large lobe of the kinase subunit. This 
effectively extends the area of the active site cleft. The binding does not affect the 
activity of the complex but possibly serves to target the CDK to regulatory molecules.
Recent work undertaken with the Xenopus sucl homologue, p9 (Patra & 
Dunphy, 1996) suggests that the consequences of depleting egg extracts of p9 depends 
on the stage of the cell cycle. In interphase extracts, depletion stops mitotic entry by 
the failure of Cdc2/cyclin B complex to activate by tyrosine dephosphorylation. 
Conversely, addition of recombinant p9 to extracts delays mitosis, again by inhibition 
of tyrosine dephosphorylation. Mitotic extracts depleted of p9 fail to exit mitosis 
because of a defect in cyclin B destruction. If these results are considered in the light of
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the crystallographic data, then p9 could act as a “docking factor” for Cdc2 regulators 
such as Cdc25.
1.2.9. Protozoan Cyclin Related Kinases
A number of cyclin related kinases (CRKs) have been isolated from protozoan 
parasites - notably Trypanosoma brucei (Mottram & Smith, 1995), Leishmania 
mexicana (Mottram et al, 1993), Plasmodium falciparum (Ross -MacDonald et al, 
1994), Theileria annulata and Theileria parva (Kinnaird et al, 1996).
In Trypanosoma brucei there is a family of cdc2 related protein kinases 
{Tbcrkl -3). Tbcrkl encodes a 34kDa protein which is 54% identical to human cdc2 at 
the amino acid level. The putative cyclin binding region contains a PCTAIRE motif 
instead of the PSTAIRE motif. Tbcrk2 encodes a 38kDa protein, with a 49% identity 
and a PSTAVRE motif. Tbcrk3 encodes a 35kDa protein with a 54% identity and a 
PQTALRE motif. In Leishmania mexicana, two cdc2- related kinase genes have been 
isolated, and additionally, an unidentified kinase has been identified which is capable of 
binding to p l3sucl but is distinct from either of the two CRKs already cloned. The 
presence of a family of cdc2 related kinases in Trypanosoma brucei and Leishmania 
mexicana suggest that these proteins may have roles in controlling aspects of the cell 
cycle linked to the differentiation of the parasite during its life cycle. In P. falciparum 
the PfPK5 gene is at present the closest cdc2 homologue isolated, with a sequence 
identity at the amino acid level of 60%. (Ross-MacDonald et a l, 1994). Work by 
Graser et al (1996a) showed that, while this kinase was capable of undergoing auto­
phosphorylation in vitro, in order to produce the fully active kinase, binding of another 
protein, probably a cyclin was also necessary. In the slime mould Dictyostelium 
discoideum genes encoding a polypeptide highly related to cdc2 and a less closely 
related CRK with a PCTAIRE motif have been isolated (Michaelis & Weeks 1992,
1993). A possible D. discoideum cyclin B homologue has also been isolated (Luo et 
al, 1995). Only the cdc2 like gene was able to complement a temperature sensitive 
CDC28 mutant of S. cerevisiae although growth of the transformants was slow and 
limited. Further work showed that the histone HI kinase activity of the cdc2 like
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protein varied during the development of D. discoideum and the activity correlates 
with the level of cyclin B protein. The level of cdc2 kinase activity was high in early 
development coincident with a period of mitosis but this activity was not associated 
with late development mitosis suggesting that another kinase may be involved. The 
mRNA levels of cdc2 and cyclin B are co-ordinately regulated during growth and early 
development and both mRNA species are reduced to undetectable levels during the 
terminal stages of differentiation (Luo et al, 1995).
To date no protozoan CRK has been able to complement the S. pombe cdc2 
temperature sensitive mutant that is the benchmark test for isolation of a functional 
cdc2 homologue. This may reflect the divergence between the yeasts and the protozoa 
or it may be that the functional cdc2 homologues have still to be isolated from these 
parasites. One means of isolating a functional cdc2 homologue would be to clone a 
parasite cDNA library in a yeast expression vector and select for complementation of a 
yeast cdc2 mutant phenotype (Mottram 1994).
In Theileria only one gene that is highly related to cdc2 has been isolated - 
ThaCRK2 (T. annulata) /ThpCRK2 (T. parva) (Kinnaird et al, 1996). The T. annulata 
gene was isolated from a cDNA expression library screen using an anti-PSTAIRE 
monoclonal antibody. Recently another related gene has been isolated by a degenerate 
PCR approach, using oligonucleotides to conserved kinase domains. This gene, 
ThaCRK3, is less related to p34cdc2 than to ThaCRK2 but has sufficient conservation of 
motifs to be classified as a member of the cdc2-related kinase family (Kinnaird et al, 
unpublished results).
There has been only one cyclin isolated from a protozoan parasite - CYC1 
from T. brucei (Affranchino et al, 1993). It has a low homology to cyclins from higher 
eukaryotes but antibodies raised to it can immunoprecipitate an active kinase complex 
from T. brucei cell extracts.
1.2.10. ThaCRK2 and ThpCRK2
Monoclonal antisera raised against the highly conserved PSTAIRE region 
recognised a polypeptide of 34kD in Western blots of piroplasm extracts while an
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antiserum specific for the C-terminus of mammalian cdc2 showed no reactivity in 
piroplasm extracts thus indicating that there is at least one protein in Theileria 
containing the PSTAIRE conserved motif but differing in the C-terminal region from 
the host cdc2 (Kinnaird et al, 1996).
In order to isolate the gene encoding this molecule, a T. annulata cDNA 
library, generated using RNA prepared from an in vitro infected lymphocyte culture 
undergoing merogony was screened with a monoclonal anti-PSTAIRE antibody. 
Independently, a related gene was cloned from T. parva by screening a genomic library 
with the P.falciparum PfPK5 gene as a probe. These experiments led to the 
characterisation of both the cDNA clone from T. annulata (ThaCRK2) and the 
genomic clone from T.parva (ThpCRK2) by sequence analysis.
ThaCRK2 and ThpCRK2 show a high degree of interspecies conservation - 
98% at the amino acid level and 91% at the nucleotide level. All amino acid 
substitutions are conservative and are located at the C-terminus which is the most 
variable region in cdc2 homologues from other eukaryotes. ThCRK2 has a 75% amino 
acid homology to the PfPK5 gene which suggests a functional conservation within the 
apicomplexan genes. There are five introns in the ThpCRK2 gene with the insertion 
points of four of these being identical to those in PfPK5, suggesting that the gene 
structure has been conserved since the evolutionary divergence of the parasites. It is 
possible that this single kinase is able to control karyokinesis and cytokinesis in 
Theileria by differential regulation of its activity.
The sequence of ThaCRK2 suggests it to be the functional equivalent of cdc2 
by virtue of the conservation of homology over certain blocks of sequence common to 
the cdc2 kinase group. However, there are two regions in ThaCRK2 which differ 
significantly from the higher eukaryotic cdc2 homologues - the first being a tripeptide 
motif LQD in S. pombe, changed to LPA in Theileria. The second is the GDSEID 
motif which appears as GISEQD in ThCRK2. This motif is the site of interaction of the 
CAK (cdc2-activating kinase) which phosphorylates a conserved T167 residue. Thus, 
whilst the PSTAIRE cyclin binding motif is conserved, regions implicated in the 
control of kinase activity are not, suggesting the evolutionary divergence of the 
structure of certain regulatory proteins (See Figure 1.2).. This probably explains the
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failure of the ThCRK2 gene to complement a yeast cdc2 mutant (Kinnaird et al,
1996).
1.2.11. Theileria induced lymphoproliferation
The lymphoproliferation induced by invasion by sporozoites has been well 
documented but is poorly understood. Various theories to explain the clonal expansion 
have been put forward. Dobbelaere et a l (1988) proposed that T, parva infected T 
cells stimulate an autocrine loop by which infected cells secrete Interleukin-2 (IL-2). It 
was later shown (Heussler et al, 1992) that nearly all T. parva infected cell lines 
express IL-2 mRNA and the 11-2 receptor (see section 1.1.11). The nature of the 
primary stimulus from the parasite or its level of interaction in the host cell are 
unknown.
Work with both T. annulata and T. parva showed that infected cells produce a 
range of cytokine mRNAs (section 1.1.11) the products of which probably act to 
induce the proliferation of non-specific T cells and possibly setting up autocrine loops 
stimulating the expansion of the infected cell population. Components of host signal 
transduction pathways have been cloned such as host casein kinase II (ole MoiYoi et 
al, 1993) and a host metalloproteinase MMP9 (Baylis et al, 1995). Levels of RNA 
and protein of both these molecules are specifically elevated in parasite infected cells. It 
is believed that the elevated levels of secreted host matrix metalloproteinases play a 
role in the pathology of the disease by allowing dissemination of infected cells 
throughout the body (Adamson & Hall, 1996). Baylis et a l  (1995) also showed that 
there is up-regulation of the transcription factor AP-1 which may be involved in 
regulation of MMP9 transcription in infected cells. This is additionally significant given 
that elevated levels of AP-1 are a response to mitogenic stimulation and there is 
evidence for a role for this transcription factor in the GO/S and Gl/S checkpoint 
controls (Muller et al, 1993). But elevated levels of these and other factors in infected 
cell lines may simply be a result of stimulated proliferation. Certainly these factors 
contribute to the transformed cell phenotype but it is extremely difficult to pick out a 
single likely candidate for the parasite produced molecule (s) which stimulates
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proliferation. Work by Carrington et a l (1996) using the toxin ricin, which specifically 
inhibits host cell protein synthesis, shows there to be exchange of polypeptides 
between the host and parasite within the infected cells.
Once intiated, host and parasite cell cycles appear to become synchronised in 
that host/parasite nuclear and cytoplasmic division must be linked to ensure even
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distribution of the parasite to daughter cells. This suggests that there must be some 
form of intracellular communication between host and parsite. In vivo, there seems to 
largely be a finite number of divisions before the development of the piroplasm stages 
after -14 days. It may be that in vivo most infected cells don’t achieve the balance of 
cell division seen with transformed cell lines grown in vitro. As the schizont enlarges 
during differentiation then the synchrony between host and parasite is lost as 
populations show a range of schizont sizes. The disruption of synchrony between the 
host cell division and the schizont nuclear division marks a switch in differentiation of 
the parasite to the merozoite stage (Shiels et al, 1992) but it is not known if nuclear 
division is synchronous within a macroschizont.
Thus differentiation and also the use of the inhibitor colchicine which inhibits 
host but not parasite microtubule formation (Carrington et al, 1995) demonstrates that 
schizont nuclear division can occur independently of host cell division. How this occurs 
is still a matter of speculation. In P. falciparum, it has been proposed that schizonts 
contain a ready pool of cyclins for activating all stages of the cell cycle and that the cell 
cycle is regulated independently in each nucleus (Leete & Rubin, 1996). A key factor 
in this is that each schizont nuclear membrane remains intact during division which 
would confine cyclin degradation to the nucleus and thus not deplete a cytoplasmic 
supply common to all nuclei. If the levels of cyclin remain high then the nuclei can 
continue with another round of division. Immunofluorescence could be used to confirm 
the existance of a cytoplasmic pool once suitable antibodies become available.
1.2.12 Project Aims
The fundamental mechanisms governing the cell cycle are likely to be similar in 
parasites to those elucidated in both higher and lower eukaryotes but there will
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probably be novel aspects to the cell cycle in Theileria. There are several questions 
linking the cell cycle to gaps in our knowledge of the life cycle of the parasite. For 
instance, how is the parasite cell cycle linked to the transformation of the host 
leucocyte? What regulates the observed synchrony given that the lengths of the cell 
cycle stages of host and parasite are likely to be different? What causes the host cell 
division to cease as the parasite switches from division to differentiation inside the 
lymphocyte?
Knowledge of the specific interactions underlying growth and division of 
Theileria will lead to a better understanding of the interaction between host and 
parasite and may eventually offer up new targets for specific therapeutic agents.
Specifically the project aims were;
1. Kinases are highly likely to be involved in different life cycle events such as control 
of control of stage regulation and entry into the cell cycle from the GO state (reviewed 
in Pines, 1996). As a means of characterising the kinases involved in different life cycle 
stages of T. annulata, yeast pl3sucl was used as a means of affinity purifying cdc2- 
related kinases from these stages. This approach would also lead to a means of 
establishing kinase activity and possibly, substrate specificity in the life cycle.
2. The interaction with the host cell cycle is important for the intralymphocytic stage of 
the parasite and this interaction changes as the parasite switches to differentiation.
With a range of markers against both host and parasite molecules involved in the cell 
cycle it was possible to examine the changes occuring in both host and parasite cell 
cycles during the intralymphocytic stage.
3. Isolation and characterisation of other parasite genes encoding proteins associated 
with nuclear division and their possible means of regulation. These proteins are also 
possible targets for chemotherapeutics and the feasibility of these were considered for 
71 annulata.
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Figure 1.2 Conserved domains of cdc2 related kinases.
This figure shows conserved domains of cdc2- related kinases 
compared with human cdc2 (Hscdc2). Dashes represent conserved residues 
and * indicates residues which undergo phosphorylation. Key - Tb - 
Trypanosoma brucei, Dd -Dictyostelium discoidium , Sp - 
Schizosaccharomyces pombe  and Th - Theileria. The ThCRK2 and 
TbCRK3 are discussed in section 1.2.9.
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Figure 1.3 M embers of the cyclin family
The mammalian cyclins A to H are shown together with the budding yeast 
Cln (G1 cyclins). The CDK7/Cyclin H complex is the CDK activating 
kinase CAK which phosphorylates a specific threonine residue (T161 in 
human cdc2, T160 in CDK2) which is phosphorylated in all active kinases. 
TFIIH contains the RNA polymerase II C-terminal domain kinase which has 
a role in transcription.
This diagram is adapted from Pines (1996).
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Cyclin Structure Size Function
A2 Destruction and Cyclin Box 48kDa G2/M, S
B1 Destruction and Cyclin Box 48kDa Mitosis
Cln Cyclin box and PEST 66kDa G1 (START)
D Cyclin box and PEST 32kDa G1(R)
E Cyclin box and PEST 44kDa G l/S
F Cyclin box and PEST 87kDa G2?
G Cyclin box 29kDa ?
H Cyclin box 37kDa CAK&TFlllH
C Cyclin box 33kDa Transcription?
Figure 1.4 Periodicity of cyclin expression.
As shown in figure 1.3, cyclins are active at certain stages o f the cell 
cycle. This figure shows the periodicity o f cyclin expression - cyclin E is 
specifically synthesised and destroyed around the G l/S  border. Cyclins A  
and B peak in G2 and M phase respectively. Cyclin D is synthesised in G1 
and levels remain high throughout the rest o f the cell cycle.
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Figure 1.5 External controls influencing G l/S  checkpoint.
This diagrams shows the interplay between various components o f the 
cell cycle during the G l/S  transition. The cycle is open to the influence o f  
external factors at this point and the signalling pathway between these 
factors and the CDK complexes is shown.
The CDK7/Cyclin H complex is the CDK activating kinase CAK which 
phosphorylates a specific threonine residue (T161 in human cdc2, T160 in 
CDK2) which is phosphorylated in all active kinases. p27 is a CDK inhibitor 
that acts upon the CDK4/cyclin D complex by preventing its 
phosphorylation by CAK (reviewed in Pines 1996).
TGF-P is transforming growth factor beta. 
cAMP - cyclic adenosine monophosphate
This diagram is adapted from Sherr (1994).
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Active ComplexGrowth
Factor
CyclinDl CyclinDl CyclinDl
regulatoiy subunit
■T-172 -PT-172
CDK4 CDK4
Catalytic
Subunit ActivatingPhosphorylation
CDK4
► ? 4 p27
^LP27
cAMP
TGF-(3 CyclinH Regulatory
Subunit CAK
Cdk7 Catalytic
Subunit
Figure 1.6 Cyclin kinase inhibitor subunits (CKI)
This figure shows cyclin dependent kinase inhibitor complexes, 
together with the stage o f the cell cycle when active. p21 is active at all 
stages and appears to be a ‘universal CDK inhibitor’.
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Major Cyclin - Cdk Cell Cycle Complexes 
Cell Cycle Stage cyclin-Cdk complex inhibitors
p l5  p l6  p l8  p21 p27
G1 cyclin D -Cdk4/Cdk6 + + + +
G l/S cyclin E - Cdk2 - +
S cyclin A  - Cdk2 - +
G2/M cyclin B - Cdc2 - +
Table 1.1 CDKs and their activating cyclins with other cdc2-related 
cDNAs.
This table is from Pines & Hunter, 1995. For each CDK it shows the 
conservation o f the PSTAIRE motif together with known cyclin partners. 
For some CDKs cyclin partners or stages of the cell cycle when active 
are unknown - this is indicated by N/D.
Key:
XI - Xenopus laevis
Dm - Drosophila melogaster
Hs - Homo sapiens
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Chapter Two
Materials & Methods
2.1 Cell Lines
BL20 is a bovine B cell lymphosarcoma cell line (Morzaria et ciL, 1982). A 
T.annulata (Ankara) macroschizont infected cell line (TaA2) was isolated from an 
infected animal’s peripheral blood mononuclear cells. A clone of this line, selected for 
its enhanced differentiation phenotype, is known as D7 (Shiels et al, 1992).
Cell lines were maintained by culturing at 37°C with 5% CO2 air in RPM I1640 
(Gibco-BRL) supplemented with 20% heat inactivated foetal calf serum (Gibco-BRL), 
Spgmf1 streptomycin, 8U ml'1 penicillin, O.bpgml*1 amphotericin B (ICNFlow), 0.05% 
NaHCOs and lOpM (3 mercaptoethanol (Brown, 1987). Cells were passaged by a five 
fold dilution every 48 hours.
2.2 Induction of in vitro differentiation
Differentiation of the D7 cell line was induced by shifting the culture 
temperature from 37°C to 41°C. The cell number was counted with a haemocytometer 
and adjusted to 1.5x10s cells ml'1 by dilution into fresh medium before induction and 
every 48 hours post induction.
2.3 Giemsa staining of induced cultures
Morphological examination of cultures at 41°C was carried out by light 
microscopy of Giemsa stained cytospin preparations. A 50f.il sample was spun at 1500 
rev min'1 (240g) for 5 minutes in a Shandon cytospin 2. The slides were then air dried 
and fixed in methanol for 30 minutes before staining in Gurr's improved R66 Giemsa 
stain (BDH) (4% solution in water).
2.4 p!3sucl Purification
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Two methods of purification were used:
1. p l3sucl was prepared from an overproducing strain of E. coli (a gift of P. Nurse) by 
gel filtration on a Sephadex G100 column (Pharmacia). Fractions were analysed on a 
15% SDS Page gel and the purest fractions pooled. These were concentrated by 
ammonium sulphate precipitation to 75% saturation and extensively dialysed against 
50mM Tris pH8.0.
Final purification was by ion exchange fast protein liquid chromatography 
(FPLC) on a Q-Sepharose column (Pharmacia). p is8™1 was eluted with a continuous 
salt gradient of 0-500mM NaCl. Purified p i3 was then coupled to an amino link gel 
(Pierce) according to the manufacturer’s instructions. Unreacted sites on the gel beads 
were blocked with 1M Tris pH8.0. The concentration of coupling was 4mg of p l3  to 
lml of gel.
2. The sucl gene was re-cloned into the pQE60 expression vector (Qiagen) which 
contains the sequence for a multiple Histidine tag at the 5' end of the cloning site thus 
allowing for an affinity purification of the expressed protein on nickel agarose (Ni- 
NTA, Qiagen). An overproducing strain of E. coli (a gift of Dr. K. Grant) was lysed by 
sonication and the supernatant was applied to an Ni-NTA column. The affinity bound 
protein was eluted in a 0-500mM imidazole gradient and fractions analysed on a 15% 
SDS-PAGE gel. The purest fractions were pooled and concentrated using a Centricon 
10 filtration unit (Amicon) and dialysed against 50mM NaPC>4 pH8.0, 300mM NaCl to 
remove imidazole. Purified pl3 was then coupled to an amino link gel (Pierce) 
according to the manufacturer’s instructions. Unreacted sites on the gel beads were 
blocked with 1M Tris pH8.0. The concentration of coupling was 5mg of pl3 to lml of 
gel.
2.5 Cell Lysis
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Native protein extracts of uninfected host lymphocytes (BL20) and Theileria 
cmnulata piroplasms were prepared by resuspending cell pellets stored at -70 °C (BL20 
cell pellets were obtained by centrifugation of 100ml cell cultures (1.5 x 105 cells/ml) 
at 3000rpm and removing the supernatant) in lysis buffer (50mM MOPS pH7.2, 
lOOmMNaCl, lOmMEDTA, ImMEGTA, 1 mM sodium orthovanadate, lOmMNaF, 
1% Triton X100) with protease inhibitors (ImM 1,10 phenanthroline, 5mM pepstatin 
A, lOmM leupeptin, lOmM phenylmethylsulfonyl fluoride) and incubating at 4°C for 
30 min prior to centrifuging at 12000x g for 30 min. The supernatants were used for 
kinase assays and Western blotting.
Macroschizonts were prepared from Theileria infected lymphocyte line D7 at 
day 5 of differentiation using the Bio-nebuliser (Hoeffer). Pelleted cells were re­
suspended in PBS at a concentration of lx l06ml'1 and passed through the nebuliser 
twice at a constant pressure of 20psi. The suspension was then centrifuged at lOOOg 
through a 20% Percoll gradient (Pharmacia). The visible fractions from the Percoll 
gradient were checked for host cell contamination using cytospin preparations which 
were Giesma stained and examined by light microscopy at xlOOO. The preparation was 
found to contain traces of host nuclei and some intact cells. Macroschizont (schizont) 
protein extracts were prepared as described above.
Extracts were assayed for protein concentration (BioRad) and volumes 
adjusted to give equal protein loadings for affinity preparations of protein kinases.
2.6 Affinity Chromatography
50f.il of pl3sucl and Tris- agarose coupled beads were added to a 2ml column 
(Pierce) and washed with 500|.il of lysis buffer. 500(.tg of each protein extract was 
added to the p 13 and Tris agarose beads and incubated at 4°C for 3 hours with mixing 
by rotation. The beads were then washed with 5x1 ml of lysis buffer (supplemented 
with 10% glycerol) and lx kinase assay buffer (KAB - see section 2.7) and re­
suspended in 20pl of SDS-PAGE sample buffer or KAB.
Each set of agarose beads was then split 75/25 by volume for Western blotting 
and kinase assays respectively.
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2.7 Histone HI Kinase Assays
The beads were washed in lx kinase assay buffer (50mM MOPS pH7.2, 20mM 
MgCbJOmM EGTA) and preincubated in 25pl of KAB at 30°C for 10 mins. 20pl of 
kinase assay mix (KAM - 5j.ig histone HI (Boehringer), 2.5pM ATP, 50nCi yATP 
(5000Ci/mmol) in KAB) was added and the mixture incubated at 30°C for 20 mins.
The reaction was stopped by the addition of20j.il of 4x SDS sample buffer. Samples 
were then boiled and centrifuged prior to loading 25j.il of supernatant onto a 12.5% 
SDS- PAGE gel. After electrophoresis gels were stained in Coomassie Brillant Blue R- 
250 and destained in 30% methanol, 10% acetic acid and dried in an 'Easi-Breeze' Gel 
Drier (Hoeffer). The dried gel was then exposed to X-ray film (Fuji) at -70°C.
2.8 Electrophoresis of Protein Gels
2.8.1 SDS-Polyacrylamide Gel Electrophoresis
Denaturing polyacrylamide gel electrophoresis of proteins was performed 
according to the method of Laemmli (1970). The ratio of acrylamide:bis-acrylamide 
was 29:1 and was purchased ready mixed from Anachem. Polymerisation was 
catalysed by addition of 0.05% ammonium persulphate and 0.03% TEMED. Resolving 
gels were either 12.5% or 8% acrylamide in 375mM Tris-HCl (pH8.8), 0.1% SDS. 
Stacking gels were 4% acrylamide in 125mM Tris-HCl (pH6.8), 0.1% SDS. Gels were 
run at a constant voltage of 100V for 2-3 hours (mini-gels) or at 55V (~ 15 hours) for 
large gels until the dye front reached the bottom of the resolving gel. The 
electrophoresis buffer was 25mM Tris, 192mM glycine (pH 8.3), 0.1% SDS.
2.8.2 Tricine SDS Gels
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In some circumstances it was more appropriate to use the Tricine SDS method 
of Schagger and von Jagow (1987). Here the gel buffer was 3M Tris-HCl (pH 8.45), 
0.3% SDS. The anode buffer was 0.2M Tris-HCl (pH 8.9). The cathode buffer was 
0.1M Tris, 0.1M Tricine, 0.1% SDS with the pH being adjusted to 8.25 by addition of 
Tricine. The running conditions are identical to those stated for the SDS-PAGE 
electrophoresis.
In both cases a glycerol/SDS sample buffer was added to the samples prior to 
loading on the gels. The sample buffer is composed of 50% glycerol, 5%SDS, 50mM 
Tris-HCl (pH 6.8) and 0.01% bromophenol blue. A minimum of 0.25 volume of the 
sample buffer was added to the samples prior to heating at 90°C for 5 minutes prior to 
loading. Low molecular weight markers (Sigma) were prepared as detailed in the 
manufacturer’s instructions.
2.9 Western Blotting
Protein gels were blotted onto Hybond C membranes (Amersham). The 
blotting protocol was essentially that described by Towbin et al. (1979). The gel was 
laid over 3MM paper then covered with Hybond C paper prior to more 3MM paper 
being overlaid. The cassette was then immersed in an electroblot holder (Bio-Rad) 
with the Hybond C paper facing the anode of the tank. The transfer buffer was 25mM 
Tris, 192mM Glycine and 20% methanol and the transfer took place at 4°C. For small 
gels, the Mini-Protean system (Bio-Rad) was electrophoresed at 0.28A for 3 hours and 
the large gel blotter (gels of 9cm by 14cm) overnight at 0.1 A. After transfer the 
Hybond membrane was stained in Ponceau S stain (0.2% Ponceau S (Sigma) in 3% 
trichloroacetic acid) to assess efficiency of transfer and equal loading of protein. The 
blots were pre-incubated in block buffer (5% low fat, dried milk, 10% horse serum in 
TBST (Tris buffered saline with Tween (lOOmM Tris-HCl pH7.5, 0.9% NaCl, 0.05% 
Tween 20)) for 1 hour at room temperature. Primary antibodies were diluted in 
blocking buffer to a working dilution and incubated with the blot for 3 hours at room 
temperature. The blots were rinsed twice then washed twice in TBS-Tween for 20
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with the secondary antibodies (Horse radish peroxidase conjugates (Sigma)) prior to 
signal development with the ECL system (Amersham).
2.10 Immunoprecipitation
Immunoprecipitation of the ThaCRK2 polypeptide from piroplasm extracts was 
as follows; piroplasm extracts were lysed as in section 2.5 and the supernatant 
incubated with 10f.il of affinity purified anti-ThaCRK2 antiserum (a gift of Dr. J. 
Kinnaird) at 4°C for 1 hour on a rocker. Then 40j.il of a 50% slurry of Protein A- 
sepharose (Pierce) was then added and incubated for a further hour at 4°C. The Protein 
A-antibody-antigen complex was then collected by centrifugation at 12000g for 20 
seconds in a microfuge and re-suspended in lOmM Tris HC1 (pH 7.5), 0.1% NP-40 for 
20 minutes at at 4°C. The centrifugation and wash steps were repeated twice and the 
final sepharose pellet re-suspended in 30|.il of SDS-PAGE sample buffer, boiled for 5 
minutes then centrifuged briefly prior to analysis on an SDS-PAGE gel.
2.11 Growth of bacterial strains
Unless otherwise stated, all liquid cultures were grown at 37°C with vigorous 
shaking. Appropriate antibiotic selections for E. coli strains transformed with plasmid 
were: E. coli strain XL-1 Blue (Stratagene) - lOOpg/ml ampicillin with 12.5ug/ml 
tetracycline.
2.12 Isolation of Plasmid DNA from E.coli
Small scale plasmid DNA purifications were performed using the Wizard Mini 
Prep kit (Promega) in accordance with the manufacturers protocol. For large scale 
preparations a Midi Prep kit (Qiagen) was used. For both these protocols, a stationary
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phase culture was harvested by centrifugation at 12000g for lOminutes at 4°C. The 
pellets were then treated according to the kit instructions.
2.13 Lambda Phage Manipulations
The host bacteria PLK-17 (Stratagene) were first grown overnight in L-broth 
supplemented with 0.2% maltose and 20mM MgS04. The cells were then pelleted by 
centrifugation (5000g for 5 minutes at 4°C) and resuspended in 0.5 volume of sterile 
cold lOmM MgS04. The suspension was diluted if the Absorbance reading at 600nm 
was greater than 2 (i.e. >1.6 x 109 cells/ml). These plating bacteria were stored at 4°C 
and were viable for up to 3 weeks.
For determining the titre of the X library used for screening, serial 10-fold 
dilutions of the phage stock were prepared in phage buffer (50mM Tris-HCL (pH7.5),
0.1M NaCl, 8mM MgS04, 0.01% gelatin). 100pi aliquots of each dilution were added 
to lOOpl of plating bacteria and the samples were incubated at 37°C for 20 minutes. 
3mls of top agarose (heated to 45 °C) was then added and the mixture poured onto 
bottom agar plates. After cooling the plates were inverted and incubated overnight at 
37 °C. The plaques were counted and the titre determined from appropriate dilutions.
2.14 Library Screening
A A,ZAP cDNA library made from D7 total RNA was prepared by Dr. Kinnaird 
and plated at a density of 20000 plaques per large petri dish (12cm diameter) as 
described in section 2.13. Filter lifts of plaques were taken by allowing the filters to 
rest on the plaques for 1 minute. Alignment marks were made through the filter paper 
and the agarose using a needle. The filters were then removed with the plaque side up 
onto a pad of 3MM paper soaked in denaturation solution (1.5M NaCl, 0.5M NaOH) 
for 5 minutes. Next the filters were transferred to another pad soaked in neutralising 
solution (1.5M NaCl, 0.5M Tris-HCl (pH7.2)) for 5 minutes. This step was repeated 
with another pad soaked in the same solution. Finally the filters were washed in 2x
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SSC (standard saline citrate, lxSSC is 0.15M NaCl, 0.15M trisodium citrate, pH 7.0), 
transferred to dry 3MM paper and allowed to dry in air, colony side up. The filters 
were fixed using a UV transilluminator (Stratagene). The filters were hybridised to a 
radiolabelled DNA probe. Positive plaques hybridising to radiolabelled probes were 
cored from the plate using a sterile toothpick into SM buffer containing a drop of 
chloroform. Phage was allowed to diffuse out for 2-3 hours prior to replating a 10'2 
and 10*4 dilution for a further round of screening. The process of filter lifts and 
hybridisations was repeated until all the plaques on a filter gave a positive signal with 
the radiolabelled probe. A single plaque was picked and the phage subjected to the in 
vivo excision protocol (Stratagene). This allows excision and re-circularisation of a 
pBluescript phagemid containing the insert by use of a ‘helper phage’ which initiates 
and terminates DNA replication from helper phage sequences inserted in the 
bacteriophage X. Positive clones can then be identified as colonies on a plate 
containing ampicillin.
For large scale preparations of lambda phage DNA, the liquid lysate method 
was used (Sambrook et al., 1989) with an equal multiplicity of infection for phage: 
bacteria and the DNA was isolated and purified using the Promega Magic Lambda 
Prep kit (Promega Corporation) according to the manufacturer’s protocol.
2.15 Restriction Digests of DNA
Restriction endonuclease digests of plasmid DNA were done according to the 
procedures recommended by the manufacturer using the buffers supplied and the 
optimal temperature for activity of the enzyme. The reaction was terminated by heat 
inactivation of the enzymes at 70°C for 15 minutes or by the addition of agarose 
loading dye (0.025% bromophenol blue, 25% Ficoll, 50mM EDTA).
2.16 Agarose Gel Electrophoresis
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DNA was visualised on horizontal agarose gels. Usually 1% gels were cast 
with lOOngml'1 ethidium bromide and run in 1XTBE (0.09M Tris-HCl, 0.09M Boric 
acid, 2.5mM Na2EDTA pH8.0) at a voltage of lOVcm'1 for 2 hours. Visualisation of 
DNA was on a UV transilluminator (302nm) and images were captured on a Gel- 
Imager system (Appligene) and stored on disk.
2.17 Recovery of DNA from Agarose Gels
DNA fragments were excised from agarose gels using a clean scapel blade and 
processed using the Qiaquick spin Kit (Qiagen). The fragment was eluted from the 
DNA binding column in 50j.il TE (lOmM Tris-HCl, ImM EDTA, pH8.0) and stored at 
-20°C.
2.18 Quantification of Nucleic Acid
Concentration and purity of nucleic acid was determined on a 
spectrophotometer (Beckman) by measuring absorbance through a pathlength of 1cm 
@ 260nm and 280nm. An absorbance of 1 at 260nm is equivalent to a solution 
concentration of SOpgml'1 of double stranded DNA. The ratio of A260/A280 indicates 
purity of the DNA preparation with a ratio of 1.8 being optimal.
2.19 Ligations
Ligations were performed in a final volume of less than 15 pi in lx T4 DNA 
ligase buffer (Promega) and 1-2 units of T4 DNA ligase (Promega). Generally, 25ng of 
vector DNA were used in each ligation, the amount of insert DNA used varied with 
the molar concentration of free ends in the reaction. Ligations were performed 
overnight at 16°C.
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2.20 Transformations
Routinely, transformations were performed using 50f.il of E.coli XL-1 blue 
supercompetent cells (Stratagene) and 25-100ng of ligated DNA according to the 
manufacturer’s protocol. The transformed cells were selected using the antibiotic 
resistance marker carried by the plasmid (Amp1). Where applicable, blue / white colony 
selection was also used to select transformants with plasmids containing inserts and for 
this, the agar media was also supplemented with 0.004% X-gal and 34|iM IPTG (final 
concentrations).
Vectors used included pBluescript (Stratagene), pTZ19R and pGEX5-2 (both 
Pharmacia) and pTAG vector (R&D systems).
2.21 Southern Blotting
Capillary transfer of DNA from agarose gel to membrane (Amersham Hybond 
N) was as described in Sambrook et al. (1989). Agarose gels were washed twice in 
denaturing solution (0.5MNaOH, 1.5M NaCl) for 15 minutes per wash then twice 
again in neutralising solution (0.5M Tris-HCl pH 7.5, 3M NaCl). The gel was then 
placed on a platform of 3MM paper which had its ends immersed in 20xSSC. Hybond 
N membrane, cut to the same size as the gel was then laid on top and this was then 
covered with 3MM paper soaked in 2xSSC then paper towels and a weight. The 
transfer was allowed to proceed overnight. Blots were dried in air for an hour before 
cross-linking using a UV transilluminator.
2.22 Northern Blotting
RNA was electrophoresed through denaturing formaldehyde 1% agarose gels 
as described in Sambrook et al (1989). lOpg of total RNA was loaded per track. RNA 
standards (Gibco BRL) and an identical set of RNA samples were cut off and stained
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in eithidium bromide after electrophoresis. The remainder of the gel was soaked for 15 
minutes in transfer buffer (15mM NaH2PC>4 , lOmM Na2HPC>4 pH 6.5) then transferred 
onto a Hybond N membrane overnight as described for Southern blotting except that 
the filter was not rinsed prior to cross-linking on a UV transilluminator.
2.23 Probe Labelling and Hybridisation
DNA probes were labelled by the random priming method (Feinberg & 
Vogelstein, 1983) using the Prime It II kit (Stratagene). Unincorporated radioactivity 
was removed by purifying the probes on the NucTrap column (Stratagene) according 
to the manufacturer’s instructions. Blots were pre-hybridised in 0.5M sodium 
phosphate buffer pH 7.0, 0.5 % SDS (Church & Gilbert, 1984) at 65°C for 30 minutes 
using a rotating bottle in a hybridisation oven (Hybaid). This solution was replaced 
with a fresh solution containing the denatured labelled probe and hybridisation was 
allowed to proceed overnight at 65°C. The blots were then washed twice in 40mM 
sodium phosphate pH7.0.5% SDS for 10 minutes at 65°C then twice in 40mM sodium 
phosphate pH7.0.5% SDS for 10 minutes at 65°C before being wrapped in Saranwrap 
and exposed to X-ray film (Fuji). For re-probing the blots were placed in boiling 0.1% 
SDS solution allowed to cool in this solution to room temperature. Filters were 
exposed to X-ray film overnight to check that the probe had been properly removed.
2.24 DNA Sequencing
Sequencing was performed on both strands. Sequencing methods included the 
chain termination method of Sanger (Sanger et al, 1977) with Sequenase kits
(USB/Amersham) and (a-^^S) dATP (Dupont UK Ltd.) on a 6% gel run in a BaseAce 
apparatus (Stratagene); automated sequencing used the LiCor sequencer (LiCor 
Corp.) with samples prepared using the Fluoro Sequenase kit (CamBio) which uses 
fluorescently end-labelled primers; alternatively an ABI373 sequencer was used with 
samples prepared with the ABI Sequenase 2.0 kit on a Geneamp 2000 PCR machine
47
(Perkin-Elmer). Both the automated sequencer protocols use a PCR amplification step 
of the template DNA. The ABI method incorporates fluorescently labelled dNTPs in 
the PCR reaction which are then read by the computer as the DNA migrates in the gel. 
Commerical primers used included T3, T7 and Sp6 (Stratagene) with the pTAG 5’ and 
pTAG 3 ’ primers (R& D systems). In some cases specially designed oligonucleotide 
primers were used (Cruachem & Strathclyde University). Analysis of sequence data 
used the University of Wisconsin GCG package (Devereux et al., 1984).
Gene Specific Primers for the T. annulata R1 subunit
Primers used for DNA Sequencing of the large subunit of ribonucleotide reductase 
from T. annulata are listed below. The position of the primer on the full length cDNA  
sequence (chapter 4) is shown.
1 3 ’ GCTCCACG AG 
TGACACAGAG5 ’
anti 322-341
2 5’CTAGCAGCCA
ACATCACCATA
G3’
sense 444-464
3 3 ’ CGAGGTGATC 
GAGGGACCTGT
5 ’
anti 500-520
4 3 ’CCCTGGCGGG 
AATCTTTAAC5 ’
anti 892-912
5 5 ’ GGG AATCTTT 
AACACACACTG 
AGC3’
sense 899-921
6 3’GCCAATCCTA 
C AGTCCC A AA5 ’
anti 1386-1406
7 5 ’ AGACCGATGG sense 1711-1737
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GTGTAGGAGTA
CAAGGT3’
8 3 ’ GCTGTGGG AC 
TGGGATAAACT 
TAAGGCAGA5’
anti 1949-1979
9 5 ’ ATTACAGAAG 
GGTGTTGAGTG 
G3’
sense 2092-2114
10 5 ’ CTTC AATATC 
AC AGGCTGGC3 ’
sense 2477-2496
11 3’GCTTCATGTG
CTCATCGT5’
anti 2698-2716
2.25 Production of Antisera
Antibody against fusion proteins was produced in New Zealand white rabbits 
kept at Biological Services, Veterinary School, University of Glasgow. Standard 
immunisation protocols were followed (Harlow & Lane, 1988). Briefly, the GST- 
fusion protein in PBS at a concentration of 1 mg/ml was mixed with an equal volume of 
a suspension of Alum (Pierce) added drop-wise with stirring for 30 minutes. Two 
rabbits were immunised with 500pg protein each and boosted after four weeks with 
250pg protein, again in Alum. Test bleeds were assayed by Western blotting and 
boosting continued every three weeks until a satisfactory immune response was 
detected.
Commercial antisera used included:
The mammalian and avian specific anti HSP 60 antibody (Boehringer) is a monoclonal 
antibody recognising an epitope between amino acid residues 383-447 of the human 
HSP-60. It is reactive with both the constitutive and inducible forms of HSP-60 
(manufacturer’s data sheet).
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The higher eukaryote specific anti-ribonucleotide reductase large subunit antibody 
(Biomedtek, Umea) is a mouse monoclonal antibody recognising an unmapped epitope 
from partially purified calf thymus R1 (manufacturer’s data sheet).
Other antisera used are described in the results section.
2.26 Polymerase Chain Reaction
A: Rapid screening of bacterial transformants for plasmids with inserts
For colony screening of transformants plasmid DNA was used as template with 
T3 and T7 primers or other primers specific for the plasmid used in the ligation 
reaction. The reagents used as listed below:
Reagents Final Concentration
Taq Polymerase 10X buffer (Promega) IX
Taq DNA polymerase 1 unit/25 pi
Acetyl ated BSA lOOpg/ml
Magnesium Chloride 1.5mM
dNTP’s (Promega) 200pM
Primers 4ng/pl
25pi of the reaction mixture was added to 0.5ml Eppendorf tubes and a sterile 
toothpick used to touch the colony on the transformation plates. The pick was then 
dipped into the reaction mixture before the mixture was overlaid with a drop of 
mineral oil and amplified over 25 cycles of 94°C for 30 seconds, 55°C for 30 seconds 
and 72°C for 2 minutes.
B: PCR amplification of the sucl homologue from T. annulata
DNA was amplified from piroplasm genomic DNA and cDNA and
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the following conditions were used. These were based on those used to amplify the 
human pl3 homologue CksHsl (Richardson et al., 1990) and modified by Mottram & 
Grant (1996) to clone the homologue from L. mexicana.
For both these protocols, degenerate oligonucleotides were designed against 
conserved regions of pl35UCl as shown in figure 3.1.
For attempts to amplify the Theileria homologue two different reaction buffers were 
tried, both using the same primers as used for the cloning of the L. mexicana 
homologue. The primers are:
5’primer - AGAGCTCGAGTAYMGNCAYGTNATGYTNCC 
3’primer - GAGGAATTCAANARNARDATRTGNGGYTCNGG 
(N=G+A+T+C, Y=T+C, M=A+C, R=A+G and D=G+T+A , Xhol and EcoRl 
restriction sites are underlined). The 5’ primer was 1000 fold degenerate and the 3’ 
primer was 12000 fold degenerate for the cloning of the L. mexicana homologue.
The buffers were:
1. 11.IX buffer - 45mM Tris HC1 (pH 8.8), llm M  ammonium sulphate, 4.5mM 
MgCl2, 6.7mM |3 mercaptoethanol, 4.4pM EDTA (pH 8.0), ImM each of dATP, 
dCTP, dGTP and dTTP, 1 unit of Taq polymerase and 113pg/ml BSA.
2. The standard reaction buffer of Richardson et a l (1990) and Mottram & Grant 
(1996) of 50mM KC1, lOmM Tris-HCl (pH 8.3), 1.5mM MgCl2, 0.01% gelatin, 
0.2mM each of dATP, dCTP, dGTP and dTTP, 0.0025 units of Taq DNA polymerase, 
lOpg of primers and 5pg of template cDNA were used and the PCR parameters were 
40 cycles of 94°C for 1 minute, 45 °C for 2 minutes and 72 °C for 3 minutes. The 
results of the PCR amplification are discussed in chapter 3 together with the various 
parameters tried.
2.27 5* Rapid Amplification of cDNA Ends (5* RACE)
5’ RACE was performed using the GibcoBRL 5’ RACE kit (GibcoBRL) 
according to the manufacturer’s protocol with lpg of total piroplasm RNA as
51
template. In brief, first strand cDNA was prepared from the total RNA using a gene 
specific primer for the large subunit of ribonucleotide reductase (TaRl). The resulting 
cDNA was dC-tailed using terminal deoxynucleotide transferase and the product, 
subsequently amplified by nested PCR. The nested PCR used another primer specific 
to for the TaRl gene together with the Anchor Primer supplied with the kit, which 
annealed to the dC-tailed region of the cDNA. These primers are listed below. The 
PCR product was cloned into the pTAG vector using the A overhangs generated by 
the reaction.
Primers
5PRIME RACE 1 - 5s AGCGATAACTTCCTGATGCG 3’ (antisense to position 289 
- 308 of the TaRl cDNA sequence.)
5PRIME RACE 2 - 5’ AAATCGTGGTCCTCATAGCC 3’ (antisense to position 127 
-146 of the TaRl cDNA sequence.)
The protocol used was identical to that supplied by the manufacturer.
2.28 Indirect Immunofluorescence Microscopy
BL20 and D7 cells were cytospun onto poly-L-lysine coated slides and fixed in 
4% formaldehyde in PBS for 10 minutes at room temperature before being 
permeabilised in 0.25% Triton X100 in PBS for a further 10 minutes. The cells were 
then preblocked in RPMI1640 medium for 30 minutes in a humidified chamber at 
room temperature. The primary antibody at a dilution of 1/200 in RPMI 1640 was 
applied to the cytospin preparation and incubated for 3 hours, again in a humidified 
chamber. The slides were then washed with several changes in 0.1% NP-40 in PBS 
over 5 minutes. The FTTC conjugated secondary antibody (Sigma) was diluted 1/500 
in RPMI 1640 and incubated with the cells for a further hour. The slides were then 
washed again in 0.1% NP-40 before being mounted in DABCO (1,4- 
diazabicyclo[2.2.2.]octane (Sigma)) in 50% glycerol and viewed with a Zeiss Axioplan 
fluorescent microscope with an MC100 Spot camera attachment. Nuclei were localised
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by staining with ljagml'1 DAPI (4,6-diamino-2-phenylindole dihydrochloride), lmgrnl'1 
p-phenylene-diamine in D ABCO/glycerol mountant.
An alternative method of fixation was tested using acetone at -20°C for 5 
minutes followed by air-drying of the slides before incubating with the antibodies.
2.29 5-Bromo-2-deoxyuridine (BrdU) Incorporation
Cells were pelleted by brief centrifugation (at 300g for 5 minutes) and re­
suspended in medium containing BrdU (Boehringer, final concentration of lOpM) at 
2xl06/ml for 60 minutes at 37°C. The cells were then again pelleted, washed three 
times in PBS then re-suspended in PBS with 5% albumin, cytospun onto poly-L-lysine 
slides and air-dried. The slides were fixed in 70% ethanol/50mM glycine pH2.0 at - 
20°C for 20 minutes. Slides were then washed three times in PBS before being 
incubated with a 1:10 dilution of the anti-BrdU antibody solution (Boehringer) for 30 
minutes at 37°C (containing nuclease). Slides were washed again before incubating 
with anti-mouse IgG FITC conjugate for 30 minutes at 37°C. The slides were washed 
in PBS before mounting in DABCO/glycerol/DAPI to visualise nuclei using a Zeiss 
Axioplan fluorescent microscope with an MCI00 spot camera attachment.
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3.1.1 Introduction
As described in section 1.2.8 of the introduction, pl3™r/ encodes a small protein 
whose exact role in the cell cycle has remained largely undefined. Very recent work with 
the Xenopus pl3 homologue suggests it acts to regulate both the activity of cdc2/cyclin 
B at the G2/M boundary and inactivation of this complex at the metaphase/anaphase 
transition via degradation of cyclin B (Patra & Dunphy, 1996). The X-ray structure of a 
human p 13 homologue complexed with CDK2 has also recently been defined (Bourne et 
al., 1996) and this analysis led to the theory that p 13 and its homologues may serve to 
direct CDKs to substrates or CDK regulatory proteins. Homologues have been identified 
from a variety of organisms (see Figure 3.1). The product of the S. pombe sucl gene is 
commonly referred to as p 13 or p Id™01 while the gene encoding this protein is referred to 
as sucl.
The ability of pl3 to bind strongly with p34cdc2 and p33CDK2 (Arison et al., 1988; 
AixAetal., 1992; Brizuela etal., 1987; Draetta et al, 1987; Ducommun et al, 1991; 
Hadwiger et al, 1989; Hayles et al., 1986; Meijer etal,  1989) allows rapid affinity 
purification of the p34cde2/cyclin B complex from cell extracts (Labbe et al., 1989; 
Pondaven et al, 1990). CDK3 was shown to bind p \3sucl only weakly (Meyerson et al., 
1992).
Another protein, p 15, has been isolated from starfish (Azzi et al., 1994) and this 
was shown to be capable of binding CDK4 and CDK5 but incapable of binding p34cdc2 
and CDK2. This p 15 protein shows common properties with p 13, particularly by being 
cross-reactive with anti-pl3™c/ and anti-p9CKShs antibodies and its ability to form stable 
complexes with CDK kinases which hint at it being another member of a possibly large 
family of p 13 related proteins.
One cdc2-related kinase has been identified in Theileria, ThaCRK2 (Kinnaird et 
al., 1996). Given that no other cdc2 like kinases had been isolated as part of that work 
via library screening and PCR, it is possible that Theileria only uses a single cdc2-like 
kinase for the control of its cell cycle, a situation analogous to that found in S. 
cerevisiae. However, more recently another cdc2-related kinase has been isolated from 
Theileria (ThaCRK3) but this is not highly related to p34cdc2 (Kinnaird, Logan & 
Langsley, in preparation).
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The aim of the work reported in this chapter was to more fully characterise the 
cdc2-related protein kinases of Theileria annulata, by utilising recombinant pl3s“c7 as a 
means of affinity purifying and assaying kinases from different life cycle stages. While the 
genes encoding two CRKs have been characterised from the parasite, nothing is known 
about their enzyme activities, substrate specificies and interaction with other molecules. 
In the bovine life cycle stages of the parasite, each stage involves nuclear division. 
Initially the uninucleate trophozoite replicates its nuclei three to four fold to produce the 
multinucleate macroschizont which then continues to replicate in concert with the host 
cell but maintaining the nuclear number at -10-15 parasite nuclei per cell. When 
differentiation to the merozoite is induced, a phase of rapid parasite division starts, 
leading to a schizont with over 500 nuclei which occupies much of the host cell. 
Merozoites are produced from this multinucleate schizont by budding of the membrane 
leading to uninucleate merozoites which then invade the erythrocytes and undergo a 
further two rounds of nuclear division to yield the piroplasm. It is not known how these 
complex series of nuclear divisions are regulated and whether different stages of the 
parasite life cycle regulate mitosis via different cell cycle associated kinases.
In order to address this question, an affinity purification based approach was 
undertaken to define the number and substrate specificity of cell cycle associated kinases 
present in the piroplasm stage using recombinant pl3-sepharose chromatography and 
biochemical characterisation. As the affinity for pl3 was low, experiments were 
undertaken to isolate the Theileria homologue of the sucl gene, the product of which 
would show a higher affinity for Theileria CRKs.
3.1.2 Expression and purification of pl3sucl
The yeast sucl gene was a gift of Prof. P. Nurse. The full length sucl gene was 
cloned into the pQE60 vector (Qiagen) and the plasmid used to transform M15[pREP4] 
E. coli (Qiagen) by Dr. K. Grant. Transformed cells were then induced to express p i3 
protein by induction with IPTG as detailed in chapter 2. The main method of purification 
of recombinant pl3SMC/ was by use of a Nickel-nitrilo-triacetic acid (Ni-NTA) agarose
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column (Qiagen) via fast performance liquid chromatography (FPLC) with bound protein 
being eluted by an imidazole gradient.
Figure 3.2 shows stages of the induction and purification of pl3. Panel A shows 
the cell supernatants after sonication and centrifugation. The supernatant (Lane 2) was 
then applied to the Ni-NTA column and fractions containing the purified p 13 were eluted 
over the range of200-300mM imidazole as shown in Panel B. The purified fractions 
were then pooled and dialysed (Panel C) prior to concentrating and cross-linking to 
Amino-link beads (Pierce) at a concentration of 5mg/ml. Control heads were prepared in 
an identical fashion by linking a 1M Tris pH7.4 solution in place of pl3 according to the 
manufacturer’s protocol.
3.1.3 Bovine CDK specifically binds to pl3
Firstly it was necessary to show, as a positive control, that the p 13 sepharose 
beads were capable of affinity purifying an active kinase complex from uninfected bovine 
cells (BL20). This was also carried out to standardise conditions of binding and washing 
which were then used in assays performed with parasite material. As mentioned in 
section 3.1 previous work had shown that in higher eukaryotes p34cdc2 and p34cdk2 were 
specifically bound to p ll>sucl and that the resulting complex was an active kinase.
Native extracts of BL20 cells were prepared and used in pl3 binding assays 
followed by detection of the eluted polypeptides by Western blotting (figure 3.3). When 
specifically bound proteins were eluted from the pl3-sepharose following extensive 
washing, there was a significant concentration of a 34kDa anti-PSTAIRE reactive 
polypeptide(s) (Panel A, lane 3). This concentration effect is not observed with the Tris 
coupled sepharose (lane 4). Similarly there is no depletion effect observed with the 
control beads (lane 2) compared to the pl3 sepharose flow-through (lane 1). Panel B 
shows an identical immunoblot probed with a vertebrate specific cdc2 polyclonal 
antibody (Gibco). This antibody was raised against the C-terminal region of human 
p34cdc2. Again, there is significant concentration of a 34kDa anti-cdc2 reactive 
polypeptide(s) with the p 13 sepharose (lane 3). There is no specific binding of 
polypeptide(s) to the Tris-coupled sepharose (lane 4). It is difficult to distinguish
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whether there has been a depletion of the reactive protein from the pl3-sepharose flow­
through lane (lane 1) because of a warping effect caused by overloading of the gel (lanes 
1 & 2) based on Coomassie blue staining of the gels after transfer.
This result shows that the buffers and conditions used for lysis and binding are 
satisfactory for the extraction and purification of bovine CDK proteins. On the 12.5% 
acrylamide gel used for these blots it is not possible to resolve the small (<2kDa) size 
difference between the p34cdc2 and CDK2. However, this is seen in Figure 3.10 (Panel A, 
Lane 3) (8% acrylamide gel). Both bands are reactive with anti-PSTAIRE antibodies as 
they both contain this conserved motif. The next step was to show that the specific 
protein(s) bound to the p 13 sepharose possessed kinase activity.
3.1.4 Purification of macroschizonts
As bovine cdc2 and CDK2 bind p 13 it was necessary to purify macroschizonts to 
analyse parasite kinase binding to p 13 in the infected lymphocyte stage of the life cycle. 
Macroschizonts were prepared by nebulisation of a differentiating D7 culture (5 days at 
41°C ) as the schizonts are larger at this point. The purified schizont material was stained 
by Giesma stain to assess host contamination. Figure 3.4 shows the material obtained 
with the nebulisation protocol. Panel B shows the host material fraction of the Percoll 
gradient after centrifugation, it contains intact schizonts indicating that the conditions 
used for nebulisation are satisfactory but that the Percoll gradient centrifugation has not 
separated the host and parasite material. From Panel C, which represents a higher band in 
the Percoll gradient, it can be seen that the schizont preparation used for the kinase 
assays in section 3.1.5 still contains host material and cell debris which would 
contaminate any assays undertaken with this material. The exact levels of contamination 
could be examined by immunoblotting of the schizont material but this was not done 
given the low yields of protein obtained.
3.1.5 An active kinase specifically binds to pl3 sepharose from bovine and 
piroplasm extracts.
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As the purified piroplasms were found to be free of significant host contamination 
and at least one parasite CRK was present in this stage, it was decided to base further 
experiments on piroplasm material.
3.1.8 Sypro orange stain detects p i3 bound protein.
The binding experiments were repeated, eluting the bound protein in a small 
volume to maximise protein loading on an 8% SDS-PAGE gel. Figure 3.8 shows the 
binding of specific proteins from both bovine and piroplasm extracts to pl3. The 
molecular weight markers are indicated on the right hand side of the figure. Sypro- 
orange is a protein stain which is as sensitive as silver staining (detection limit 2-5 ng of 
protein) and gels treated with Sypro-orange can be immunoblotted after staining which is 
not possible with silver stained gels.
With piroplasm extracts, elution after pl3 binding (Lane 1) showed a 45kDa 
polypeptide was most clearly detected by the staining. The intensity of staining of this 
band suggests that this polypeptide is considerably concentrated by the pl3-sepharose 
purification which hints at a high affinity interaction between yeast pl3swc7 and the 45kDa 
molecule. This could be the ThaCRK3 kinase which has a predicted size of 45kDa. There 
are also some lower molecular weight polypeptides of approximately 31, 33 and 37kDa 
visible in the piroplasm eluate (Lanes 1) which would be in the correct size range for the 
CRK/CDK proteins. There are also higher molecular weight polypeptides of 70-80 and 
>100kDa. The 70kDa polypeptide is also present in BL20 cells and could be due to the 
presence of residual bovine serum albumin which was used to pre-block the pl3- 
sepharose prior to binding. The >100kDa protein stains very strongly and is specific to 
piroplasms suggesting, again, a high affinity reaction. With bovine protein bound to p i3 
sepharose and eluted there is a band visible band at about 50kDa together with some 
minor polypeptide bands at around 34kDa which may be the cdc2/CDK2 proteins. Since 
pi 3 will bind the CRK/CDK protein complex, it is possible that some of the higher 
molecular weight polypeptides seen may represent components of this complex such as 
cyclins. This experiment was repeated with the gel western blotted after staining.
61
3.1.9 Lnmunoblotting with Sypro stained gel.
An identical set of experiments was undertaken to those in section 3.1.8 with the 
gel being immunoblotted after staining. The protein extract that was applied to the p 13 
column, the material eluted after binding to the column and the non-pl3 bound material 
(flow-through) from both BL20 and piroplasms were run out on the gel. Both extracts 
applied to the column gave a heavy staining pattern (Lanes 1 & 4) while the non-bound 
material (tracks 3 & 6) show a prominent polypeptide at ~68kDa arising from the bovine 
serum albumin (BSA) used to pre-block the p 13 column.
There are a number of proteins visible in the track containing piroplasm eluate from p 13 
sepharose (Lane 5) with the strongest being 45kDa similar to the profile seen in figure 
3.8. The 35kDa polypeptide is also clearly visible.
Panel B shows an immunoblot of the stained gel in Panel A. Lane order is as 
above. There are two distinct proteins of molecular weights of 33 & 34 kDa reactive 
with the anti-PSTAIRE antiserum present in the BL20 pl3 sepharose eluate (Lane 2) 
which probably represent bovine CDK2 and p34cdc2. There is a concentration of bovine 
CDK seen in the BL20 eluate compared to the flow-through (Lanes 2 & 3). There is a 
fainter reactive polypeptide of 32kDa in piroplasm p 13 sepharose eluate (Lane 5) 
showing again a PSTAIRE reactive protein binding to p 13 from piroplasm extracts. The 
signal intensity of the 32kDa reactive protein is similar between the eluate and flow­
through, despite the flow-through lane being higher in total protein. This indicates that 
the 32kDa protein is being concentrated to some extent by the p 13 beads. Because the 
supernatant and flow-through lanes are so disproportionately loaded in both cases, it is 
not possible to assess the efficiency of depletion of CRKs from the supernatant by the 
pl3 beads. Blotting a Sypro stained gel seems to reduce the signal strength from the 
immunoblot and so, the experiment was repeated using the same protein extracts for 
probing with the anti-ThaCRK2 antiserum but without staining the gel prior to blotting.
3.1.10 ThaCRK2 may bind pl3 with a low affinity.
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The immunoblotting was repeated using piroplasm and bovine supernatants 
prepared in section 3.1.9 to detect binding of parasite ThaCRK2 to pl3 sepharose (figure 
3.10).
Panel A shows the immunoblot profile with the anti PSTAIRE antiserum. There are two 
distinct bovine proteins of moleular weights 33 & 34 kDa, running as a doublet which 
are specifically binding to pl3 and reacting with the anti-PSTAIRE antiserum - these are 
likely to be p34cdc2 and CDK2 (Lane 3) (These are as seen in figure 3.9 Panel B lane 2).
A parasite protein specifically concentrated by pi 3 binding also reacts with this antibody 
(Lane 1). The piroplasm supernatant also has PSTAIRE reactive polypeptides which 
look to be running as a doublet (Lane 2). There are other higher molecular weight 
polypeptides recognised by this serum which cross-react with the polyclonal anti- 
PSTAIRE serum. This blot was then stripped and re-probed with the anti-ThaCRK2 
antiserum and the results are shown in Panel B. The lane order is as above. Again there is 
no cross reactivity with bovine protein (Lane 3). The antiserum shows strong reactivity 
with the 34kDa ThaCRK2 in the piroplasm supernatant track (Lane 2) but only faint 
reactivity visible after pl3 binding and elution (Lane 1). This shows there may be a very 
weak interaction between ThaCRK2 and p i3 and confirms the preliminary results shown 
in figure 3.8. Comparing the relative reactivities between lanes 1 & 2 using either the 
anti-PSTAIRE antibody (Panel A) or the anti-ThaCRK2 antibody (Panel B) suggests that 
there are, at least, two polypeptides in piroplasms with a PSTAIRE like motif. The 
difference in reactivities between lanes 1 & 2 with the anti-PSTAIRE antibody (Panel A) 
is less than the difference between the weak reactivity with anti-ThaCRK2 in lane 1 and 
in lane 2 (Panel B) .Though it is difficult to be quantitative, anti-ThaCRK2 reactivity 
appears to be -10 fold less than the supernatant (Panel B, lane 2). This suggested that 
there may be more than one anti-PSTAIRE reactive protein contributing to the signal 
with anti-PSTAIRE antibody. The 45kDa protein which was shown by Sypro staining to 
bind strongly to pl3 is not reactive with anti-ThaCRK2 but may be slightly reactive with 
anti-PSTAIRE (Panel A, lane 1, arrowed).
Since there may be two parasite proteins capable of binding to pl3, it was 
decided to immunoprecipitate the ThaCRK2 protein from piroplasm extracts to produce 
a depleted supernatant which was then used for binding assays.
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3.1.11 Immunoprecipitation of ThaCRK2 from piroplasm extracts.
The anti-ThaCRK2 antiserum was used to irmnunodeplete piroplasm extracts of 
the CRK2 protein which had been shown to bind p 13, albeit very weakly. Figure 3.11 
shows the immunoprecipitation of the extract.
Lane 1 shows the reactivity of supernatant with the antibody prior to immunodepletion. 
There is no binding of ThaCRK2 to the Protein A sepharose (lane 2) as all reactivity 
remains in the supernatant from the control incubation of supernatant with Protein A 
sepharose only (lane 3). Lane 4 shows the supernatant from the immunoprecipitation 
reaction which has been nearly totally depleted of ThaCRK2. There is specific 
immunoprecipitation of ThaCRK2 by the anti-ThaCRK2 antisera (Lane 5). The 
immunodepleted supernatant (Lane 4) was then hound to p 13 as previously described.
3.1.12 Immunodepletion removes ThaCRK2 from extracts but kinase 
activity remains
Immunodepleted and non-depleted extracts were then incubated with p i a n d  
p l2 cksl, the recombinant polypeptide product of L. mexicana homologue of the sucl 
gene (a gift of Dr. K. Grant, Mottram & Grant, 1996). It was postulated that the 
Theileria CRKs may have a higher specific affinity for p 12cksl since it is from another 
protozoan. Specifically bound proteins were eluted from the beads and assayed by 
Western blotting. Figure 3.12 (Panel A) shows the resulting immunoblot probed with the 
anti-ThaCRK2 sera. Comparison of the flow-throughs from p 12 and p 13 binding to 
immunodepleted (lanes 5&7) and nondepleted extracts (lanes 6&8) showed a significant 
reduction in the levels of ThaCRK2 by the antibody. From this, it is possible to conclude 
that the immunoprecipitation has removed most of the ThaCRK2 from the extract. 
However, in the case of the depleted extract flow through after binding to pl2-sepharose 
(Lane 5), there is a larger amount of ThaCRK2 present than in corresponding flow­
through from p 13. Any remaining ThaCRK2 in the depleted extracts has not bound 
either p 13 or p 12 to any detectable extent (Lanes 3 & 4). With non-depleted extract
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eluates, there is possibly better binding of ThaCRK2 to p 13 than to p 12 though the 
difference in antibody reactivity is very small (Lanes 1 & 2).
This blot was then stripped and reprobed with a monoclonal antibody (5E1) 
raised against a predominant 30kDa protein present on both the merozoite surface and 
the piroplasm which showed that the difference in reactivity between non-depleted and 
depleted tracks (Lanes 8 & 7 and Lanes 6 & 5 ) was not simply due to protein loading. 
This is shown in Panel B. This also shows that the washing conditions are sufficiently 
rigorous to remove all traces of the 30kDa protein in the eluates. Since the reactive hand 
is of equal intensity in lanes 5-8, it is possible to say that the decrease in reactivity of the 
anti-ThaCRK2 sera (Panel A) in the immunodepleted extracts is specific and that all 
samples had similar amounts of total piroplasm protein. The next step was to determine if 
the immunodepleted extracts still contained protein(s) capable of binding pl3 and p 12 
sepharose which had kinase activity.
3.1.13 Immunodepleted piroplasm extract retains kinase activity.
The immunodepleted extracts were bound to pl3 and p 12 sepharose and assayed 
for kinase activity as described in section 3.1.6. The same three substrates were used to 
determine if there were any differences in substrate specificity between the depleted and 
non-depleted extracts after binding to pl2 and p 13 (figure 3.13).
Using ThaCRK2 depleted extracts, in the absence of added substrate there is a 
phosphorylated polypeptide of 45kDa (Panel A, lanes 1 & 5). With non depleted extract, 
there are 3 distinct phosphorylated proteins of 60, 45 and 35kDa (Panel B, lanes 1 & 5,) 
which undergo a heavier phosphorylation in the presence of pl3 sepharose again 
indicating that an active ThaCRK2 may bind to pl3 sepharose. Casein is heavily 
phosphorylated by the immunodepleted extracts bound to pl3 (Panel A, Lane 2) but to a 
lesser extent by the p 12 bound kinase (Panel A, Lane 6). Histone is equally 
phosphorylated by p 13 and p 12 bound kinase but less well phosphorylated with 
immunodepleted extract (Panel A, Lanes 3 & 7) when compared to the phosphorylation 
of histone by non-depleted extract (Panel B, Lanes 3 & 7). This may suggest the histone 
is a better substrate for the ThaCRK2 kinase. This could not be concluded from figure
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3.6. Again, as seen in a previous assay (figure 3.6), there is poor phosphorylation of 
myosin light chains with both p 13 and p 12 bound kinases when added as an exogenous 
substrate. The absence of any decrease in casein phosphorylation by pl3 bound protein 
from depleted extracts suggests the presence of another kinase with affinity for p 13 and 
substrate specificity directed towards casein. It seems that p 13 has a higher affinity than 
pl2 for the unidentified parasite CRK polypeptide(s) as while similarly, there is no 
difference in the level of casein phosphorylation by p 12 bound protein between 
immunodepleted and non-depleted extracts, it is much less than with p 13. It could be that 
the unknown kinase does not phosphorylate histone at all as there was residual 
ThaCRK2 left in the extract after immunodepletion. Though this did not bind detectably 
bind to p 13 or p 12 (figure 3.12) there could be sufficient binding to account for the small 
amount of histone phosphorylation by the depleted extracts. There is definitely binding of 
ThaCRK2 since immunodepletion shows it clearly contributes to the phosphorylation of 
histone and no substrate phosphorylation profile. It is possible that the ThaCRK2 
polypeptide can undergo auto-phosphorylation in the absence of exogenous substrate 
(Panel B, lane 1) or be phosphorylated by the other kinases bound to p 13 as band Z 
corresponds to the size of ThaCRK2. The latter may be more likely as the non-depleted 
extracts bound to pl2  show only very weak phosphorylation of Z. The 35kDa labelled 
polypeptide (Z) is removed upon immunodepletion of the extracts suggesting it is either 
phosphorylated by IhaCRK2 or is ThaCRK2 (Panel A, lane 1). A summary of the 
binding affinities and phosphorylation patterns is given in Table 3.1. Though it is not 
possible to be completely quantitative with this type of experiment, there appears to be a 
slightly higher level of casein phosphorylation in the immunodepleted p 13 bound sample. 
This may reflect a degree of competition for the p 13 binding sites by unidentified kinase 
and ThaCRK2. Thus when the majority of ThaCRK2 is removed, the p 13 sepharose can 
bind more of the other kinase(s) hence a higher phosphorylation of casein. Also, the fact 
that the endogenous kinase activity in the absence of substrate is higher in non-depleted 
pl3 bound protein suggests ThaCRK2 itself may have higher affinity for p 13 than p 12.
To determine if another PSTAIRE reactive protein was present in the ThaCRK2 
immunodepleted extracts another set of immunoblots were undertaken using these 
supernatants and post-binding flow-through samples. These are shown in figure 3.14. 
Panel A shows the blot probed with the anti-ThaCRK2 antibody. Only the non-depleted
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extracts react (lanes 1, 3 & 5). Panel B shows an identical blot probed with the 
polyclonal anti-PSTAIRE antiserum. In this case, there is reactivity in the ThaCRK2 
depleted samples (lanes 2 ,4 & 6). This indicates that although the immunodepletion has 
removed the majority of the ThaCRK2 reactivity, there remains another PSTAIRE 
reactive protein in these depleted extracts. A further binding experiment would need to 
be done with this depleted extract to prove that this PSTAIRE reactive protein was 
capable of binding pl3 although the data from the kinase assays on the immunodepleted 
material suggests that it is capable of binding.
It is probable that ThaCRK2 would exhibit a higher affinity for the Theileria 
p ! 3 «<c/ jlomoi0gue> ^  order to clone and sequence the Theileria sucl homologue, 
primers were designed using conserved regions of sucl homologues from a range of 
species and PCR amplification undertaken.
3.1.14 PCR for sucl homologue in Theileria annulata
The oligonucleotide primers chosen were those used to clone the L. mexicana 
sucl homologue -(a gift of Dr. J. Mottram): The location of the primers within the gene 
sequence is shown in figure 3.1 (shaded region). The primers had the following 
sequences:
5’primer - AGAGCTCGAGTAYMGNCAYGTNATGYTNCC 
3’primer - G AGG AATTC A AN ARN ARP ATRTGNGG YTCN GG
The 5’primer corresponds to a perfectly conserved amino acid sequence 
EYRHVMLP and the 3’primer encodes PEPHILLF as seen in figure 3.1.
(N=G+A+T+C, Y=T+C, M=A+C, R=A+G and D=G+T+A , Xhol and EcoRl restriction 
sites are underlined). The 5’ primer was 1000 fold degenerate and the 3’ primer was 
12000 fold degenerate. This is considerably smaller than the degeneracies of similar 
primers used to clone CksHsl from human cDNA (Richardson et al., 1990).
Figure 3.15 shows results of a PCR reaction using parameters cited in Mottram 
and Grant (1996) for the cloning of the L.mexicana homologue. A variety of different 
annealing conditions and PCR reagent concentrations were tried to amplify a homologue
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from Theileria. These are given in Table 3.2 together with PCR reagent conditions used 
to clone the human and Leishmania homologues. Lane 3 shows the positive control used 
which was the pQE plasmid containing the full length sucl gene as template, this gives a 
predominant band of -200 bps, the predicted size of the yeast PCR product. Two bands 
of 230 and 180bps were amongst a series obtained with Theileria genomic DNA These 
two fragments which were in the predicted size range were excised from the gel, purified 
and cloned into the pCR vector (Invitrogen) and sequenced using T7 and SP6 primers. 
The 180bp fragment was found to have high homology to a well conserved region of the 
large subunit of ribonucleotide reductase (chapter 4). The 230bp fragment had no 
significant homology to any protein sequences in the databases in any of the six reading 
frames. The lack of other regions well conserved between different sucl homologues 
makes the design of other primers for PCR difficult (shown in Figure 3.1) and the failure 
of PCR to amplify a Theileria homologue suggests that it may be sufficiently different in 
these regions to prevent amplification. Now that more Theileria genes have been 
sequenced, a statistical analysis of codon bias could be carried out which could allow 
codon bias for Theileria to be incorporated into the primers.
However this approach would not work if the Theileria homologue is not 
conserved in amino acid sequence in these regions and other means of isolating the 
Theileria homologue would be to screen a Theileria expression library with antiserum 
raised against pl3SMc7. However, this was not considered a viable option as a Western 
blot of host and parasite extracts reacted with antiserum generated against recombinant 
yeast p i3 did not detect any polypeptide of the expected molecular weight range either 
in bovine or parasite extracts as shown in figure 3.16. The pl3 protein is detectable in S. 
pombe extracts used as a positive control (lanes 7 & 8). This result suggests that most of 
the immunogenic epitopes are not conserved across species. Interestingly though this 
serum does cross-react with a macroschizont specific polypeptide of 28kDa and a 
piroplasm specific polypeptide of 45kDa, but it is highly unlikely that these polypeptides 
represent the sucl homologue. It would be of interest to determine if the reactive 
polypeptides seen in the piroplasm extracts could be blocked by pre-incubating the serum 
with pl3. Another approach would be to undertake a low stringency heterologous library 
screen with a L. mexicana or S. pombe probe. The failure of the PCR approach and the 
difficulties associated with a library screen led to abandoning the cloning of the sucl
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homologue in Theileria and to concentrate on the large subunit of ribonucleotide 
reductase since it is an essential enzyme in the DNA replication machinery and by its 
nature closely linked to the cell cycle.
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3.2 Discussion and Conclusions
The work presented in this chapter focuses on the existence of at least two 
p \3sucl binding proteins with kinase activity that are present in piroplasm stage extracts of 
Theileria annulata. Prior immunodepletion of the ThaCRK2 from piroplasm extracts 
gave a reduction in histone phosphorylation significantly using p 13 and slightly less with 
pl2 bound proteins. This indicates that one of the proteins capable of binding p 13sucI is 
ThaCRK2. This gene was isolated using a monoclonal anti PSTAIRE antibody (Kinnaird 
et al., 1996). The reactivity profile of this anti-serum on Western blots shows a 
predominant polypeptide of 34 kDa in piroplasm extracts and at least two polypeptides 
in infected lymphocytes, probably representing the bovine p34cdc2 and p32cdk2 
homologues (Kinnaird et al, 1996). Both the bovine p34cdc and p32cdk2 are capable of 
binding to pl3 (Figure 3.9 Panel B) and both presumably bind as part of an active kinase 
complex although it is not possible to discriminate between their relative activities in any 
of the assays undertaken. This binding shows that the p 13 beads functioned as a specific 
affinity tag for cdc2-related kinases in the experiments performed in this chapter. The 
anti-ThaCRK2 reactivity of the p 13 eluated material is very weak whilst the anti- 
PSTAIRE reactivity is considerably stronger. As prior depletion of ThaCRK2 suggests 
the presence of more than one pl3 binding kinase it is likely that one other bound kinase, 
at least, also has anti-PSTAIRE reactivity (figure 3.14). However because different anti­
sera have different titres and the anti-ThaCRK2 reactivity is consistently weaker than 
anti-PSTAIRE polyclonal antiserum it is not possible to conclusively identify another 
kinase with anti-PSTAIRE reactivity binding and eluting from p 13 beads (figure 3.10). 
However work by Kinnaird et al, (1996) who undertook immuno screening of a cDNA 
expression library with an anti-PSTAIRE monoclonal antibody, led to the identification 
of a large number of reactive cDNA clones from the late stages of differentiation to 
extracellular merozoites, all of which were ThaCRK2. If the second kinase was 
expressed at much lower levels than ThaCRK2 at this stage then library screening may 
not readily isolate this gene. Additionally, as the anti-PSTAIRE monoclonal can react 
with other kinases which have a degree of divergence in the PSTAIRE region (Meyerson 
et al, 1992, Mottram & Smith 1995) such as PCTAIRE etc., it suggests that other 
kinases in Theileria could be divergent in the PSTAIRE motif. Also
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immunoprecipitation from piroplasm extracts with anti-ThaCRK2 antibody removed the 
vast majority of polypeptide reactive with the anti-PSTAIRE monoclonal antibody 
(Kinnaird et al, 1996). There are two alternative interpretations for this result: firstly, 
incomplete clearance of ThaCRK2 from the extract and secondly, the presence of 
another protein of exactly the same molecular weight that is weakly reactive with the 
anti-PSTAIRE monoclonal sera. The evidence presented here for the existence of 
another PSTAIRE reactive protein is based upon use of a polyclonal antibody but it is 
difficult to know why the corresponding gene was not isolated during the library screen 
with the monoclonal antibody. One difference is that the library was made from D7 
differentiating cells and the experiments here used piroplasm extracts so it is possible that 
there could be differential expression of the kinases in different life cycle stages.
Although both the PSTAIRE antibodies were raised against the same peptide, it is 
possible that they recognise different epitopes. Unfortunately, our stock of monoclonal 
anti-PSTAIRE is finished so it is not possible to repeat the experiment presented in 
figure 3.14 for comparison with this serum.
Another cdc2-related kinase (ThaCRK3) has recently been cloned from T. 
annulata (Kinnaird, Logan & Langsley, unpublished). This gene has the sequence 
HFTTLRE in the region corresponding to PSTAIRE, suggesting that it will bind a very 
different class of cyclin partner. Similarly to the expression of ThaCRK2, the gene is 
expressed in all intracellular bovine stages of the parasite. As a species specific antiserum 
is currently being generated it will be interesting to determine the affinity of ThaCRK3 
for p 13. However, based on the current literature regarding regions involved in pl3 
interaction, it is possible to make a prediction. The binding affinity for ThaCRK2 seems 
to be very low or highly unstable as judged by the low reactivity of the specific anti-sera 
against piroplasm stage p 13 bound eluates compared to that ofpl3  eluates fromBL20 
extracts but the slight increase in pl3 bound casein kinase activity in ThaCRK2 depleted 
extracts suggests ThaCRK2 does compete, to some extent, with the unknown kinase for 
pl3 binding (section 3.10/3.11). There may be a number of reasons for weak binding - 
the first would be that the interaction between ThaCRK2 and p 13 is unstable and easily 
removed by the washing procedure, designed to reduce non-specific binding. 
Alternatively, only a small amount of ThaCRK2 could be available for binding to pl3. 
This could be due to a competitive effect between the yeast p 13 and the Theileria p 13sucl
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homologue in the piroplasm extracts. The association of ThaCRK2, if already bound to 
the Theileria pl3 homologue would not be easily disrupted by the presence of 
exogenous pl3, especially if this has a lower specific affinity for parasite CRK relative to 
the parasite pl3™c7 homologue. The consequence of this scenario is that most, if not all 
of the parasite CRK would be present in the flow-through fractions of the binding assays, 
being unavailable for binding to pl3-sepharose. This could be easily determined if the 
parasite p i3 ^  homologue had been isolated and could be used as an affinity tag. 
Binding affinities can be partly predicted by examining differences in the primary 
structure of ThaCRK2 and cdc2. As mentioned before, the binding affinity between pl3 
and ThaCRK3 is unknown and cannot be assessed due to the specific antiserum not 
being yet available. However, its structure is considered here in parallel with ThaCRK2 
for its likely binding affinity for p i3. A number of papers have studied the interactions 
between the cdc2 protein and its partners using an analysis of mutant phenotypes. 
Ducommun et al. (1991) used an alanine scanning mutagenesis method to look at the 
interaction between yeast pl35Mc; and human cdc2, although use of the human sucl 
homologue p9Chsksl gave similar results. This paper showed that there are several clusters 
of mutations on the p34cdc2 protein, including sites directly involved in catalytic activity 
that determine pl3™c; binding.
Figure 3.17 shows a pileup of ThaCRK2/3 with human and S. pombe p34cdc2. Regions 
known to be involved in the pi 3 binding are highlighted in bold. These were present in 
both small and large lobes of cdc2. Marcote et al, (1993) defined these clusters more 
precisely by looking at the effects of single substitutions within some of these clusters. 
The rationale behind this is that gross changes involving several amino acids may have 
multiple effects and indeed he says that in general, single replacements tended to have 
less severe effects on binding. Specifically:
a) Within the cluster K21GRHK25 (II), replacement of H24 by Ala had the largest effect on 
pl3 binding in the assay (50% of wildtype). This residue is not conserved in ThaCRK2 
(N) or in ThaCRK3 (D). The acidic residue in ThaCRK3 will considerably change the 
structure but being charged could still undergo bond formation albeit with a different 
residue. Neither are conservative substitutions and it is not possible to predict the effects 
on binding but although these might not be as severe as replacement with Ala. However 
the importance of this region is emphasised by analysis of charged —> Ala clusters on
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either side, E2 - E 12 and K33 - E42 both of which had virtually no effect on binding in the in 
vitro assay.
b). In the cluster K^ELRH60 (IV) replacement of H60 had the largest effect on binding of 
pl3 (reduced to 20%). This residue is conserved in both Theileria kinases.
c). In the cluster R180 - D186 (VIII), which is not generally well conserved in Theileria, 
two specific replacements were analysed, R180 and D186. R180 ->■ Ala had almost no effect 
on binding but D186 Ala reduced binding to 20% of wildtype levels. This residue is 
conserved in Theileria and is conserved in the cAMP dependent protein kinase in which, 
as shown from the crystal structure (Knighton et al., 1993) it forms a bond with the 
backbone of the catalytic region. Similarly the residue E173 in the cluster R170 - E173 is 
predicted to form an internal ionic bond with R275 in the cluster D271 -R275 (XIII). 
Mutation of any of these three residues is likely to disrupt the conformation of the large 
lobe and thus indirectly affect p 13 binding. As these residues are conserved in ThaCRK2 
and ThaCRK3 it suggests that the conformation may not be that different and that 
binding affinity to yeast p 13 may depend on direct interaction with specific residues. 
However effects of other differences on conformation cannot be ruled out.
d). In the cluster R215 - R218 (XI) replacement of R215by Ala had a major effect on pl3 
binding. This residue is predicted to have a surface location in the large lobe and directly 
interact with p 13. This region is quite well conserved in both ThaCRK2 and 3 and is 
therefore unlikely to affect binding to p 13.
e).Certain residues in p34cdc2 have been predicted to be involved in binding of pl3sucl by 
Endicott (1994) from a structural model which was based on analysis of yeast mutant 
phenotypes combined with the X-ray crystal structure of the cAMP dependent protein 
kinase (Knighton, ibid). These p34cdc2 mutants can be rescued by over-expression of 
p U ™1. The homologous wildtype residues in all 6 mutant alleles are conserved in 
ThaCRK2 and 3 (Figure 3.17 indicated by A). However, other residues as yet 
unidentified are probably also important in either direct binding of pl3 or indirectly 
through tertiary structure.
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f). A region represented by a deletion of 20 amino acids, S233 - H253 (XII), was 
characterised by Ducommun (1993) as abolishing 90% of the binding of human cdc2 to 
yeast p 13. However, Alanine scanning mutagenesis of the small cluster K243 -K245 within 
this region had no effect on binding, suggesting that some of the other residues within 
the deletion are more important but it is equally possible that such a large deletion could 
have a disruptive effect on the conformation of the protein. This region has not been 
extensively analysed although in the crystal structure of the inactive form of human 
CDK2 some of the residues are predicted to have a surface location (de Bondt et al., 
1993) and therefore is likely to be a site of interaction with another protein. The region 
of this deletion is part of a 25 amino acid insertion that is not present in the cAMP 
dependent protein kinase but is typical of cdc2-related kinases. Because of this it was not 
been modelled in the 3-dimensional structure proposed by Marcote. While deletion of 20 
amino acids suggests that it may be a point of pl3 binding, a yeast mutant with a three 
amino acid deletion (L240-D242 in S.pombe) contained within this insertion, had a 
dominant lethal phenotype when over-expressed causing cells prematurely enter mitosis 
without completing S phase. This led to the proposal that while the activity of the kinase 
was unaffected, it was likely that the mutant failed to interact with a negative regulator of 
mitosis , perhaps a CDK inhibitor (Labib et al., 1995, Endicott et al., 1994). This region 
is quite divergent in ThaCRK2 (19%, identical, 28% similar) and slightly less so in 
ThaCRK3 (29% identical, 35% similar), whereas S. pombe p34cdc2 and human cdc2 are 
over 50% identical, 57% similar. Given the possible importance of this area in pl3 
binding either through its effect on the conformation of the large lobe or direct 
interaction with p 13, it seems possible that the degree of divergence in the Theileria 
CRK’s may affect their affinities for yeast p 13. In summary, on the basis of available
on O/iinformation, this latter region and the cluster K -K containing the important H 
residue contain the differences most likely to influence p 13 binding.
Very recently, the X ray crystal structure of human CDK2 complexed with a 
human p 13 homologue, p9ckshsl, has been published (Bourne et al, 1996). This has shed 
considerable light on the interaction of the two proteins and points to a possible role for 
pl3 like molecules. The strong conservation amongst eukaryotes of key residues defined 
by the structure of the CDK2/ Ckshsl complex suggested that the interaction will be 
very similar for other closely related CDKs and p 13 homologues. Die results of this
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study also pin point certain residues which are not well conserved in the two Theileria 
kinases, again suggesting the affinity for yeast pl3 is not optimal. The crystal stucture 
showed that Ckshsl binds directly or “interfaces” with two domains in the C terminal 
lobe of CDK2. It does not appear to interface at all with the N-terminal lobe in which a 
small region of charged residues was implicated in p 13 binding by the mutagenesis 
approaches of Ducommun (1991) and Marcote (1993) described above. In order to 
reconcile the apparently conflicting data the authors suggest that certain mutations in the 
N- terminus may have a conformational effect on the structure of the kinase which 
indirectly affects sub-unit binding. The domains in the CDK C-terminus extend over the 
residues G206 - L220in human cdc2 (figure 3.17 region X) and residues S233 - P246 (XIII), 
part of the 25 amino acid insertion unique to cdc2-related kinase and which forms a loop 
structure. These regions have already been described as being divergent in ThaCRK2 and 
ThaCRK3 (here and Kinnnaird et al., 1996). Specifically, within the region covering the 
20 amino acid deletion described by Ducommun which is within the interfacing 25 amino 
acid loop sequence, Bourne et al. (1996) identified a conserved aromatic P residue which 
had been mutated in S.cerevisae CDC28 to L. This mutant is defective in pl3 binding but 
still retains kinase activity. This residue is not conserved in either ThaCRK2 or 3 
suggesting that this would abolish pl3 binding. However the results presented here show 
that ThaCRK2 at least binds to p 13 and thus possibly other substitutions may modify or 
stabilise the binding to some extent. To confirm cross species conservation several 
mutants of CksHsl were created in the CDK2 contact region, all of which were defective 
in their yeast cdc2 binding affinities compared to the wild type CksHsl.
The side of CksHsl away from the side that interfaces with CDK2 is also 
conserved between species and is positioned in the CDK2 catalytic cleft in such a way as 
to extend the surface area of the cleft. On this basis it is proposed that p 13 like proteins 
function to target CDK’s to substrates or kinase regulatory proteins.
Given the M ure to PCR the sucl homologue of Theileria it is possible that the 
Theileria homologue differs quite extensively in the regions used to design primers. Thus 
other approaches would need to be employed to isolate the sucl homologue. It would 
then be of interest to determine if ThaCRK2 and ThaCRK3 would exhibit a higher 
binding affinity to the homologue compared to yeast pl3 and I would suspect that they
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quite probably will. This would perhaps also be the easiest way to determining the 
identity of the second kinase or kinases whose existence is suggested by the lack of 
reduction in casein kinase activity in piroplasm extracts immunodepleted of ThaCRK2 
prior to p i 3 binding. One of these may be ThaCRK3 as analysis of protein sequence 
suggests it may bind p i3. This will be confirmed with a specific antiserum. However, a 
45kDa protein from piroplasm extracts was shown to bind strongly to p i3 sepharose. 
This did not react with the anti-PSTAIRE antiserum. Rather interestingly, the predicted 
molecular weight of ThaCRK3 is 46kDa and it does not react with anti-PSTAIRE 
antiserum (Logan & Kinnaird, unpublished).
Work undertaken with Paramecium tetraurelia shows parallels with the findings 
here. Using an anti-PSTAIRE anti-serum it was shown that there were two polypeptides 
of 34 and 36kDa which were recognised by this antibody (Tang et al, 1994). Both 
polypeptides exhibited different binding affinities for p i 3 sepharose with the 36kDa 
molecule possessing the higher binding affinity. Neither of these two molecules were 
recognised by sera against the C-terminal region of the human p34cdc2 suggesting that 
there is divergence in this region. When the putative p34cdc2 was cloned by PCR from P. 
tetraurelia it was shown to contain longer N and C-termini than the S. pombe 
polypeptide. Overall the homology between this homologue and other cdc2 proteins is 
only of the order of 50% at the amino acid level (Tang et al, 1995). This protein was 
shown to be the 34kDa anti-PSTAIRE antibody reactive protein described in the earlier 
paper which did not show appreciable pl3 binding. There is the possibility this gene from 
P. tetraurelia may not be the cdc2 homologue given that it is no more identical to human 
cdc2 than it is to cdk3 and that human cdk3 had been shown to bind to pl3 very weakly 
(Meyerson et al, 1992). The authors state that the pl3 binding sites as defined by 
Ducommun (1991) and Marcote (1993) are not conserved in the P. tetraurelia 
polypeptide. It is believed that this protein from P. tetraurelia possesses histone HI 
kinase activity as a monomer although this may be an in vitro effect. (Tang et al, 1994). 
Similarity work in L. mexicana showed the existence of at least two cdc2 related kinases, 
crkl and crk3 (Mottram et al, 1993 and unpublished) together with another kinase 
capable of binding to p i3 sepharose but which is distinct from either the crkl and crk3 
genes already isolated. Specific anti-serum raised against the crkl polypeptide showed 
that this molecule bound weakly to pi 3 sepharose and although being able to bind the
76
Leishmania homologue pl2 with a higher affinity, it was not responsible for the majority 
of the histone HI kinase activity precipitable from the p i2 sepharose (Mottram & Grant, 
1996).
With respect to the second pl3 bound kinase activity in Theileria identified by 
this work, a number of conclusions can be drawn about its identity on the basis of 
experiments detailed in this chapter. It has a relatively higher specific affinity for yeast 
p i3 than Leishmania pl2 and is more specific for casein as a substrate than histone. 
Although these substrates indicate a bias of different kinases, they are common substrates 
in kinase assays and, in many cases, the exact physiological substrate of the CDK’s are 
unclear. It is probably reactive with a polyclonal anti-PSTAIRE serum (figs 3.10 & 3.14) 
suggesting that it possesses this conserved domain which, in turn, suggests that it is a 
member of a conserved cdc2-related kinase family. This result also suggests that it has 
similar molecular mass to ThaCRK2 and a mass typical for cdc2-related protein kinases. 
However, it must differ at the C-terminal region from the ThaCRK2 kinase since it does 
not cross react with the anti-ThaCRK2 sera. Further work would be productive in 
determining the identity of this kinase. One step would be to screen an expression library 
with the polyclonal PSTAIRE serum. It may also be feasible to isolate sufficient 
quantities of the protein by pl3 purification and subsequent gel filtration for 
microsequencing allowing design of oligonucleotides and cloning via PCR amplification, 
using the PSTAIRE region to design the second oligonucleotide primer. In addition, 
given the high affinity of pi 3 for CDKs it may be possible to screen an expression library 
with recombinant Histidine tagged p i3 with the ‘p i3 binding plaques’ being detected by 
an antibody to the Histidine tag or to p i3 assuming that the cDNA can express and fold 
properly in the bacterial expression system.The presence of phosphorylated proteins 
identified by SDS-PAGE following kinase assay in the absence of substrate suggests that 
bound kinases may autophosphorylate but other molecules in the CDK complex such as 
CKIs can be phosphorylated by the CDK to which they are bound (Morgan et a l, 1995).
Work by Tamaru and Okada (1996) showed there to be two major kinases 
associated with p i 3 in mature rat brain. These were characterised by an in situ SDS- 
PAGE gel kinase assay showing the sizes of the kinases to be 45 and lOOkDa. The 
smaller kinase was purified to near homogenity and was shown not to cross-react with
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anti-PSTAIRE sera. Its preferred substrates are histone HI and myelin basic protein but 
there was poor phosphorylation of caseins and neurofilaments. It does not appear to 
need regulatory subunits for activity as it is active in a monomeric form. p45 is a possible 
member of the large family of proline-directed kinases. This work raises the possibility 
that there may be a range of kinases capable of binding to pl3 which share little or no 
features of the CDK’s.
In conclusion, there are at least two kinases in Theileria annulata which have 
different binding affinities for pl3, possibly based either on differences in tertiary 
structure of the proteins or in specific residues that interact with pl3. One of these is 
ThaCRK2 which is capable of binding to pi 3 as a part of an active kinase complex. 
ThaCRK2 is PSTAIRE reactive and was identified as binding through the use of a 
specific antiserum. Another anti-PSTAIRE polyclonal reactive kinase can also bind. This 
kinase may also be capable of undergoing autophosphorylation. A 45kDa polypeptide 
was identified by Sypro orange staining as binding to pl3. This was not significantly anti- 
PSTAIRE reactive. It is possible that ThaCRK3, which has a predicted mass of 46kDa 
and does not detectably react with anti-PSTAIRE antiserum on Western blots (Kinnaird 
et al., unpublished), could bind to pl3. Further work should perhaps concentrate on the 
isolation of the second anti-PSTAIRE reactive kinase as a potential member of the cyclin 
related kinase family in Theileria annulata.
A strong histone specific kinase activity was present in piroplasms which is 
probably mainly due to the ThaCRK2. However, histone is a substrate commonly used in 
in vitro assays and may not reflect true substrate specificity. As T. annulata piroplasms 
show only limited division (Conrad et al, 1985) and expression of genes known to be 
associated with DNA replication is low in the population as a whole (Chapter 6) it may 
be that this kinase activity fulfils a role not associated with nuclear division, such as 
organisation of the piroplasm for subsequent development in the tick into gametes.
Attempts to isolate the Theileria sucl homologue with a view to developing a 
more specific assay system were unsuccessful suggesting that it may be quite divergent.
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Figure 3.1 Alignment of su c l  homologues
Figure courtesy of Dr. J. Mottram. Key Ckslhs, Cks2hs - human p9 
CKS1 and p9 CKS2, Patsuc - Patella vulgata p9CKS1? Cksphy - Physarum 
polycelphalum  p9CKS1, LmmCKSl - L. mexicana p l2 CKS1, Cksl - S. 
cerevisiae p l8 CKS1 and sucl - S. pombe p l3 sucl.
Shaded blocks indicate highly conserved regions used for primer 
design.
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1 50
Ckslhs MSHKQ IYYSDKYDDE EF gYRHVMLP
Cks2hs MA-- ------- F- - HY --
Patsuc M-AR- ------- F- - D-
Cksphy MPRDT -Q--E--Y-D K- 1(1111:
LmmCKSl MPAKPAQDFF SLDANGQREA LIIIKKLQCK -L-----Y-D M- H I
Cksl MYHHYHA FQGRKLTDQE RARVLEFQDS -H--PR-S-D NY — 111111
sucl MSKS GVPRLLTASE RERLEPFID- -H--PR-A-D -Y — -----
51 9:
Ckslhs KDIAKLVPKT ......... H LMSESEWRNL GVQQSQGWVH YMIHP PE PH I
Cks2hs RELS- Q---- ----E ---R- -----L ---- -- —
Patsuc ----- M -- N ----A ---SI -----H--I- -- K- -
Cksphy P-V-- EI--N ......... R -L- -G-- G- ----------- -AL-R  ^^ v, w
LmmCKSl --L-R -- TS ......... R ----M ---Q- ----------- - -Kr-1
Cksl -AML- VI-SD YFNSEVGTLR ILT-D-- G- -IT--L--E- -EC-A
sucl -AML- AI-TD YFNPETGTL- ILQ-E-- G- - IT--L-- EM -EV-V -----
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Ckslhs | § | | | PLPKK PKK 9
Cks2hs ----D QQ- 9
Patsuc KVTGQ 9
Cksphy EV-MP AASLSHNP 9
LmmCKSl *■" K “-RT 12
Cksl --NYE AELRAATAAA (Q )16 HQTQSISNDMQVPPQIS 18
sucl EKDYQ M-FSQQRGG 13
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kDa
kDa
kDa
Figure 3.2 Expression and purification of p!3.
Recombinant clones containing the su cl gene within the pQE60 
vector (Qiagen) were induced with ImM IPTG for 5 hours at 37°C, 
harvested and resuspended in sonication buffer (50mM sodium phosphate 
buffer pH8.0, 300mM NaCl). The solution was then treated with lysozyme 
(lmg/ml) at 37°C for 15 minutes prior to a freeze/ thaw cycle at -80°C 
followed by sonication. Cellular debris was cleared by centrifugation at 
40000g. The cleared supernatant was applied to a Ni-NTA agarose column 
at 0.2ml/min. The column was washed in sonication buffer at a flow rate of 
0.5ml/min, then with wash buffer (50mM sodium phosphate buffer pH6.0, 
300mM NaCl, 10% glycerol) at the same rate. Bound protein was eluted 
from the column using a linear gradient of 0 to 500mM imidazole in wash 
buffer. Fractions containing purified p l3  protein were pooled and dialysed 
against 50mM sodium phosphate buffer pH6.0, 300mM NaCl and 
concentrated using a Centricon-10 filter prior to coupling to Aminolink 
beads (Pierce) at a concentration of 5mg/ml.
Panel A  is a 15% SDS-PAGE gel showing the high speed centrifugation 
pellet and supernatant fractions after sonication and application of 
supernatant to the Ni-NTA column. Lane 1 is the pellet fraction. Lane 2 is 
the supernatant fraction and lane 3 is the supernatant after passing through 
the column.
Panel B shows aliquots of fractions eluted from the column analysed by 15% 
SDS-PAGE gel.
Panel C shows the pooled protein from fractions 18-28 after dialysis prior to 
concentration with the Centricon 10 filter. Tracks 1&2 show purified p l3  
protein.
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Figure 3.3 Affinity purification of bovine CDK on p!3-sepharose.
Cell extracts from BL20 cells were incubated with control and p i3 beads 
and washed as detailed in chapter 2.. The extracts were then separated on a 
12.5% acrylamide gel, blotted onto Hybond N  membrane and probed with 
sera as listed below. Signal development was carried out by 
chemiluminscence using the ECL detection system (Amersham).
Panel A  shows a Western blot o f extracts and p i3 affinity purified protein 
using an anti-PSTAIRE monoclonal antibody.
Panel B shows a Western blot as in (A) only using an anti human cdc2 C- 
terminal polyclonal antibody (Gibco). The sizes are as shown on the right of 
the panels.
Key:
Lane 1 Flow through after p l3  binding.
Lane 2 Flow through after Tris binding.
Lane 3 Eluate from p i3 sepharose beads.
Lane 4 Eluate from Tris sepharose beads.
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Figure 3.4 Purification of macroschizonts
A differentiating D7 culture (5 days at 41°C) was lysed by 
nebulisation and centrifuged through a Percoll gradient. The fractions were 
examined by Giesma staining to assess levels o f purity.
Panel A  shows the intact cells prior to nebulisation.
Panel B shows the host material after centrifugation.
Panel C shows the parasite material after centrifugation.
Key:
hn host nucleus 
ms macroschizont
Magnification is X I000 with the scale bar representing 10pm.
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Figure 3.5. Histone HI kinase assay of pl3 sepharose and Tris 
sepharose bound protein from BL20, purified macroschizont and 
piroplasm extracts.
Cell extracts from BL20, macroschizonts isolated by nebulisation of D7 
cells and piroplasm stage extracts were incubated with control and p i3 
beads. Kinase activity bound to beads, as assayed by the ability to 
phosphorylate histone H I, was detected after SDS/PAGE electrophoresis 
and autoradiography. Macroschizont preparation and purity of preparation is 
detailed in section 3.1.4.
Key:
Lane 1 BL20 p i3 bound protein.
Lane 2 BL20 Tris bound protein.
Lane 3 Macroschizont p i3 bound protein.
Lane 4 Macroschizont Tris bound protein.
Lane 5 Piroplasm p i3 bound protein.
Lane 6 Piroplasm Tris bound protein.
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Figure 3.6 Kinase assay with pl3 sepharose bound protein from 
piroplasm extracts using a variety of substrates.
Equivalent volumes of piroplasm p i3 bound extracts were assyed for kinase 
activity in the presence of various substrates. Kinase activity was detected 
by SDS/PAGE and autoradiography as before.
Key:
Lane 1 No exogenous substrate added.
Lane 2 a  casein as the exogenous substrate.
Lane 3 Histone as the exogenous substrate.
Lane 4 Myosin light chains as the exogenous substrates.
Arrows indicate bands X, Y and Z which are referred to in the text.
84
1 2  3 4
97kDa
66kDa
45kDa
29kDa
Figure 3.7. Reactivity profile of various cell extracts with anti-sera 
against vertebrate cdc2, ThaCRK2 C-terminal and PSTAIRE.
BL20, D7 and piroplasm extracts were prepared as detailed in chapter 2, 
normalised for protein concentration and separated on a 12% SDS/PAGE 
gel prior to blotting onto Hybond C membrane (Amersham.). Efficient 
transfer and equal loading was assessed by staining the nitrocellulose filter 
with 0.3% Ponceau S, in 5% TCA. Antibodies used to probe membranes are 
as detailed below. Secondary antibodies used for signal development were 
either anti-mouse or anti-rabbit IgG HRP conjugates. Signal development 
was carried out using chemiluminescence (ECL, Amersham).
Key:
Lane 1 BL20 extract.
Lane 2 D7 extract (undifferentiated - grown at 37 °C).
Lane 3 D7 extract ( Day 6 of differentiation at 41°C).
Lane 4 Piroplasm extract.
Panel A  shows a Western Blot probed with a vertebrate specific monocbnal 
anti-cdc2 antisera.
Panel B shows a Western blot reactivity profile of a polyclonal anti- 
ThaCRK2 antiserum.
Panel C shows a Western blot reactivity profile of a polyclonal anti 
PSTAIRE antiserum.
Sizes are as indicated to the right of the panels.
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Figure 3.8 Sypro-Orange detection of protein binding to p l3  from
piroplasm and BL20 extracts.
An equivalent concentration of BL20 and piroplasm extract was added to 
equal volumes of p l3  bead slurry and the eluate from each was separated on 
a 8% SDS polyacrylamide gel prior to staining with 1% Sypro-Orange stain 
(Bio-Rad).
Key:
Lane 1 Piroplasm protein bound and eluted from p i3 sepharose.
Lane 2 BL20 protein bound and eluted from p i3 sepharose.
The size markers are as shown on the right hand side.
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Figure 3.9 Sypro-Orange stained gel of piroplasm and bovine p l3  
bound proteins subsequently Western blotted and detected by anti- 
PSTAIRE antisera
Equivalent amounts of BL20 and piroplasm extracts were incubated with 
equal volumes of p i 3 bead slurry. The supernatant extract, flow-through and 
eluate from both BL20 and piroplasms were separated on a 12.5% SDS 
polyacrylamide gel. The gel was then stained in 1% Sypro-Orange stain 
(Bio-Rad) prior to immunoblotting. Detection of signal was via the ECL 
system (Amersham).
Key:
Lane 1 BL20 supernatant.
Lane 2 BL20 eluate after p i3 binding.
'Lane 3 BL20 flow-through after binding.
Lane 4 Piroplasm supernatant.
Lane 5 Piroplasm eluate after binding.
Lane 6 Piroplasm flow-through after binding.
Panel A  shows the gel stained with Sypro-Orange.
Panel B shows the Western blot of the same gel probed with polyclonal anti- 
PSTAIRE antiserum. Lane order is as in Panel A.
Markers are as indicated by arrows.
87
A97kDa ^
6 6k D a -----►
4 5 kD a ^
31 kD a ►
B
97kDa » m
66kDa ■ ►
45kDa * t • i '
31 kD a-----►
Figure 3.10 Western blot showing antibody reactivity of piroplasm and 
bovine proteins eluted from pi3 sepharose
Equivalent amounts of BL20 and piroplasm extracts were incubated with 
equal volumes of p i 3 bead slurry. The extracts were identical to that used in 
figure 3.9. The supernatant extract and eluate from both BL20 and 
piroplasms were separated on a 10% SDS polyacrylamide gel and 
immunoblotted. Efficiency of transfer was verified by staining the nitro­
cellulose filter in 0.3% Ponceau S, in 5% TCA. Detection o f signal was via 
the ECL system (Amersham). The filter was stripped according to 
instructions supplied with the ECL kit and reprobed with the second 
antibody.
Key:
Lane 1 Piroplasm eluate.
Lane 2 Piroplasm supernatant.
Lane 3 BL20 eluate.
Lane 4 BL20 supernatant.
Panel A  show the reaction profile o f the polyclonal anti-PSTAIRE 
antiserum.
Panel B shows the same immunoblot incubated with the anti-ThaCRK2 
antiserum.
Markers are as indicated by arrows.
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Figure 3.11 Immunoprecipitation of ThaCRK2 by anti ThaCRK2 sera.
IO jlxI of affinity purified anti-ThaCRK2 antisera was incubated with 
piroplasm extract supernatant for 1 hour at 4°C with rotation. lOpl o f a 
suspension of washed protein A beads (Pierce) were added and incubated 
for a further 1 hour. The supernatant was then collected by centrifugation 
and beads washed with lOmM Tris-HCl (pH7.5), 0.1% NP-40 for 20 
minutes at 4°C. Elution of bound protein was by addition of an equal volume 
of 4X SDS/PAGE sample buffer. Samples were run on a 12.5% SDS 
polyacrylamide gel and immunoblotted after electrophoresis. Antibody used 
to develop the blot was the same anti-ThaCRK2 C-terminal anti-serum. 
Signal development was via the ECL Chemiluminescence system 
(Amersham).
Key:
Lane 1 Piroplasm supernatant after lysis.
Lane 2 Eluate from control binding to protein A  sepharose alone (no
ThaCRK2 antibody).
Lane 3 Supernatant from protein A  control binding.
Lane 4 Supernatant from immunoprecipitation with ThaCRK2
antibody.
Lane 5 Eluate from ThaCRK2 immunoprecipitate from piroplasm 
extract.
The size o f immunoprecipitated ThaCRK2 is indicated by the arrow.
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Figure 3.12 p l3  binding profile of ThaCRK2 immunodepleted extracts.
Equivalent concentrations of piroplasm depleted and non-depleted extracts 
were incubated with equal volumes of p i 3 and p l2  bead slurries. An aliquot 
of the flow-through and eluate from each sample were separated on a 12.5% 
SDS polyacrylamide gel and immunoblotted. Transfer was assessed by 
staining the nitrocellulose filter with 0.3% Ponceau S, in 5% TCA. Signal 
development was by the ECL/chemiluminescence system (Amersham).
Panel A  shows the Western blot with immunodepleted and non­
depleted piroplasm extract bound to p i3 and p i2 probed with the anti- 
ThaCRK2 anti-serum. The blot was then stripped and re-probed with a 
monoclonal antibody against the 30kDa merozoite antigen (5E1). This blot 
is shown in Panel B.
Key:
Lane 1 Eluate from p 12 sepharose binding to non-immunodepleted extracts
Lane 2 Eluate from p 13 sepharose binding to non-immunodepleted extracts
Lane 3 Eluate from p 12 sepharose binding to immunodepleted extracts
Lane 4 Eluate from p 13 sepharose binding to immunodepleted extracts
Lane 5 Flow through from p 12 sepharose binding to immunodepleted extracts
Lane 6 Flow through after p 12 sepharose binding to non-depleted extracts
Lane 7 Flow through after p 13 sepharose binding to immunodepleted extract
Lane 8 Flow through after p 13 sepharose binding to non-depleted extract
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Figure 3.13 Kinase assay with p l3  and p l2  bound immunodepleted 
piroplasm extracts with a variety of substrates.
Equivalent volumes of piroplasm p l3  and p l2  bound extracts were asa>ed 
for kinase activity in the presence of various substrates as detailed for figure 
3.6. Kinase activity was detected by SDS/PAGE and autoradiography.
Panel A  shows kinase assay profiles with the use of immunodepleted 
extracts as prepared in Figure 3.12.
Panel B shows kinase assay profiles using non-depleted extracts as 
previously shown in Figure 3.6.
Key:
Lanes 1-4 are with assays with the piroplasm protein bound to p l3  
sepharose.
Lane 1 No exogenous substrate added to the reaction.
Lane 2 Histone with the exogenous substrate added.
Lane 3 a  casein as the exogenous substrate added.
Lane 4 Myosin light chains as the exogenous substrate
Lanes 5-8 are identical to Lanes 1-4 respectively but with p l2  sepharose
bound proteins. Lane order is identical for Panels A & B.
Bands X, Y and Z are discussed in the text.
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Figure 3.14 Immunoblotting of depleted extracts
Aliquots o f the same supernatant and flow-through samples prepared 
in figure 3.12 were separated on a 12.5% SDS-PAGE gel, Western blotted 
and probed with anti-ThaCRK2 and anti-PSTAIRE antibodies are previous.
Panel A  shows the immunoblot probed with the polyclonal anti-ThaCRK2 
anti-serum.
Panel B shows an identical blot probed with the polyclonal anti-PSTAIRE 
anti-serum.
Key:
Lane 1: Non depleted supernatant
Lane 2: Immunodepleted supernatant
Lane 3: Non-depleted flow-through after p 13 binding
Lane 4: Immunodepleted flow-through after p i3 binding
Lane 5: Non-depleted flow-through after p i2 binding
Lane 6: Immunodepleted flow-through after p 12 binding
Molecular weights are as marked.
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Figure 3.15 PC R  for su c l  homologue from Theileria annulata
Various parameters were tried as listed in Table 3.2. This reaction 
was done using the parameters listed in Mottram & Grant, 1996. The PCR 
cycling was done for 30 cycles of 94°C for 1 minute, 45°C for 2 minutes and 
72°C for 2 minutes.
Key:
Lane 1 T. annulata genomic DNA from piroplasm stage
Lane 2 T. annulata cDNA made from RNA purified from D7 cells
after 6 days at 41°C.
Lane 3 Yeast su cl cloned into the pQE60 vector (positive control)
Sizes are as indicated on the left of the figure.
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Figure 3.16 A nti-p l3 antisera reactivity with bovine and parasite 
extracts
A Western blot of various extracts was probed with a polyclonal anti- 
pl 3 antiserum (a gift of P. Nurse).
Key:
Lane 1 BL20 extracts
Lane 2 D7 @ 37°C extracts
Lane 3 D7 (4 days at 42°C) extracts
Lane 4 D7 (7 days at 42°C) extracts
Lane 5 D7 (10 days at 42°C) extracts
Lane 6 Piroplasm extracts
Lane 7 S. pom be extracts
Lane 8 S. pombe extracts
The location of the yeast pi 3 is indicated by an arrow.
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Figure 3.17 Pileup of ThaCRK2, ThaCRK3, human and S. pombe cdc2 
showing regions important for p l3sucl binding
This figure shows the regions important for interactions between CDK 
and p l3 sucl. Regions in bold are listed from I to XIII. Other important 
residues conserved across species are highlighted in grey. Mutation of these 
residues which are involved in internal bond formation in the large lobe 
affect binding indirectly by causing a conformational change. An arrow 
marks residues defined by Endicott et a l, (1994) by mutational analysis as 
being important in CDK and p!3sucl interaction.
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ThaCRK2 .............................................................
ThaCRK3 MVKRVKKSAE KTGKARKLNE GVKLKEEKDD EIKSENTETV EDSKDLKNVD
cdc2h .............................................................
Spcdc2 .............................................................
I
ThaCRK2  MRRYHKMEK. IGEGTYGWY 19
ThaCRK3 NVDKNVQKIN EEVDDKQEDS VTDSNGSDSL DKRFTPVGKH LGEGTYGQVI 100
cdc2h ................................... MEDYTKIEK. IGEGTYGWY 19
Spcdc2 ................................... MENYQKVEK. IGEGTYGWY 19
II III
ThaCRK2 KAQNN.HGEI CALKKIRVEE EDEGIPS...............T AIREISLLKE 56
ThaCRK3 KAMDTLTGKM VAIKKVKNIE YKKGVTKDRQ LVGMVGIHFT TLRELKVMTE 150
cdc2h KGRHKTTGQV VAMKKIRLES EEEGVPS...............T AIREISLLKE 57
Spcdc2 KARHKLSGRI VAMKKIRLED ESEGVPS...............T AIREISLLKE 57
IV V VI
ThaCRK2 L  HHPNI VWLRDVIHSE KCLTLVFEYL DQDLKKLLD. ...ACDGGLE 98
ThaCRK3 L S  HENL MGLVAVYVKE GSINIVMDIM A S D L K K W D ....... AKVRLT 191
cdc2h L  RHPNI VSLQDVLMQD SRLYLIFEFL SMDLKKYLDS IP..PGQYMD 101
Spcdc2 VNDENNRSNC VRLLDILHAE SKLYLVFEFL DMDLKKYMDR ISETGATSLD 107
ThaCRK2 PTTAKSFLYQ ILRGISYCHD HRILHRDLKP QNLLINREGV LKLADFGLAR 14 8
ThaCRK3 EPNVKCIMSQ ILTGLSVLHA SSFAHRDLSP ANIFIDTFGV CKIADFGLAR 241
cdc2h SSLVKSYLYQ ILQGIVFCHS RRVLHRDLKP QNLLIDDKGT IKLADFGLAR 151
Spcdc2 PRLVQKFTYQ LVNGVNFCHS RRIIHRDLKP QNLLIDKEGN LKLADFGLAR 157
VII * VIII IX
ThaCRK2 AFAIPV....................R SYTHEW TLWYRAP|vL MGSKKYSTAV 182
ThaCRK3 TVNPPIFRDC SDLETMELNA SRERMTSKW TLWYRAP|LF MGAECYHFAC 291
cdc2h AFGIPI R VYTHEW TLWYRSPEVL LGSARYSTPV 185
Spcdc2 SFGVPL.................... RNYTHEIV TLWYRAPlvL LGSRHYSTGV 191
X XI 4 *
ThaCRK2 ilWSVGCIFA EMINGVPLFP GISEQDQLKR IFKILGTPNV DSWPQWNLP 232
ThaCRK3 iFWSVGCIFG ELLSGKPLFP GTNEIDQLGK IYNLLGTP.E NSWPQASKLP 34 0
cdc2h |lWSIGTIFA ELATKKPLFH GDSEIDQLFR IFRALGTPNN EVWPEVESLQ 235
Spcdc2 ilWSVGCIFA EMIRRSPLFP GDSEIDEIFK IFQVLGTPNE EVWPGVTLLQ 241
4 4 ^
XII XIII
ThaCRK2 AYNPDFCYYE KQAWSSIVPK LNESGIDLIS RMLQLDPVQl ISAKEALKHD 282
ThaCRK3 LY.TQYSFSK PKDLSLHFQH ANSVTLDLLS KLLKLNPNEg ISAKEALDHE 38 9
cdc2h DYKNTFPKWK PGSLASHVKN LDENGLDLLS KMLIYDPAK& ISGKMALNHP 285
Spcdc2 DYKSTFPRWK RMDLHKWPN GEEDAIELLS AMLVYDPAHfc ISAKRALQQN 2 91
ThaCRK2 YF K DLHRPSEFLN GVH*...... 2 98
ThaCRK3 YFKVQPLKCK PIDLPFDFIT K*....... 410
cdc2h YF N DLDNQIKKM*........... 297
Spcdc2 YL R DFH*.................297
Table 3.1 Binding affinities and substrate preferences of ThaCRK2 and 
other kinase.
Affinity Substrate Specificity
pl3 pl2 No Sub Histone Casein
ThaCRK2 ++ + ++ +++ +
Kinase X +++ + +/- +/- ++
Key:
+++ indicates relatively strong binding/ phosphorylation 
+/- indicates relatively poor binding/ phosphorylation 
indicates no detectable phosphorylation 
N o sub - no exogenous substrate added to kinase assay 
MLC - myosin light chains used as exogenous substrate
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Table 3.2 Conditions used in attempt to PCR su c l  homologue.
The primers used as listed in chapter 2. A  number o f different 
conditions were varied during the PCR experiments as listed in the table.
Parameters Used
Source of DNA  
Concentration of DNA  
Annealing temperature 
Primer concentration 
Magnesium concentration 
Use o f detergent
Range of Parameters Tested
Genomic and cDNA
1 OOng to 1 pg for both types
40 to 55°C
1 pM to 3pM
ImM to 4.5mM
Triton X I00 added to 0.1%
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Chapter Four
Isolation & Characterisation 
of the 
Large Subunit 
of
Ribonucleotide Reductase 
from 
Theileria annulata
4.1.1 Introduction
Attempts were made to clone the sucl homologue from T. annulata by PCR 
amplification using degenerate oligonucleotide primers (a gift of Dr. J. Mottram). The 
primers were designed against two conserved regions of amino acid sequence present in 
a range of different organisms and had been used to clone a sucl homologue from 
Leishmania mexicana. (Mottram & Grant, 1996). Two PCR fragments of 230 and 
180bps were isolated and cloned as described in section 3.14. The sequence of one 
fragment (180bps) had a high degree of homology to other ribonucleotide reductases in 
the sequence databases.
Although the isolation of this gene fragment was fortuitous, studies in a number 
of organisms have shown the transcription of this gene is regulated in a cell cycle specific 
manner (reviewed in Greenberg & Hilfmger, 1996, and discussed in the introduction to 
chapter 5) and, given its central role in DNA replication, further study would elucidate 
another aspect of the cell cycle regulation of Theileria since ribonucleotide reductase 
activity varies greatly during the cell cycle. It is highest when DNA synthesis occurs and 
is hardly detectable in quiescent cells. In higher eukaryotic cells the variation in RR 
activity at different stages is due to the fluctuation in R2 protein levels whereas the levels 
of R1 protein remains constant. It has also emerged as a potential chemotherapeutic 
target.
Ribonucleotide Reductase - a new therapeutic target
Ribonucleotide Reductase (RR) (EC 1.17.4.1-2) plays a central role in the 
biosynthesis of DNA. It converts ribonucleoside diphosphates into the corresponding 
deoxyribonucleotides (dNTPs) by catalysing the reduction of Carbon -2 on the ribose 
ring. dNTPS are used almost exclusively in the biosynthesis of DNA and hence, RR is 
subject to intricate regulatory mechanisms (reviewed in Thelander & Reichard, 1979, 
Stubbe, 1990). The chemical reduction of a ribonucleotide must be initiated by an 
organic free radical. Different means of achieving this have evolved and, to date, at least 
five different classes of reductases have been characterised, all with different primary 
protein structures (reviewed in Harder, 1993).
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Class I enzymes include all known eukaryotic and viral reductases and some 
aerobic bacterial enzymes. The E.coli reductase is the best characterised. They all 
contain two subunits, the large (Rl) and small subunit (R2) arranged in an R12R22 
quaternary structure. Each Rl subunit (85 kD) has one substrate binding site with redox 
active thiols for ribose reduction and two separate allosteric sites. R2 has the tyrosyl 
radical from Tyrl22 and each R2 polypeptide (43 kD) has an iron [Fe(III)] centre which 
generates and maintains the tyrosyl radical which initiates the chemical reduction 
reaction.
Studying the differences in biochemistry and protein structure of parasitic 
protozoa and their hosts can lead to the identification of rational targets for 
chemotherapy. By and large, the biochemical and metabolic pathways of protozoa have 
not been well characterised but some striking differences have already emerged 
(reviewed in Cox, 1993). For example, all parasitic protozoa studied to date are 
incapable of synthesising the purine ring de novo thus necessitating a unique set of 
salvage enzymes for the scavenging of host purines. Most are prototrophic for 
pyrimidine synthesis. However, Trichinella vaginalis and Giardia lamblia are obligatory 
deoxyribonucleotide scavengers suggesting that they lack a ribonucleotide reductase 
activity or possess a homologue with a very different substrate specificity to that of the 
mammalian counterparts.
A species specific anti-proliferative drug?
Pioneering work with the Herpes simplex virus RR showed that synthetic 
peptides corresponding to the first six amino acids at the carboxy terminus of the R2 
subunit could inhibit the viral enzyme by preventing subunit association (Dutia et 
al, 1985, Krogsrud et al, 1993). This sequence is not well conserved between 
prokaryotic and eukaryotic subunits and so the inhibition is specific to the viral enzyme 
which makes it an ideal antiviral agent. Further work using chemically modified 
derivatives of the hexapeptide has produced much more potent inhibitors of the viral 
enzyme in vivo (Luizzi et al, 1994) and some of these compounds have been cleared for 
clinical trials. Indeed many major pharmaceutical companies have therapeutic peptides
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undergoing clinical trials for efficacy against a range of conditions (Kelley, 1996). Most 
of these molecules are highly potent hormones or their analogues (the smallest being a 
tripeptide, the thyrotropin-releasing hormone). Some peptide analogues are in pre- 
clinical trials and these include inhibitors against HTV and hepatitis viruses together with 
endotoxin neutralising peptides but problems may arise in terms of the quantities needed 
to be synthesised if used for clinical applications. This may necessitate new developments 
in the bio-synthesis of peptides since the traditional bulk peptide synthesis by adding a 
single amino acid in a stepwise fashion will not achieve an economy of scale comparable 
with those drugs produced by conventional drug manufacture.
Given the successful use of peptide analogues designed to block subunit assembly 
of the Herpes simplex RR, it may be possible to exploit the differences in R2 C terminus 
sequences to design species specific anti-proliferative peptides against a wide range of 
parasites.
In order to test whether the RR subunits of Theileria are sufficiently distinct from 
the mammalian counterparts and, therefore, whether RR could be considered as a 
suitable chemotherapeutic target, experiments were undertaken to fully characterise the 
large subunit. As studies in other organisms have shown that the enzyme activity and 
transcription are regulated in relation to the cell cycle, experiments were undertaken to 
analyse the expression and sub-cellular localisation of the molecule in Theileria annulata. 
As the promoter regions of other cell cycle regulated genes have been studied, a genomic 
clone encoding the Rl subunit of T. annulata was isolated with the aim of sequencing 
the region 5’ to the start codon. This region, together with the regulation of the 
expression of R l, is considered in chapter 5.
This chapter focuses on the isolation and characterisation of the full length cDNA 
from a library using the PCR fragment generated (chapter 3) as a probe, isolation and 
restriction enzyme analysis of a genomic clone and analysis of the expression of the 
parasite gene in the bovine life cycle stages. A parasite specific region of the parasite 
cDNA was cloned into an expression vector to produce a fusion protein used for 
immunisation. This gave parasite specific serum which recognises a polypeptide of the 
predicted molecular weight of the large subunit on immunoblots. Expression and 
localisation of the Rl polypeptide during various stages of the life cycle were analysed by 
Western blotting and immunofluorescence.
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4.1.2 Isolation of a Theileria Ribonucleotide Reductase PCR Fragment
The primers designed to amplify a conserved region of the sucl gene from T. 
annulata are described in section 3.14 and the conditions used are as described in 
Mottram & Grant (1996). Two fragments of 230 and 180 bps were cloned from PCR 
performed with piroplasm DNA as template. Both fragments were gel purified and 
ligated into the pCR vector (Invitrogen). When sequenced, the 180bp fragment was 
found to contain a single open reading frame (figure 4.1a) that had high homology to a 
conserved region of several eukaryotic large subunits of ribonucleotide reductase. This 
was determined by searching the SwissProt database using the GCG FASTA 
programme. This homology is shown in Figure 4.1b, using the species with the highest 
homology, P. falciparum, as an example.
4.1.3 Southern Blotting shows the PCR fragment is parasite derived
The TaRl (T.annulata Ribonucleotide Reductase subunit 1) 180 bp PCR 
fragment was used to probe a Southern blot to confirm its parasite origin and to test for 
homology with the bovine Rl gene.
The probe hybridised strongly with the piroplasm DNA (Figure 4.2, Panel C) and 
weakly with the cloned macroschizont cell line D7 DNA (Panel B) which is 
predominantly host DNA. There are some faint bands hybridising to the BL20 DNA 
(Panel A) which are probably due to the probe hybridising to repetitive DNA sequence 
restriction fragments of the same mobilities seen on the ethidium stained gel (data not 
shown). This blot also showed that the gene is likely to be single copy in the parasite 
genome. The three restriction enzymes used do not have sites within the TaRl PCR 
fragment used as the probe (see figure 4.3b). The cloned cell line DNA showed single 
hybridising bands of 8.6, 9 and 9.5kb with each enzyme and as this cell line is derived 
from a single parasitised cell it should contain a single parasite genome. The signal is 
fainter than that obtained with piroplasm DNA due to the small parasite contribution to
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the total DNA isolated from the cell line. Piroplasms as they are isolated from an 
infected animal, are always composed of more than one genotype and hence there is 
polymorphism seen with the BamHI digest (Panel C Lane 1) giving three extra bands of 
11, 9.2 and 2.7kb.
4.1.4 Isolation and characterisation of a full length cDNA clone
The PCR fragment was used to screen both cDNA and genomic libraries by filter 
hybridisation. The cDNA library was constructed in the ^ZAP II vector (Stratagene) 
from total RNA isolated from cell line D7 at day 7 during differentiation and the genomic 
DNA library was constructed in the MDASH vector (Stratagene) using purified D7 
merozoite DNA. Both libraries were prepared by Dr. J. Kinnaird. A total of 20000 
plaques were screened from the cDNA library of which 0.25% were positive after the 
first round of screening. Twenty plaques were selected for a second round of screening 
and, after two further rounds of screening, nine cDNA clones were isolated. The cDNA 
clones were in vivo excised and DNA purified from the resulting pBluescript vector. The 
DNA preparations were then restriction digested to determine insert size and two 
suitable inserts were selected for sequencing. One insert was 2 kb long while the other 
was possibly a full length clone of 2.9kb. For the genomic library screen, a total of 6000 
plaques were screened and twelve clones were isolated after three rounds of screening. 
One of these was selected and studied in detail and was shown to contain the entire 
cDNA sequence by hybridisation and restriction mapping (section 4.1.6).
Initially sequencing was carried out from either end of the cDNA inserts using 
Sp6 and T7 primers. Sequencing from the T7 primer revealed an SphI site. Restriction 
mapping of the plasmid with SphI confirmed the presence of a l.Okb SphI fragment 
which was subcloned into the pTZ19R vector (Pharmacia) and sequenced as before. 
Internal primers were designed from sequence data to complete the sequencing analysis 
of the cDNA on both strands due to the lack of any other suitable restriction sites for 
subcloning (shown on figure 4.3b). The sequence data was assembled and analysed using 
the GCG package (Devereux et al, 1984).
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T. annulata R l cDNA
The cDNA encoding the large subunit of ribonucleotide reductase of T. annulata 
is 2.8kb long and has an open reading frame of 2712 nucleotides encoding a polypeptide 
of 891 amino acids from the first in frame start codon with a predicted mass of 97kD. 
Figure 4.3a shows the full length cDNA sequence with the translated amino acid 
sequence.
The cDNA sequence contains three possible ATG translation start codons, all of 
which are in frame. The first ATG (Ml, figure 4.3a) encountered in the ORF has the 
highest homology to a protozoan consensus sequence for translational initiation (see 
4.1.5). There is an in frame TGA stop codon 39bps upstream from this most 5’ ATG 
codon. As shown in figure 4.4, the pileup comparison with other eukaryotic Rl proteins 
suggests that the third ATG (M3) is the most likely start codon. As it has not yet been 
determined whether the sequence encoding this possible N-terminal extension is 
translated, this ATG (most downstream) will be referred to as 1 in future numbering. 
From this start codon there is an open reading frame of 2499 bps encoding a protein of 
832 amino acids. At the 3' end, the eukaryotic polyadenylation signal AAUAAA is not 
present but a 20bp poly [A] tail is seen 60bp downstream of the first in frame stop 
codon.
R l Sequence Conservation
There is a high degree of conservation in regions of functional importance. Table 
4.1 shows the % identity and similarity between T. annulata R l compared to other R l 
subunits from other species present in the database calculated from M3, the third start 
codon (i.e. omitting the possible N-terminal extension). The T. annulata R l (TaRl) has 
the highest identity to the Rl subunit from the related Apicomplexan, P. falciparum 
(PfRl - 72%) but TaRl is slightly more similar to mammalian R l subunits than is PfRl - 
for example - TaRl is 70% identical to human Rl whereas PfRl is only 66% identical to 
the human Rl. Mammalian Rl subunits appear to be very highly conserved (97% identity 
between mouse and human). Rather surprisingly the fission and budding yeast subunits 
are only 76% identical to each other which perhaps reflects the evolutionary divergence
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between the two yeasts. Generally, the overall degree of conservation is not high 
between eukaryotic /  viral Rl subunits and E. coli Rl (22-33% identical) but when 
conservative substitutions are taken into account this rises to between 40 and 50%. 
Figure 4.4 shows a pileup comparison of the amino acid sequence of TaRl with 
representative R ls from other phylogenetic groups. The regions important in the 
chemistry of the enzyme are discussed below, showing how these regions are conserved 
in the Theileria subunit.
From X-ray crystallography studies on the Exoli Rl subunit by Uhlin & Eklund 
(1994), it was shown that the Rl subunit is composed of three domains:
1) A mainly helical N-terminal domain of -220 residues.
2) One a  helix/p barrel domain of -480 residues.
3) An a|3aa|3 domain of -70 residues.
Since all the eukaryotic Rl subunits show homology to the Exoli subunit over 
the length of the polypeptide, it is reasonable to assume they fit a similar three 
dimensional structure.
The active site contains one pair of cysteine residues which undergo oxidation 
during the reaction to form a disulphide bridge. However, as in many other thiol redox 
proteins, these are not located near to each other, but are separated by over 200 residues 
(Cys225 & Cys462 in Exoli). Both are present in the Theileria Rl(Cys216 & Cys442) 
and the surrounding regions are highly conserved. This cysteine pair come into close 
contact once the polypeptide chain folds, being on two adjacent (3 strands. A further 
cysteine (Cys439 in Exoli, Cys427 in T. annulata) acts directly on the substrate ribose 
ring to create a thiyl substrate radical. Figure 4.5 shows how these three cysteines and 
flanking sequences have been conserved between the prokaryotic and eukaryotic R l 
subunits. Other highly conserved residues include those lining the pocket of the active 
site which flank the active cysteines as seen in figure 4.5. These residues are either polar 
or hydrophobic. There are no aromatic residues within the substrate cavity and the only 
charged residue is Glu441 in E. coli (Glu 429 in TaRl) which may serve to bind the 
ribose moiety of the substrate or function as a base in the redox reaction.
Uhlin & Eklund proposed the following mechanistic model for ribonucleotide 
reduction based on their structural studies of the Rl from Exoli.
1. Removal of the 3’ Hydrogen atom by a thiyl radical of Cys439.
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2. Protonation of the ribose ring 2’OH by the Cys225 with the resulting positive charge 
at 03 being stabilised by Glu441.
3. Redox reaction by Cys225 and Cys462.
4. Reduction of the disulphide bridge between Cys225 and Cys462 by the transfer of 
thiol exchange reactants via the flexible carboxyl terminal of Rl. This involves two 
further conserved cysteines (Cys754 and Cys759) and effectively reactivates the enzyme. 
Two tyrosine residues (Tyr730 and Tyr731) aid in the electron transfer between the large 
and small subunit (Ekberg et al., 1996). Tyr730 is hydrogen bonded to Tyr731 and 
Cys439. These are conserved in the Theileria Rl (Tyr 737 and 738) and Tyr731 lies 
close to where the R l and R2 subunits interact. These three residues together with five in 
the R2 subunit form a hydrogen bonded network running through the holoenzyme 
complex. The degree of homology between prokaryote and eukaryote R l subunits is 
remarkably high over these regions showing a conservation of mechanism common to all 
class I ribonucleotide reductases. (Figure 4.5). The divergence between Theileria R l and 
other higher eukaryotic enzymes only becomes striking over the last 50 amino acids at 
the C- terminus and it was for this reason that this region was used as to generate 
parasite specific serum (see section 4.1.8).
Both the Plasmodium and Theileria N termini show differences from the 
mammalian Rls which may indicate that the allosteric regulation of the parasite enzymes 
differs from that of their mammalian hosts. If the putative extensions on the Plasmodium 
and Theileria R ls were shown to exist in the mature polypeptide then this may add 
weight to the possibility of the allosteric regulation being different to that of mammalian 
enzymes. The C terminal cysteines (Cys 817,827 and 830 in Theileria) that interact with 
thioredoxin and glutaredoxin are conserved, together with the Asp 56 (Glu 54 in TaRl) 
which is involved in dATP feedback inhibition (Caras & Martin, 1988). The position of 
the last Cys residue is highly conserved being placed three residues 5’ to the translational 
stop (except in HSV where it is two residues from the stop). Although the conservation 
of the first two (Cys 817, 827) is not obvious because of the gaps introduced to 
maximise the alignment, in all species there is a highly conserved spatial arrangement 
with the first and second being separated by 8-10 residues and the second being 2-4 
residues from the last. Plasmodium and Theileria show a very high degree of spatial 
arrangement of these cysteine residues.
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The R1/R2 Binding Site
It was shown that deletion of at least 6 residues from the carboxyl terminus of the 
Herpes simplex virus (HSV) R2 prevented subunit association (Filatov et al., 1992). This 
has also been confirmed for the small subunit of ribonucleotide reductase from other 
species, intensifying interest in the use of peptidomimetric inhibitors as potential 
therapeutics.
Attempts to locate the site of binding of R2 on the large subunit have utilised 
NMR studies of purified mouse proteins (Lycksell et al, 1994) which showed that the 
R2 C- terminus loses much of its free mobility after introduction of the Rl protein into 
the solution. More recent work has employed peptide protection assays and photoafFmity 
labelling (Davis et al, 1994). Peptide protection assays mapped the R2 binding to 
residues C terminal to aa 325 in the mouse R l. Photoreactive R2 peptides labelled the 
Rl protein at positions 724-736 and 778-789 which lie very close to the C-terminal of 
the Rl subunit. As mouse Rl is likely to be very similar to the bovine Rl and since these 
regions are likely to be important for the design of species specific inhibitors, the degree 
of sequence conservation between mouse and Theileria was analysed in detail over these 
two regions (Figure 4.6). The homology in region 2 is not as high as that for region 1 
and is displaced in the pileup comparison by an insertion of 30-40 residues in Theileria as 
seen in figure 4.4 though the positions relative to the extreme C-termini are very similar. 
However, this insertion may have a significant effect on the three dimensional structure 
assumed by the R l subunit upon folding.
There is considerable variation between species in the C-terminal of Rl which is 
reflected in the R2 C terminal sequences. The actual position of the R2 subunit 
interaction is conserved in the 3D model of the E.coli and mouse Rl despite the regions 
involved having very low homology between the pro - and eukaryotes.
Region of R l subunit dimerisation
Connor et a l (1993) made deletion mutants of the Herpes simplex Rl to map the
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R1/R2 site of interaction and also to determine the region ofR l required for 
dimerisation. In HSV, residues required for dimerisation stretch from 421-434 but they 
conclude that other regions may also be necessary. The strength of interaction between 
the mutant Rl subunits was not determined. The homology over this region between the 
HSV and other Rl sequences is shown in figure 4.7. This region is not well conserved 
between species therefore it is not possible to infer that the same region is involved in 
dimerisation of other Rl subunits. It is possible that dimerisation is highly species 
specific. It would perhaps be more meaningful to compare regions known to be involved 
in Rl dimerisation in the higher eukaryotes given that the homology of Theileria to HSV 
Rl is only approximately 30% but to date this work has not been done in the higher 
eukaryotes.
4.1.5 Translation initiation site of TaRl
The open reading frame of the TaRl cDNA clone extended for 229 base pairs 
upstream of the consensus ATG codon encoding the consensus N-terminal methionine of 
other eukaryotic Rl genes. Analysis of this region showed it to contain two additional 
upstream in frame ATG codons shown in figure 4.8. This hints at the possibility that this 
may be a possible N-terminal extension of the polypeptide.
A comparison of the nucleotide sequence around translation initiation sites 
(Kozak, 1987) has revealed an optimal sequence for vertebrates which is GCCACCatgG, 
although the most important effects on translation appear to be a requirement of a purine 
at the -3 and G at the +4 position. A similar database search was undertaken for the 
sequence flanking the translational initiation site in protozoa (Yamauchi 1991). For the 
sporozoans the consensus sequence was found to be
a/t t/a NTTNT t/a NAAAAATGA a/g a/t
If sequence flanking each of the three ATG codons in the upstream region are 
lined up with the above sequence and the % fit to the sporozoan consensus sequence is 
calculated (figure 4.8) then the first ATG codon encountered has the best fit to both
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protozoan and Kozak consensus sequences. Ml and M3 both fit the minimum Kozak 
consensus of a purine at -3 and G at +4 which gave 60-90% efficiency of translation 
(Kozak, 1987). Yamauchi noted that the sporozoans exhibited a T bias in positions -13 
to -5 (the A of the ATG codon is counted as +1) which could form a stem loop structure 
with the A residues flanking the ATG codon. If applied to the three sequences 
surrounding the start codons (Ml-M3), the best fit with the Yamauchi consensus 
sequence is found with the 1st ATG codon (Ml).
Sequencing of a 2.9kB P. falciparum R l cDNA clone showed there to be 
another in frame start codon prior to the consensus eukaryotic start codon based on 
homology (Chakrabarti et al, 1993). But, as with the T. annulata N-terminal region, this 
has not been shown as yet to be present in the mature polypeptide and it may be that 
these regions are untranslated (see chapter 5).
4.1.6 Restriction mapping of genomic clones
Of the 12 genomic clones isolate by library screening, one (X3) was selected for 
further analysis. By Southern blotting and hybridisation this clone was shown to be very 
likely to contain the entire TaRl gene sequence by hybridisation with 5’ (Pstl/Xhol 
fragment of 768bps) and 3’ (XhoUXbal fragment of 170bps) specific probes prepared 
from the cDNA clone. Using various restriction enzyme digests combined with 
hybridisation analysis using 5’ and 3’ probes from the TaRl cDNA clone (an example is 
shown in figure 4.9) it was possible to construct a restriction map of the entire genomic 
region - this is shown in figure 4.10. The whole insert is 16.5 kb and using double digests 
where one enzyme cuts in the XDASH polylinker, the fragments adjacent to the left and 
right arms of the X vector could be positioned.
Subcloning from X3
In order to begin a preliminary analysis of gene structure in relation to the cDNA, 
to obtain sequence for the study of possible promoter elements and to map the 
transcriptional start site (chapter 5), a suitable fragment was selected for sub-cloning 
from X3. A 2.7 kb fragment, produced by digesting the X3 clone with BamHI and EcoRI
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which hybridised to the 5’ probe only (figure 4.9 panel A lane 9), was predicted to 
contain sufficient 5’ non-coding sequence and to extend to the BamHI site represented in 
the cDNA clone (at position 121 lbp figure 4.3a+b). This was subcloned into the 
pBluescript vector, restriction mapped and partially sequenced. The insert was sequenced 
from either end using T3 and T7 primers. From the BamHI site used in the sub-cloning 
266bps of sequence was obtained extending towards the 5’end of the gene. This was 
99% identical to the cDNA clone and no introns were found (figure 4.10). Generally, 
introns in Theileria, tend to be small, ranging from 20-120 bps in the ThCRK2 for 
example (Kinnaird et al., 1996). There is a single intron in the P. falciparum R1 gene of 
184 bases further upstream from the region sequenced in Theileria. However it is 
possible that introns may be present elsewhere in the gene. Analysis of the 3’region 
would require a further subcloning step using a BamHI/ Hindlll digest of the genomic 
lambda clone. Given that the location of four of the five introns in PfPK5 are conserved 
in the ThCRK2 gene, it is possible that the intron site found in the P. falciparum R1 gene 
is conserved in T. annulata.
4.1.7 Expression of TaRl in bovine life cycle stages.
Since the large subunit of ribonucleotide reductase is involved with the 
production of deoxyribonucleotides for DNA replication, it follows that it should be 
expressed in those life cycle stages actively undergoing DNA replication. To investigate 
this experimentally, RNA was available from non-differentiating and late stage 
differentiated D7 cells and from piroplasms. The original TaRl 180bp PCR fragment was 
used to probe a Northern blot to determine its expression in different bovine stages of 
the life cycle (Figure 4.11, Panel A).
The gene is transcribed as a 2.8kb message in all intracellular bovine stages of the 
parasite with an apparent increase in transcript levels during the differentiation of the 
parasite to the merozoite stage and a decrease in the piroplasm stage. Because of the 
mixture of host and parasite RNA in the intralymphocytic stages it is difficult to estimate 
the absolute contribution of parasite RNA. Probing identical samples with a probe from 
the T. annulata DNA polymerase 6 subunit (Panel B)(Smyth & Kinnaird, in preparation)
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gave similar related levels between the two intralymphocytic stages but there was no 
comparable decrease in the piroplasm stage. With the T. annulata tubulin probe (Panel 
C) there is a similar pattern to the TaRl signal is seen, with a decrease in signal in the 
piroplasm stage. The tubulin probe detects two abundant messages, one of which (1.8kb) 
corresponds to the predicted size of the tubulin mRNA. The origin of the second 
message is uncertain and is currently being investigated (Logan, pers.comm.). There was 
no cross-hybridisation with bovine RNA indicating that the hybridisation detected is 
parasite specific. Ethidium staining of an identical set of samples run in parallel on the 
same gel showed the relative contributions of host and parasite large and small ribosomal 
RNAs (Panel D).
4.1.8 Production of a parasite R1 specific antisera
Commercial antibodies are available, generated against the large subunits of 
higher eukaryote ribonucleotide reductase which also recognised the bovine R1 (see 
chapter 6), In order to distinguish between host and parasite molecules, it was important 
to produce a Theileria specific antiserum against the R1 for use in immunoblots and 
immunofluorescence assays. By comparing the pileup amino acid sequences between 
Theileria and higher eukaryotic Rl, it was decided to express the 3’ end of TaRl in E. 
coli and use the resulting recombinant protein as an immunogen as this region differed 
extensively from any of the mammalian Rl subunits (see Fig. 4.4).
It was decided to use the GST fusion protein system (Pharmacia) as it allows for 
a single step purification by virtue of high affinity binding to glutathionine - sepharose. 
The protein is expressed fused to a portion of the glutathione S transferase (GST) of 
Schistsoma japonicum. The purified GST fusion protein is then eluted from a glutathione 
sepharose affinity column using lOmM glutathione. A GST expression vector (pGEX- 
5X-2) was digested with BamHI and Xhol and purified using the Wizard Clean Up Kit 
(Promega). A 270bp San3AI-XhoI at the extreme C-terminus of the cDNA clone (the 
Xhol site being in the polylinker) was compatible with the sites in the vector and was in 
frame. However, as Sau3AI cuts frequently in the cDNA clone, a 480bp Sphl-Xhol 
fragment was isolated initially. This fragment was purified and then digested with Sau3AI
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to give two fragments of 270bps and 210bps. Since only the 270bp fragment had 
compatible ends with the linearised vector the whole digest was used in the ligation. 
Transformants were screened for the presence of the 270bp insert and some were 
sequenced using a 5’ pGEX specific primer to ensure that the insert was in the correct 
reading frame. A small scale expression was performed to optimise sonication and 
purification conditions prior to a large scale expression with 2 litres of culture. The 
stages of expression and purification are shown in Figure 4.12. On induction with IPTG, 
a prominent polypeptide of 36kDa was detected when extracts of the induced bacteria 
were analysed by SDS-PAGE gel electrophoresis. This is the predicted size for GST + 
TaRl (26 kDa + lOkDa). The fusion protein was detectable in the supernatant of the 
sonicate (Lane 4) and was purified on a glutathione sepharose column. The purified 
protein was eluted using excess glutathione (Lane 5). The yield of fusion protein was 
approximately 3mg per litre. This was used to immunise 2 rabbits according to standard 
procedures (Harlow & Lane, 1988).
Sera from both rabbits were tested for reactivity against BL20 and piroplasm 
extracts by Western blotting and the results of are shown in Figure 4.13 together with 
the reactivity of the pre-immune serum. The final bleed of rabbit CM97 (figure 4.13 
Panel B) recognises a protein of ~97kDa which is the predicted size for the Rl subunit 
from Theileria. No cross-reactivity with the bovine R l was detected. It is not possible to 
determine if the size of this reactive protein could account for the presence or absence of 
the putative N-terminal extension due to the limits of resolution of the gels in this size 
range. The serum also recognises a smaller protein of approximately 45kDa which is not 
detected in the pre-immune serum. Serum from rabbit CM82 also recognises a 97kDa 
polypeptide (Panel A, final bleed lane 2) but less strongly than CM97 together with a 
faint 66kDa polypeptide but no 45kDa polypeptide. The background of the pre-immune 
serum was high with CM82 so it was decided to proceed mainly with CM97 serum for 
immunoblotting (Chapter 6).
If serum CM97 is pre-incubated with GST, the detection of the 97kDa and the 
45kDa polypeptides is not blocked which eliminates the possibility of cross-reactivity of 
the rabbit serum with an epitope common to GST and an unknown parasite protein. Pre­
blocking the serum with the fusion protein removes both reactive bands suggesting that 
an epitope on this part of TaRl is present in parasite polypeptides of 97kDa and 45kDa.
I l l
It may be that immunoprecipitation of native protein would be specific for the R l 
subunit, in that the serum may recognise a denatured epitope in the unknown polypeptide 
of 45kDa.
The antiserum was not subjected to any purification procedure since background 
was low at the dilutions used for Western blotting (1/200).
Immunolocalisation of TaRl
It was of interest to determine if the Rl subunit in Theileria localised to the 
cytoplasm as had been shown for mouse Rl (Engstrom et al, 1984). Both sera were 
used successfully in immunofluorescence assays (IFA), although as before the 
background with serum CM82 was higher. Several different fixation protocols were 
undertaken (see chapter 2). Specific parasite reactivity was only obtained with cell 
preparations fixed with 4% formaldehyde followed by permeabilisation in 0.25% Triton 
X100. Figure 4.14 shows both the anti-TaRl sera reacting specifically against the 
schizont nuclei. Panel A shows D7 cells stained with DAPI staining - clearly indicating 
host and parasite nuclei. Panel B shows the same cell with FITC detection of the CM82 
anti-TaRl antibody reactivity with the reactivity localised to all the parasite nuclei within 
the schizont. It seems that the nuclei are reactive with this serum although this should be 
confirmed by immunoelectron-microscopy. Panel C shows a BL20 cell stained with 
DAPI while panel D shows the same uninfected cell stained with FITC labelled TaRl 
antibody from rabbit CM82. There is no specific reactivity, only background staining of 
the host cytoplasm. Panel F shows the CM97 anti-TaRl serum reacting also with the 
schizont nuclei in D7 cells. This is a highly specific reaction as judged by the very low 
reactivity of D7 cell extracts on Western blots with the pre-immune serum from rabbit 
CM97. The fact that both rabbit anti-sera recognise schizont nuclei and the only common 
polypeptide reacting by Western blotting common to both sera is a 97kDa polypeptide, 
the predicted size of the TaRl subunit, shows that this is a specific reaction with the 
TaRl subunit. This appears predominantly localised to the parasite nuclei and all nuclei 
in every infected cell were reactive.
A monoclonal antibody against an unmapped epitope of mouse R l was
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purchased (Inro-Biomedtek, Sweden) and was used in IFA and immunoblot assays. 
Figure 6.3 (Panel D) shows that this antibody recognises only a polypeptide of the 
predicted molecular weight for the bovine Rl subunit. Figure 4.15 shows that the 
antibody only reacts with the host by immunofluorescence. Panel A shows BL20 cells 
stained with DAPI while panel B shows the same cells stained with FITC labelled MAb. 
There is a diffuse staining throughout the cell cytoplasm, a location identical to that 
found in studies undertaken with mouse MDBK and fibroblast cells (Engstrom et al., 
1984). Generally, the intensity of staining was uniform but a few cells were noted where 
the intensity of reactivity in the cytoplasm was considerably brighter. Panel C shows a 
D7 cell stained with DAPHI, Panel D shows the same cell with FITC labelled mouse Rl 
antibody. There is no cross-reactivity with the parasite macroschizont, some cells clearly 
showing a reduction in the level of staining over the area occupied by the schizont and 
localisation of the host Rl again is to be dispersed throughout the cytoplasm. The 
fixation procedure is identical to that used by Engstrom et al. (1984) which showed that 
the cytoplasmic reactivity is specific and not due to lack of permeabilisation of the 
nuclear membrane by the fixation protocol. This was demonstrated with an antibody 
directed against the polyoma virus large tumour antigen which was localised to the 
nucleus in virus infected mouse fibroblast cells under the same fixation conditions. Thus 
it is likely that for all higher eukaryotes, the Rl subunit is localised in the cytoplasm. This 
contrasts with the localisation of the TaRl subunit to the parasite nuclei in the D7 cells 
(Figure 4.14 Panel B & F).
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4.2 Discussion and conclusions
This chapter deals with the isolation of the large subunit of ribonucleotide 
reductase from T. annulata. The number of clones isolated during the library screen and 
the intensity of hybridisation signal suggests that it is very abundant in differentiating 
cells. However it is not clear as to whether the expression is up-regulated or whether the 
increase in signal intensity mirrors the increase in parasite nuclear content. The transcript 
pattern is most like that of p-tubulin with a similar signal intensity in D7 @ 37°C and a 
considerable increase at day 7 in differentiation but for the 1.8kb tubulin transcript this is 
not as high as TaRl. However, the picture is complicated by the presence of the 3.2kb 
hybridising RNA which is also strong with the tubulin probe. There is a greater decrease 
in hybridisation signal with the tubulin probe in the piroplasm stage. The increase in 
hybridisation with the polymerase 6 probe from day 0 to day 7 is apparently less but the 
transcript levels are surprisingly high in the piroplasm stage given the limited division 
occuring in T. annulata piroplasms. As antibodies are not yet available for tubulin and 
polymerase 6, it is not possible to tell if these transcript levels are reflected in the protein 
concentration. It certainly seems that all three genes may be differently regulated in the 
piroplasm stage although it is possible that this could be due to differences in messenger 
stability. It should be possible to measure the relative transcription rates in these stages 
by preparing nuclei and performing nuclear run-on assays.
Both antisera generated against the GST-TaRl fusion protein showed that TaRl 
has a predominantly nuclear localisation in the macroschizont stage. All the nuclei in each 
macroschizont of infected cells were equally reactive. This in itself indicates that the 
protein level does not fluctuate significantly over the parasite nuclear division cycle, 
supporting the view that control of RR activity is by expression of the small subunit. It 
may ultimately be possible to demonstrate cyclical regulation of activity using 
synchronised parasite populations. However, because of difficulties in distinguishing host 
from parasite enzymes this will probably rely on specific immunoprecipitation of host and 
parasite enzymes.
The nuclear localisation is interesting and leads to the conclusion that 
deoxyribonucleotides are synthesised very near to the site of use. It is not possible to say 
how much of the dNTP synthesis pathway occurs in the nucleus or which molecules
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can be transported across the nuclear membrane. It is probable in Theileria that the 
nuclear membrane does not break down at mitosis, a situation found in other lower 
eukaryotes (reviewed in Fantes, 1989). In mammalian cells, R l is present in the 
cytoplasm and the nuclear membrane does not break down until early in mitosis and after 
DNA synthesis has taken place. The peak of RR activity is in S phase (Murphree et al, 
1969) suggesting that dNTPs are transported into mammalian cell nuclei across the 
nuclear membrane. There is no information in the literature of the subcellular localisation 
of Rl in other lower eukaryotes.
The cDNA clone isolated may encode a unique N-terminal extension which 
would make the polypeptide longer than any of the other higher eukaryote R l subunits 
isolated to date. The fact that this extension contains an in-frame start codon which fits 
the Kozak and Yamauchi consensus sequences suggests that the translation start site lies 
here. It is necessary to confirm that this extension is present in the mature protein, 
possibly by producing a fusion protein to this region, raising anti-sera to this protein and 
then testing whether reactivity can be detected in parasite protein extracts. Certainly, it is 
interesting to speculate why T. annulata should contain this extension and whether it 
serves any function in the mature enzyme.
The reason for such a long N-terminal extension is unclear. It could be possible 
that the apicomplexan Rl mRNAs encode N-terminal extensions. This will become 
clearer when the sequencing of the Toxoplasma gondii Rl is completed (Kim, pers. 
comm.). Since it has postulated that the N-terminal region has a functional role in the 
allosteric regulation of the enzyme (Caras & Martin, 1988), it may be that the 
apicomplexans have a different means of allosteric regulation to that used by higher 
eukaryotes. Certainly, there may be some fundamental differences between the 
mammalian and the Plasmodium RR enzyme as might be expected in order to provide 
sufficient quantities of the dATP and dTIP for the replication of Plasmodium DNA 
given the AT richness of the Plasmodium genome. Whether this is via a different 
allosteric feedback mechanism or a differential sensitivity of the enzyme to feedback 
inhibition by dATP will require characterisation of the recombinant Plasmodium enzyme 
(J.Salem, pers. comm.).
Thus, I would conclude that the presence of a coding N-terminal extension may 
be a feature of the apicomplexan Rls and may indeed be a feature of protozoans R ls in
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general. It is also possible that the presence of 3 ATG codons may indicate alternative 
translational starts sites which could be used in different life cycle stages to modulate the 
activity of the enzyme.
With respect to the differential expression of TaRl in the bovine stages of the life 
cycle, it is possible that the increase in signal intensity during differentiation parallels the 
increase in size and RNA content of the macroschizont. This is a stage where there is 
considerable nuclear division occuring in the schizont and the increase in TaRl RNA 
reflects this. It is constitutively expressed at all life cycle stages and appears to increase 
at day 7 rather more than for tubulin and considerably more than DNA polymerase 6. 
Scanning these Northern blots would allow these increases to be clarified in relation to 
one another. The piroplasm stage in T. annulata only undergoes two rounds of nuclear 
division (Conrad et al, 1985) and the population is asynchronous. This would be 
reflected as a reduced requirement of the components of DNA synthesis and the 
reduction of the signal on the Northern blot suggests that the transcription of TaRl is 
down-regulated when nuclear division is arrested. However, there is no similar decrease 
in hybridisation signal from the DNA polymerase 6 probe, suggesting that its 
transcription is subject to a different regulatory mechanism in the piroplasm stage.
The region upstream of the consensus start ATG of TaRl is 57% AT which is 
well below the mean %AT of 80% calculated by Yamauchi for the sporozoan mRNAs. It 
is possible that this high % plays a role specific for lower eukaryotes in translational 
efficiency. This figure is biased in favour of the large number of Plasmodium sequences 
in the database. If only Babesia, Toxoplasma and Theileria sequences are considered 
then the %AT falls to 60%. Coding regions tend to have 50-60% AT whilst non-coding 
intergenic regions contain -70% AT. This suggests that the N-terminal region may well 
be translated. Complete clarification of the true translation start site will depend on 
further experiments aimed at direct N terminal sequencing of the purified protein from 
cell extracts or by generation of a specific anti-serum against either a peptide sequence 
from the putative N-terminal extension or a fusion protein made from this region.
The genomic sequencing could be completed which would show if there are any 
introns within in the genomic clone and if so, does the location match the intron site 
found in the P. falciparum Rl gene. The sequencing of the upstream region of the 5’ end 
is discussed in chapter 5.
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The identity of the cross-reacting protein of 45kDa seen on immunoblots with 
the CM97 anti-TaRl anti-serum is unknown but it does appear to be parasite specific. It 
would be of interest to screen a library with this serum to try to isolate a cDNA clone 
expressing this molecule as results in chapter 6 suggests that it may be constitutively 
expressed in intracellular bovine stages at least.
Could Anti-sense oligonucleotides be targetted against TaRl?
One disadvantage of drugs interfering with protein function (i.e. 
postranslationally) is that usually only one or two point mutations are needed to cause 
resistance to the drug. Use of antisense deoxyribonucleotides (AS-ODN) to inhibit 
specific mRNA expression and translation would need several sequence mutations to 
destabilise binding of the AS-ODN and target sequence. The mechanism of action of AS- 
ODNs is either by steric blocking of gene expression or by activation of cellular RNAseH 
which cleaves the RNA component of the duplex. The blocking effect would prevent 
pre-mRNA splicing, polyadenylation or transport of the mRNA if the RNA/DNA hybrid 
forms in the nucleus. Within the cytoplasm the hybrid would block initiation of 
translation or ribosomal elongation (Sharma & Narayanan, 1995).
In vitro AS-ODN has been shown to inhibit the replication of T. brucei 
(Verspieren et al., 1987) and L. amazonensis (Ramazeilles et al., 1994). Work in P. 
falciparum using antisense oligos in vitro (Barker et al., 1996) against a range of targets 
such as dihydrofolate reductase (DHFR), triose phosphate isomerase (TPI) and RR 
showed that they may have potential as chemotherapeutic agents but also as a molecular 
tool for examing gene function in relation to parasite biology. The oligonucleotides were 
modified by the addition of phosphorothioate bonds to reduce the nuclease sensitivity of 
the oligonucleotides. The inhibitory effects of the AS-ODNs on DNA synthesis was 
assayed by [3H] hypoxanthine incorporation after addition of AS-ODN. A number of 
interesting conclusions arise from this study - antisense oligos are best designed against 
sequence downstream from the transcription start site and that they are specifically taken 
up into parasite infected erythrocytes. The exact mechanism of uptake is unknown but it 
probably involves changes in membrane permeability caused by the parasite. However, 
AS-ODNs will enter most cells and are now being used in clinical trials for HIV
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treatment (Barker, pers.comm.). Work with AS-ODNs in L. amazomnsis showed that 
linking the AS-ODN to a palmityl group enhanced the uptake into parasite infected 
macrophages which expressed an appropriate receptor on the surface(Mishra etal.,
1995). In P. falciparum the inhibitory effect of an AS-ODN complementary to the R2 
mRNA sequence was assayed by labelled hypoxanthine incorporation. Significant 
inhibition was shown to occur at l.OpM concentration for both asynchronous and 
synchronous cultures (Chakrabarti et al, 1993). An alternative approach to blocking the 
expression of RR is to develop specific inhibitors of enzyme activity and Rubin (Univ.of 
Penn.) has been over-expressing the P. falciparum RR to provide sufficient material for 
inhibition assays (pers. comm.).
The only report of antisense RNA expression studies in Theileria is on T. parva 
infected cells by Eichhorn & Dobbelaere (1995). Their work builds on earlier findings 
that infected cells constitutively express IL-2 receptors which may be part of an 
autocrine loop for the continual proliferation of T. parva infected cells. Part of the 
bovine EL-2 a  chain cDNA was cloned into a plasmid with an inducible promoter in both 
sense and anti-sense orientations. These constructs were transfected into T. parva 
infected cells and only the anti-sense configuration had a negative effect on growth rate 
under both induced and non-induced conditions. There was also a corresponding 
reduction in IL-2a chain mRNA in anti-sense transfected cells.
However, it may be difficult to get 100% inhibition of parasite growth with AS- 
ODN since they will be ineffective if the target enzyme is already present and has a long 
half life or if it is non-essential. Thus from what is known about the turnover ofR l and 
R2 in the mouse, it may well be that AS-ODN are not well suited for inhibition of the 
Plasmodium RR. However, nothing is known about the turnover in this parasite. The use 
of peptidomimetic inhibitors looks to be a more promising approach, particularly since 
they have been shown to be species specific inhibitors.
With respect to future work in Theileria, it will be necessary to isolate and 
characterise the small subunit. This will allow peptidomimetic inhibitors to be designed 
and tested on D7 cells. It may also be feasible, if the N-terminal extension was shown to 
be present in the mature polypeptide, to use peptides matching this region in inhibition 
assays as they are not likely to interfere with the host subunit.
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Figure 4.1 Gap analysis o f the predicted amino acid sequence o f the 
180bp PCR fragment to the P. falciparum  R l subunit
Figure 4.1a shows the predicted amino acid sequence o f the PCR 
fragment. The GAP program was used to calculate the %  identity and 
similarity over the region o f the PCR fragment at the amino acid level to the 
R l subunit from P. falciparum  as shown on figure 4.1b.
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Figure 4.1a
CATATTGACGAAATCCCAAGCCACATCAAGGAACTATATAAAACTGTTTGGGAGATTAAG
2 2 2 1   + --------------------+ ------------------- + ------------------ + -------------------- + ------------------ + 2 2 8 0
GTATAACTGCTTTAGGGTTCGGTGTAGTTCCTTGATATATTTTGACAAACCCTCTAATTC
H I D E I P S H I K E L Y K T V W E I K
CAGAAGCACATCATTGACATGGCAGCAGACCGTGGCATTTTCATTGACCAGTCACAGTCA
2 2 8 1  -------------------+ -------------------- + ------------------- + ------------------ + -------------------- + ------------------ + 2 3 4 0
GTCTTCGTGTAGTAACTGTACCGTCGTCTGGCACCGTAAAAGTAACTGGTCAGTGTCAGT
Q K H I I D M A A D R G I  F I  D Q S Q S
CTCAACATCCACATGGAACAGCCTACATTCAGTAAACTCACGAGCATGCACTTTTATGGC
GAGTTGTAGGTGTACCTTGTCGGATGTAAGTCATTTGAGTGCTCGTACGTGAAAATACCG
L N I  H M E Q P T F S K L T S M H F Y G
T
2 4 0 1  -  2 4 0 1  
A
Figure 4.1b
Gap Weight: 3.000 
Length Weight: 0.100
Quality: 77.1
Ratio: 1.285
P e r c e n t  S i m i l a r i t y :  8 6 . 6 6 7
Average Match: 0.540
Average Mismatch: -0.3 96
Length: 807
Gaps: 0
P e r c e n t  I d e n t i t y :  8 0 . 0 0 0
1 ................. HIDEIPSHIKELYKTVWEIKQKHIIDMAADRGIFIDQSQSLNIHMEQPTFSKLTSMHFYG 60
- I ■ I I I * * : I I I I I I I I I I I I I : I I I I I I I I I I I I I I I I I I I I * : - I I I - I I - I I I I I I
651 WDEDMKQQLIAHNGSIQYISEIPDDLKELYKTVWEIKQKNIIDMAADRGIFIDQSQSLNIYIQKPTFAKLSSMHFYG 75 0
Figure 4.2 Southern blot analysis o f genomic DNA.
10 jug o f BL20, cloned infected cell line D7 and 5 jig o f piroplasm 
DNA was digested with 3 different restriction enzymes and separated on a 
0.8% agarose gel then transferred onto Hybond N  membrane. The blot was 
then hybridised and washed by the Church & Gilbert SDS - phosphate 
method . The TaRl PCR fragment was labelled by random priming with 
50pCi o f 32P a  dATP.
Key:
Panel A. Lane 1: BL20 genomic DNA digested with BamHI.
Lane 2: BL20 genomic DNA digested with EcoRI.
Lane 3: BL20 genomic DNA digested with Hincfill.
Panel B. Lane 1: D7genomic DNA digested with BamHI.
Lane 2: D7 genomic DNA digested with ZjcoRI.
Lane 3: D7 genomic DNA digested with HindUl.
Panel C. Lane 1: Piroplasm genomic DNA digested with BamHI.
Lane 2: Piroplasm genomic DNA digested with EcoRI.
Lane 3: Piroplasm genomic DNA digested with HindiII.
Sizes are as indicated to the left o f the panel A in kb.
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A
1 2 3
B
1 2 3
Size in 
kB
Ml
1 TGATACAAACTCGTTATTTCCTTGATTGTTTTTAAAGTTAAGATGGATGCACATCAACAG 6 0 
* Y K L V I S L I V F K V K M D A H Q Q
6 1  GATCATAACAATACCACAAGTGGTTTTCCGCCTGAGGATGTGTCGGAAAGCTCACGTGGC 12  0 
D H N N T T S G F P P E D V S E S S R G
1 2 1  TATGAGGACCACGATTTACCCTCAAATAAGTCCAGAGAGTCTGATCATGCCCACAATTCG 18  0 
Y E D H D L P S N K S R E S D H A H N S  
M2 M3
1 8 1  CCAATGTTGAGTTTTTTTGGCGAGGCCGAGTCGAAGATAATGTACGTTATCAATAGGCAC 24 0 
P M L S F F G E A E S K I M Y V I N R H
2 4 1  GGCGAGAAGGAAGATGTATCATTTGACAAGATTCTAAACCGCATCAGGAAGTTATCGCTG 3 00  
G E K E D V S F D K I L N R I R K L S L
3 01  G G A C T G C A C T C A T T G G T G G A T i^i^Ii^^ii^ iiiii^i^C G TT A T A A A C G G A A T G T A C  36 0 
G L H S L V D A P R V T Q S V I N G M Y
3 6 1  ACAGGAATCCGAACGTCAGAACTGGACGAACTGGCTGCACAAACCTGCGCCTACATGGCT 4 2 0 
T G I R T S E L D E L A A Q T C A Y M A
4 2 1
V T H P D Y S R L A A N I T I D N L H K
4 8 1  AACACATCAAAAG ATTTCAGiiSiSSS^^^fSgi^tiii^ATGATTATGTG AACGTTAAT 54  0 
N T S K D F S E V I E D L Y D Y V N V N
5 4 1  GGACGGCCCTCAAGTCTGATAAGTGACGATGTGTTGGAGTTTGTTATGGAGAACAACGAC 6 0 0 
G R P S S L I S D D V L E F V M E N N D
6 01  CGCTTGAACCGAGAAATAGACTATTCCCGTGATTTCCAGTACGACTACTTCGGCTTTAAG 66  0 
R L N R E I D Y S R D F Q Y D Y F G F K
6 6 1  ACACTAGAGCGTTCGTATTTGCTGAACATTAACGGCAAGATCGTTGAGCGTCCACAGCAC 72  0 
T L E R S Y L L N I N G K I V E R P Q H
7 2 1  ATGATAATGCGAGTTTCTGCAGGTATTCACTGCGGAGATTTGGAACGCACTATCCAAACA 78  0 
M I M R V S A G I H C G D L E R T I Q T
7 8 1  TATCATCTTATGAGTCAGAGATATTTCACGCACGCGACCCCGACACTTTTCAATGCCGGC 84  0 
Y H L M S Q R Y F T H A T P T L F N A G
8 4 1  ACCAAACACCCACAGATGTCGTCCTGTTTTCTTTTATCCATGAAAGACGACTii^@!¥i§iE©i|j|9 0 0
t k h p q m s s c f l l s m k d d s l a "
9 01  (|||||fii|^ |»ii|i||||||§ i|i|C A G T G C G C C C T C A T A A G T A A A T C A G C T G G T G G G A T A G G G  96 0 
G I F N T L S Q C A L I S K S A G G I G
9 6 1  CTCGCGATTCACAAGATCAGAGCCAGCGGCTCGTACATTCGAGGTACAAACGGCATCTCA 1 0 2  0 
L A I H K I R A S G S Y I R G T N G I S
1 0 2 1  AATGGGATTGTACCAATGCTAAAAATTTTTAACTCAACAGCCAAATATGTAGACCAGGGA 1 0 8  0 
N G I  V P M L K I  F N S T A K Y V D Q G
1 0 8 1  GGTGGAAAGCGCAAAGGCTCGTTTGCGATATACCTGGAGCCCTGGCATGCTGACATTTTT 1 1 4  0 
G G K R K G S F A I Y L E P W H A D I  F
1 1 4 1  AAGCTGCTGGACCTCAGGAAAAACCACGGCTCAGAAGACCAGCGCGCACGCGACCTATTT 12  0 0 
K L L D L R K N H G S E D Q R A R D L F
12 01  TACGCGCTTTGGATCCCCGACCTGTTCAGGAAACGTGTCGAGGCAAACAAGAACTGGACA 1 2 6  0 
Y A L W I  P D L F R K R V E A N K N W T
12 61  CTCATGTGCCCAGACGAGTGTCGAGGTTTGTATGAGGTCTGGGGAGACGAGTTCGAACGG 1 3 2  0
L M C P D E C R G L Y E V W G D E F E R
13 21  CTCTACACCCAGTACGAACAACAAGGGATGGGACGAAAAACAATTCCAGCCCAAAAACTG 13 8 0
L Y T Q Y E Q Q G M G R K T I  P A Q K L
13 81  T G G TT^^iim ii^iii^^ii^ iST C G A A A C TG G G A C C C C G TA C A TG TTA TA C A A G G A T  1 4 4  0 
W F A I  L Q S Q  I E T G T P Y M L Y K D
14 4 1  \GCATGCAACTCCAAGAGTAATCAGCAAAACTTGGGCACGATTAAATCTAGTAACCTGTGC 1 5 0  0 
A C N S  K S N Q Q N L G T  I K S S N L C
15  01  TGCGAAATTGTTCAATTCACGAGCAAGGATGAGGTTGCAGTGTGTAATTTAGCGTCAGTA 1 5 6  0
C E  I V Q F T S  K D E V A V C N L A S V
Figure 4.3a cDNA sequence of R l subunit from T. annulata
This figure shows the nucleotide and predicted amino acid sequences 
of the cDNA clone encoding the large subunit of ribonucleotide reductase 
from T. annulata. The first three in frame start codons are marked in bold. 
Sequencing primers used are shown in greyscale with the direction of 
priming indicated by arrows. The SphIrestriction sites used in the 
subcloning are shown by underlining. The BamHI site referred to in the 
genomic analysis is overlined. The Sau3AI site used in the cloning of the 3 ’ 
end into the pGEX expression vector is shown overlined also. The location 
of the 180bp PCR fragment is indicated by the amino acid sequence in bold.
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Ml
1 TGATACAAACTCGTTATTTCCTTGATTGTTTTTAAAGTTAAGATGGATGCACATCAACAG 6 0 
* Y K L V I S L  I V F K V K M D A H Q Q
6 1  GATCATAACAATACCACAAGTGGTTTTCCGCCTGAGGATGTGTCGGAAAGCTCACGTGGC 12  0 
D H N N T T S G F P P E D V S E S S R G
1 2 1  TATGAGGACCACGATTTACCCTCAAATAAGTCCAGAGAGTCTGATCATGCCCACAATTCG 18 0 
Y E D H D L P S N K S R E S D H A H N S  
M2 M3
1 8 1  CCAATGTTGAGTTTTTTTGGCGAGGCCGAGTCGAAGATAATGTACGTTATCAATAGGCAC 24  0 
P M L S F F G E A E S K I M Y V I N R H
2 4 1  GGCGAGAAGGAAGATGTATCATTTGACAAGATTCTAAACCGCATCAGGAAGTTATCGCTG 3 00  
G E K E D V S F D K I L N R I R K L S L
3 01 GGACTGCACTCATTGGTGGATG^G©A<!saft«SK&tesS{2S83SfeCGTTATAAACGGAATGTAC 36  0 
G L H S L V D A P R V T Q S V I N G M Y
3 6 1  ACAGGAATCCGAACGTCAGAACTGGACGAACTGGCTGCACAAACCTGCGCCTACATGGCT 42  0 
T G I R T S  E L D E L A A Q T C A Y M A
4 21  GTGACGCACCCAGACTACTCTCGCCm^GS^BMSA^^^AmGATAACCTACACAAA 4 8 0 
V T H P D Y S R L A A N I T I D N L H K
4 8 1  AACACATCAAAAGATTTCAGOGAGGTGAl^AGdft^CfliStATGATTATGTGAACGTTAAT 54 0 
N T S K D F S E V I E D L Y D Y V N V N
5 4 1  GGACGGCCCTCAAGTCTGATAAGTGACGATGTGTTGGAGTTTGTTATGGAGAACAACGAC 6 0 0 
G R P S S L I S D D V L E F V M E N N D
6 01  CGCTTGAACCGAGAAATAGACTATTCCCGTGATTTCCAGTACGACTACTTCGGCTTTAAG 6 6 0 
R L N R E I  D Y  S R D F Q Y D Y F G F K
6 61  ACACTAGAGCGTTCGTATTTGCTGAACATTAACGGCAAGATCGTTGAGCGTCCACAGCAC 72  0
T L E R S Y L L N I N G K I V E R P Q H
7 2 1  ATGATAATGCGAGTTTCTGCAGGTATTCACTGCGGAGATTTGGAACGCACTATCCAAACA 78  0 
M I M R V S A G I H C G D L E R T I Q T
7 81  TATCATCTTATGAGTCAGAGATATTTCACGCACGCGACCCCGACACTTTTCAATGCCGGC 8 4 0
Y H L M S Q R Y F T H A T P T L F N A G
8 4 1  ACCAAACACCCACAGATGTCGTCCTGTTTTCTTTTATCCATGAAAGACGACTt?eC?tS3<5?!<$ 9 0 0  
T K H P Q M  S S C F L L S M K D D S L A
9 01  (^ i a ^ i ^ mfM^P^CAGTGCGCCCTCATAAGTAAATCAGCTGGTGGGATAGGG 96 0 
G I F N T L S Q C A L  I S K S A G G I  G
9 6 1  CTCGCGATTCACAAGATCAGAGCCAGCGGCTCGTACATTCGAGGTACAAACGGCATCTCA 1 0 2  0 
L A I H K I R A S G S Y I R G T N G I S
10  21  AATGGGATTGTACCAATGCTAAAAATTTTTAACTCAACAGCCAAATATGTAGACCAGGGA 1 0 8  0 
N G  I V P M  L K  I F N S T A K Y V D Q G
1 0 8 1  GGTGGAAAGCGCAAAGGCTCGTTTGCGATATACCTGGAGCCCTGGCATGCTGACATTTTT 1 1 4  0 
G G K R K G S  F A I  Y L E P W H A D I  F
1 1 4 1  AAGCTGCTGGACCTCAGGAAAAACCACGGCTCAGAAGACCAGCGCGCACGCGACCTATTT 12  0 0 
K L L D L R K N H G S E D Q R A R D L F
12  01 CCAGCGCTTTGGATCCCCGACCTGTTCAGGAAACGTGTCGAGGCAAACAAGAACTGGACA 1 2 6  0 
P A L W I  P D L F R K R V E A N K N W T
12  6 1  CTCATGTGCCCAGACGAGTGTCGAGGTTTGTATGAGGTCTGGGGAGACGAGTTCGAACGG 13  2 0
L M C P D E C R G L Y E V W G D E F E R
13 2 1  CTCTACACCCAGTACGAACAACAAGGGATGGGACGAAAAACAATTCCAGCCCAAAAACTG 13 8 0
L Y T Q Y E Q Q G M G R K T I  P A Q K L
13 8 1  TGGTT<?^M7YKr^& G ft<3^r‘<hftA?<TCGAAACTGGGACCCCGTACATGTTATACAAGGAT 1 4 4  0
W F A I L Q S Q I E T G T P Y M L Y K D
14 4 1  GCATGCAACTCCAAGAGTAATCAGCAAAACTTGGGCACGATTAAATCTAGTAACCTGTGC 15  00
A C N S K S N Q Q N L G T I  K S S N L C
15  0 1  TGCGAAATTGTTCAATTCACGAGCAAGGATGAGGTTGCAGTGTGTAATTTAGCGTCAGTA 1 5 6  0
C E  I V Q F T S  K D E V A V C N L A S V
1561
1621
1681
1741
1801
1861
1921
1981
2041
2 1 0 1
2161
2 2 2 1
2281
2341
2401
2461
2521
2581
2641
2701
2761
GCACTACCAAAATTCGTAAATACACAAACGAGGACATTTGACTTCAAAAAACTCTATGAA 16  2 0 
A L P K F V N T Q T R T F D F K K L Y E
ATATGTCGTGTAATAACATACAACCTCAATAAAGTAATCGATAGGAATTATTACCCGGTG 16 8 0 
I C R V I T Y N L N K V I D R N Y Y P V
 ►
AAACAAGCCAGGGCGTCTAATTTCAGACACfcS&6G&MSB&S$!e&ft6&SH8!JKg&fcS&SCTA 1 7 4  0 
K Q A R A S N F R H R P M G V G V Q G L
GCAGATACGTTAGTGCTAATGAGTTACCCTTACAGTTCGACGGAGGCGAAAGAACTCAAC 18  0 0 
A D T L V L M S Y P Y S S T E A K E L N
AAACGCATATTCGAAACCATGTATTATGCCTGTTTATCAGAGAGTATTGATTTGGCAAGA 18 6 0 
K R I  F E T M Y Y A C L S E S  I D L A R
CAGTATGGAGCTTACGAGTCATATGTTGGGTCACCAGCTTCTAAGGGTTTACTACAATTT 1 9 2  0 
Q Y G A Y E S Y V G S P A S K G L L Q F
G A T A T G T G G A A C G C G A A A G T C C C A A A T A T ^ g ^ ia ^ ^ ^ iS M S ^ e ^ ^ ^ S A ^ C  1 9 8  0 
D M W N A K V P N M L W D W D K L K A D
CTACGTGAGCATGGGTTAAGAAATTCTTTATTTATTGCACCAATGCCTACAGCTAGTACC 2 04  0 
L R E H G L R N S L F I A P M P T A S T
TCGCAGATTCTTGGTAACAATGAATCATTTGAGCCCTACACTAGCAACATTT&^jSeSlSft 2 1 0  0 
S Q I L G N N E S F E P Y T S N I Y Y R
'.CJEkGTGAGTTTTTTGTGGTTAACCCTCATTTACTAAATGACCTGATTGAC 2 1 6  0 
R V L S G E F F V V N P H L L N D L I D
TTGGGGCTCTGGAACGAGACAATGAAACAGAAGCTTATCGCCTACAACGGCTCACTAAAG 2 2 2 0 
L G L W N E T M K Q K L I A Y N G S L K
CATATTGACt JAAATCCCAAGCCACATCAAGGAACTATATAAAACTGTTTGGGAGATTAAG 2 2 8 0 
H I D E I P S H I K E L Y K T V W E I K
CAGAAGCACATCATTGACATGGCAGCAGACCGTGGCATTTTCATTGACCAGTCACAGTCA 2 3 4  0 
Q K H I  I D M A A D R G I F I D Q S Q S
CTCAACATCCACATGGAACAGCCTACATTCAGTAAACTCACGAGCATGCACTTTTATGGC 24 00  
L N I H M E Q P T F S K L T S M H F Y G
TGGAAAAAGGGTCTAAAAACAGGAGTTTACTACCTCAGGACTCAACCAGCCACAGATGCT 24  6 0 
W K K G L K T G V Y Y L R T Q P A T D A
 >
I K F T V D A S  I S Q L A K S R V K P A
AACTCAATCATGAGCGATGGTAACATGACTTCGATCATGAGTGACGGGACAATGTCAACG 2 5 8  0 
N S  I M S D G N M T S I M S D G T M S T
ACTGAAACTCTAGATGTGCTTCAACCCCTAGCATCAGTTGAAGAAACCAATAGAGACGAC 2 64  0 
T E T L D V L Q P L A S V E E T N R D D
<----
TTCGCCAGCGCCGACGAACCCCAAATGTGTTCTCTAAATCCCAACCCCAACGAACCAT^i 2 7  0 0 
F A S A D E  P Q M C S L N P N P N E P C
# ^ ^ ^ P iM S^ ^ ’A G C C C A CT A A A ACTG TTG TAACCG G TTAAtttactaccaacttt 2 7 6 0  
F M C S S  * P T K T V V T G *
ct11acataccaact11cacaaaaaaaaaaaaaaaaaaaactca 2 8 04
Figure 4.3b Restriction map of TaRl cDNA
This figure shows the location of restriction sites in the TaRl cDNA 
together with the region of the orginal PCR fragment isolated and the region 
of the 3’ end used to make a fusion protein.
Scale: lcm = 200bps 
ATG - location of first methionine residue 
||g || - location of PCR fragment isolated 
** - stop codons
- location of 3’ region used for pGEX subcloning. Xbal! Xhol 
fragment used as 3’ probe for genomic analysis (170bps)
- location of 5’ probe used for genomic analysis 
(Pstl/Xbal 770bps fragment).
!} |- multiple cloning site of pBluescript
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SphI SphI SphI Sau3AI
P stI
ATG
m y .................................J
EcoRII L3cunHI EcoRII H in d llI Xhol
* *
X bal
X bal
Figure 4.4 Pileup showing homology between prokaryotic and 
eukaryotic large subunits
This analysis was carried out using the PILEUP program in the GCG 
package. To generate optimal homologies between the subunits gaps are 
introduced - these are indicated by a dot. For clarity, only a selection o f  
sequences available in the database have been used - a higher eukaryote, 
lower eukaryote, bacterium, viral and the 2 protozoan parasites. Numbering 
here is based on TaRl using the third ATG as the start methionine based on 
homology. The region o f TaRl used to prepare a 3 ’ specific fusion protein 
are listed in bold.
Key:
THEILERIA - T. annulata
PLASMODIUM - P. falciparum
HUMAN - H. sapiens
YEAST - S. cerevisiae
E. coli - E. coli
HSV - Herpes simplex virus
123
THEILERIA *YKLVISLIV FKVKMDAHQQ DHNNTTSGFP PEDVSESSRG YEDHDLPSNK
PLASMODIUM MGDNVKRL PLPSENGEIK
HUMAN .......................................................
YEAST .......................................................
E. coli .......................................................
1 27
THEILERIA SRESDHAHNS PMLSFFGEAE SKIMYVINRH GEKEDVSFDK ILNRIRKLSL
PLASMODIUM KSTSGRLSDD GIKRTPSGKP IQTMYVLNRK GEEEDISFDQ ILKRIQRLSY
HUMAN MHVIKRD GRQERVMFDK ITSRIQKLCY
YEAST MYVYKRD GRKE PVQFDK ITARISRLCY
E. coli ........ M NQNLLVTKRD GSTERINLDK IHRVLDWAAE
HSV
28 75
THEILERIA GLH.SLVDAP RVTQSVINGM YTGIRTSELD ELAAQTCAYM AVTH.PDYSR
PLASMODIUM GLH.ELVDPA RVTQGVINGM YSGIKTCELD ELAAQTCAYM ATTH.PDFSI
HUMAN GLNMDFVDPA QITMKVIQGL YSGVTTVELD TLAAETAATL TTKH. PDYAI
YEAST GLDPKHIDAV KVTQRIISGV YEGVTTIELD NLAAETGAYM TTVH.PDYAT
E. coli GLHN..VSIS QVELRSHIQF YDGIKTSDIH ETIIKAAADL ISRDAPDYQY
HSV ........ M SQETIISNLI DMLKVSAGW. ___DREANE
76 124
THEILERIA LAANITIDNL HKNTSKDFSE VIEDLYDYVN V.NGRPSSLI SDDVLEFVME
PLASMODIUM LAARITTDNL HKNTSDDVAE VAEALYTYKD V.RGRPASLI SKEVYDFILL
HUMAN LAARIAVSNL HKETKKVFSD VMEDLYNYIN PHNGKHSPMV AKSTLDIVLA
YEAST LAARIAISNL HKQTTKQFSK WEDLYRYVN AATGKPAPMI SDDVYNIVME
E. coli LAARLAIFHL RKKAYGQFEP ..PALYDHV. VKMVEMGKYD NHLLEDYTEE
HSV ISGRLFHKLM DMSSTETISQ YMSLF.... EPHILEFIQN
125 164
THEILERIA NNDRLNRE.I DYSRDFQY.. ---DYFGFK TLERSYLL.. NIN.GKIVER
PLASMODIUM HKDRLNKE.I DYTRDFNY.. ___DYFGFK TLERSYLL.. RIN.NKIIER
HUMAN NKDRLNSA.I IYDRDFSY.. ---NYFGFK TLERSYLL.. KIN.GKVAER
YEAST NKDKLNSA.I VYDRDFQY.. ___SYFGFK TLERSYLL.. RIN.GQVAER
E. coli EFKQMDTF.I DHDRDMTF.. ....SYAAVK QLEGKYLVQN RVT.GEIYES
HSV YEQEIDEVCL EYRASYDFMC LRNCGILPAK RFYDTYVLPP RTEMNGKYES
165 189
THEILERIA PQHMIMRVSA GI.... HCG DLERTIQ,.. ...... TYH
PLASMODIUM PQHLLMRVSI GI.... HID DIDKALE ...... TYH
HUMAN PQHMLMRVSV GI.... HKE DIDAAIE... ...... TYN
YEAST PQHLIMRVAL GI.... HGR DIEAALE... ...... TYN
E. coli AQFLYILVAA CLFSNYPRET RLQYVKR... ...... FYD
HSV IPHFFARIAA YCAWNCIMCE PLKDTLVYVQ KRDWNVEIKT DMQIFKYFYK
190 216 238
THEILERIA LMSQRYFTHA TPTLFNAGTK HPQMSSCFLL SMKDDSLAG. IFNTLSQCAL
PLASMODIUM LMSQKYFTHA TPTLFNSGTP RPQMSSCFLL SMKADSIEG. IFETLKQCAL
HUMAN LLSERWFTHA SPTLFNAGTN RPQLSSCFLL SMKDDSIEG. IYDTLKQCAL
YEAST LMSLKYFTHA SPTLFNAGTP KPQMSSCFLV AMKEDSIEG. IYDTLKECAL
E. coli AVSTFKISLP TPIMSGVRTP TRQFSSCVLI E .CGDSLDS. INATSSAIVK
HSV VISSQLVCCA TPVMRSAGVA GENLSSCFII APTLDTEKST ISSIFGELAP
239 288
THEILERIA ISKSAGGIGL AIHKIRASGS YIRGTNGISN GIVPMLKIFN STAKYVDQGG
PLASMODIUM ISKTAGGIGV AVQDIRGQNS YIRGTNGISN GLVPMLRVFN DTARYVDQGG
HUMAN ISKSAGGIGV AVSCIRATGS YIAGTNGNSN GLVPMLRVYN NTARYVDQGG
YEAST ISKTAGGIGL HIHNIRSTGS YIAGTNGTSN GLIPMIRVFN NTARYVDQGG
E. coli YVSQRAGIGI NAGRIRALGS PIRGGEAFHT GCIPFYKHFQ TAVKSCSQGG
HSV LLASRSGVGV DVTKFS FGGK NIHSCLKLIN AQVEFF.... ...... NDK
289 338
THEILERIA GKRKGSFAIY LEPWHADIFK LLDLRKNHGS EDQRARDLFY ALWIPDLFRK
PLASMODIUM GKRKGSFAVY IEPWHSDIFE FLDLRKNHGK EELRARDLFY AVWVPDLFMK
HUMAN NKRPGAFAIY LEPWHLDIFE FLDLKKNTGK EEQRARDLFF ALWIPDLFMK
YEAST NKRPGAFALY LEPWHADIFD FIDIRKNHGK EEIRARDLFP ALWIPDLFMK
E. coli V .RGGAATLF YPMWHLEVES LLVLKNNRGV EGNRVRHMDY GVQINKLMYT
HSV SVRPVSVATY IEVWHCQIHE FLSAKLPENP D..RCNSIFQ GVCVPSLFFK
339
THEILERIA RVEANKN..W TLMCPDECRG 
PLASMODIUM RVKENKN..W TLMCPNECPG 
HUMAN RVETNQD..W SLMCPNECPG
YEAST RVEENGT..W TLFSPTSAPG
E. coli RLLKGED..I TLFSPSDVPG 
HSV MYESDPNGLW YLFDPQDAPN
383
THEILERIA PAQKLWFAIL QSQIETGTPY 
PLASMODIUM LAQDLWFAIL QSQIETGVPY 
HUMAN KAQQLWYAII ESQTETGTPY
YEAST KAQKLWYSIL EAQTETGTPF
E. coli KAVELFSLMM QERASTGRIY 
HSV TLKSLMFSLI NTIIKTGSPY
432 442
THEILERIA QFTSK........ DEVAVCN
PLASMODIUM EYTSP........ DEVAVCN
HUMAN EYTS K........ DEVAVCN
YEAST EYSAP........ DETAVCN
E. coli LPTKPLNDVN DENGEIALCT
HSV QQPKQF......... TSTCN
466
THEILERIA YEICRVITYN LNKVIDRNYY 
PLASMODIUM YEITKIITRN LDKIIERNYY 
HUMAN AEVTKVWRN LNKIIDINYY
YEAST HEIAKWTRN LNRVIDRNYY
E. coli EELAILAVRA LDALLDYQDY 
HSV EYAVQAAVFI INACILSP..
516
THEILERIA YPYSSTEAKE LNKRIFETMY 
PLASMODIUM YPYESDAAKE LNKRIFETMY 
HUMAN YPFESAEAQL LNKQIFETIY
YEAST LPFDSEEARL LNIQIFETIY
E. coli KRYSDGSANN LTHKTFEAIQ 
HSV YGYLDLESEC LDRDIFETMY
564
THEILERIA LLQFDMWNAK VPN.... ML
PLASMODIUM ILQFDMWNAK VDN.... KY
HUMAN ILQYDMWNVT . PT.....DL
YEAST ILQFDMWDQK . PY.....GM
E. coli ILPIDTYKKD LDTIANEPLH 
HSV VFHWATWDAM PQRVP M
609
THEILERIA QILGNNESFE PYTSNIYYRR 
PLASMODIUM QILGNNESFE PYTSNIYYRR 
HUMAN QILGNNESIE PYTSNIYTRR
YEAST QILGYNECFE PVTSNMYSRR
E. coli QISNATNGIE PPRGYVSIKA 
HSV QLTGYTDSFY PYFANMSSKV
659
THEILERIA LIAYNGSLKH IDEIPSHIKE 
PLASMODIUM LIAHNGSIQY ISEIPDDLKE 
HUMAN IIACNGSIQS IPEIPDDLKQ
YEAST LITQNGSIQG LPNVPQELKD
E. coli ................EHLHD
HSV VRFYGGDVSM MPEDVSTRYK
708
THEILERIA LNIHMEQPTF S ...... KL
PLASMODIUM LNIYIQKPTF A ...... KL
HUMAN LNIHIAEPNY G ...... KL
YEAST LNLFLRAPTM G ...... KL
E. coli ANTNYDPSRF PSGKVPMQQL 
HSV LTLFLTEENV QSAKY L
382
LYEVW...GD EFERLYTQYE QQGMGRKT.I 
LSETW...GE EFEKLYTKYE EENMGKKT.V 
LDEVW...GE EFEKLYASYE KQGRVRKV.V 
LSDCY...GD EFEALYTRYE KEGRG.KT.I 
LYDAFFADQE EFERLYTKYE KDDSIRKQRV 
LTRLY...GL EFEEEYLRLV SEKKY.KQSV
427 431
MLYKDACNSK SN.QQNLGTI KSSNLCCEIV 
MLYKDSCNAK SN.QKNLGTI KCSNLCCEII 
MLYKDSCNRK SN.QQNLGTI KCSNLCTEIV 
WYKDACNRK SN. QKNLGVI KSSNLCCEIV 
IQNVDHCNTH SPFDPAIAPV RQSNLCLEIA 
VISKEAMNKH HWYETQGEAI NCSNLCAEIV
465
LASVALPKFV NT QTRTFDFKKL
LASIALCKFV DL. . EKKEFNFKKL
LASLALNMYV .TSE:___H. ...TYDFKKL
LASVALPAFI ETSE:___DG KTSTYNFKKL
LSAFNLGAI. ___NNLDEL
LANVCLPKCL NSSNFPYTCS NTAQFDFSKL
515
PVKQARASNF RHRPMGVGVQ GLADTLVLMS
PVKEAKTSNT RHRPIGIGVQ GLADTFMLLR
PVPEACLSNK RHRPIGIGVQ GLADAFILMR
PVEEARKSNM RHRPIALGVQ GLADTFMLLR
PIPAAKRGAM GRRTLGIGVI NFAYYLANDG
SPTSSATVGQ RERSMGIGCH GLADVFSEMG
563
YACLSESIDL AR. .QYGAYE SYVGSPASKG
YAALEMSVEL AS . .IHGPYE SYQGSPASQG
YGALEASCDL AK. .EQGPYE TYEGSPVSKG
HASMEASCEL AQ..KDGPYE TFQGSPASQG 
YYLLKASNEL AK..EQGACP WFNETTYAKG 
YTAVKTSSEI CSVGKGQPFA GFRKSKLAHG
608
WDWDKLKADL REHGLRNSLF IAPMPTASTS 
WDWDELKAKI RKHGLRNSLL LAPMPTASTS 
WDWKVLKEKI AKYGIRNSLL IAPMPTASTA 
WDWDTLRKDI MKHGVRNSLT MAPMPTASTS 
YDWEALRESI KTHGLRNSTL SALMPSETSS 
KQWIHLQDNI KKFGVFNSQF IALMPTAGTS
658
VLSGEFFWN PHLLNDLIDL GLWNETMKQK 
VLSGEFFWN PHLLKDLFDR GLWDEDMKQQ 
VLSGEFQIVN PHLLKDLTER GLWHEEMKNQ 
VLSGEFQWN PYLLRDLVDL GIWDEGMKQY
SKDGILRQW PDY..................
SNKEEIMKPN ITFLKNVKPQ DL..... CT
707
LYKTVWEIKQ KH.IIDMAAD RGIFIDQSQS 
LYKTVWEIKQ KN.IIDMAAD RGIFIDQSQS 
LYKTVWEISQ KT.VLKMAAE RGAFIDQSQS 
LYKTVWEISQ KT.IINMAAD RSVYIDQSHS 
AYELLWEMPG NDGYLQLVGI MQKFIDQSIS 
HFLTAFDYCP EAQ.MRRASI RAPYVDQSQS
737/738 750
TSMHFYGWKK GLKTGVYYLR TQPATDAIKF 
SSMHFYGWEK GLKTGAYYLR TQAATDAIKF 
TSMHFYGWKQ GLKTGMYYLR TRPAANPIQF 
TSMHFYGWKK GLKTGMYYLR TQAASAAIQF 
LKDLLTAYKF GVKT.LYYQN TRDGAEDAQ. 
KDLLLLGFRL GLKTIMYYCR VKKTTKLLQL
751 797
THEILERIA TVD...ASIS QLAKSRVKPA NSIMSDGNMT SIMSDGTMST TETLDVLQPL
PLASMODIUM TVD. ..T... HVAKNAVKLK NA..DGVQIT REVSRETIST ESTV......
HUMAN TLNK..EKLK DKEKVSKEEE EKERNTAAMV CSLENRDEC............
YEAST TID...QKIA DQATENVADI SNLKRPSYMP SSASYAASDF VPAAVTANAT
E. coli   DDLVPSIQDD GCESGA.........................
HSV ECLKLDEHTK KDAQIVLADL ARELPDSHKT EDACPLDQSE CIACQ.....
798 828
THEILERIA ASVEETNRDD FASADEPQMC SLNPNPNEPC F ...................
PLASMODIUM  TQNVC PLRRNNDEQC L ...................
HUMAN  L ...
YEAST IPSLDSSSEA SREASPAPTG SHSLTKGMAE LNVQESKVEV PEVPAPTKNE
E. coli .......................................................
HSV .......................................................
832
THEILERIA .................................... MCSS*
PLASMODIUM.................................... MCSG*
HUMAN  MCGS*
YEAST EKAAPIVDDE ETEFDIYNSK VIACAIDNPE ACEMCSG*
E. coli ......................................CKI*
HSV ........................................
Figure 4.5 Functional conservation of residues implicated in thioyl 
transfer reaction of the large subunit.
This figure shows the conservation o f several cysteine residues shown 
to be involved in the reaction mechanism o f the E. coli R l (Ekland et a l , 
1996, Uhlin & Eklund, 1994). The first number refers to the amino acid 
sequence o f the E. coli subunit, the second number in brackets corresponds 
to the T. annulata residue.
124
Block 1 Cys 225 (Cys 216)
E. coli TRQFSSCVLI 
THEILERIA HPQMSSCFLL 
PLASMODIUM RPQMSSCFLL 
HUMAN RPQLSSCFLL
YEAST KPQMSSCFLV
HSV GENLSSCFII
Block 2 Cys 439 (Cys 427)
E. coli RQSNLCLEIA 
THEILERIA KSSNLCCEIV 
PLASMODIUM KCSNLCCEII 
HUMAN KCSNLCTEIV
YEAST KSSNLCCEIV
HSV NCSNLCAEIV
Block 3 Cys 462 (Cys 442)
E. coli GEIALCTLSAFNL
THEILERIA DEVAVCNLASVAL
PLASMODIUM DEVAVCNLASIAL
HUMAN DEVAVCNLASLAL
YEAST DETAVCNLASVAL
HSV ...TSTCNLANVCL
Block 4 Cys 759 (Cys 830)
THEILERIA. ..MCSS* 
PLASMODIUM...MCSG*
HUMAN ...MCGS*
YEAST ACEMCSG*
E. coli ....CKI*
HSV  *
Block 5 Tyr730/731 (Tyr 737/738)
E. coli GVKT.LYYQNTRDG
THEILERIA GLKTGVYYLRTQPA
PLASMODIUM GLKTGAYYLRTQAA 
HUMAN GLKTGMYYLRTRPA
YEAST GLKTGMYYLRTQAA
HSV GLKTIMYYCRVKKT
Figure 4.6 GAP program in GCG used to show homology between 
mouse and Theileria regions implicated in R1/R2 binding.
This figure shows the homology over 2 regions of the large subunits 
of mouse and Theileria RR which have been implicated in the binding of the 
large subunit to the small subunit. The second region (778-789 in the mouse 
R l) has a gaps introduced, indicated by dots to maximise the line up with 
the same region in the Theileria R l. The percentage similarity and identity is 
as calculated by the GAP program in the GCG package.
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Region 1 - residues 724 - 736
Percent Similarity: 92% 
Percent Identity: 85%
Mouse 724 HFYGWKQGLKTGM 73 6
Theileria 724 HFYGWKKGLKTGV 736
Region 2 - residues 778 - 789 (816 - 829 in TaRl)
Percent Similarity: 75%
Percent Identity: 50%
Mouse 
Theileria
778 VCSL..ENREECLM 789
: I I I : - 1 - 1  = 1
816 MCSLNPNPNEPCFM 82 9
Figure 4.7 Homology between region implicated in R l subunit 
dimerisation from studies in HSV.
This figure shows a PILEUP of the eukaryotic R l subunits with the 
region 420-440 of HSV R l which was shown to be important in R l subunit 
dimerisation (Connor et a i,  1993).
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Region 421 - 434 of HSV R l implicated in dimerisation in bold
HSV NSSNFPYTCSNTAQFDFSKL
THEILERIA NT........QTRTFDFKKL
PLASMODIUM DL........EKKEFNFKKL
HUMAN .TSE....H ....TYDFKKL
YEAST ETSE....DGKTSTYNFKKL
Figure 4.8 TaRl cDNA clone contains 3 in frame ATG translational 
start codons
The cDNA clone encoding TaRl extends for 229 bps upstream from 
the consensus start codon found in the higher eukaryotic R l genes.
This figure shows this region with the in frame start codons marked in bold. 
Below this is a comparison o f the sequence flanking the putative 
translational start codons with the consensus sequence for a translational 
initiation site in protozoa (Yamauchi, 1991). The fit to this consensus is 
given to the right o f the sequence, expressed as % o f nucleotides matching 
the consensus.
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1 TGCTTCCTTC TGATACAAAC TCGTTATTTC CTTGATTGTT TTTAAAGTTA 
Ml
5 1  AGATGGATGC AC AT CAACAG GATCATAACA ATACCACAAG TGGTTTTCCG
1 0 1  CCTGAGGATG TGTCGGAAAG CTCACGTGGC TATGAGGACC ACGATTTACC
M2
1 5 1  CTCAAATAAG TCCAGAGAGT CTGATCATGC CCACAATTCG CCAATGTTGA
M3
2 0 1  GTTTTTTTGG CGAGGCCGAG TCGAAGATA ATG
Consensus a/t t/a NTTNT t/a NAAAAatgA a/g a/t sequence
% Fit to
consensus
Ml T T TTAAA G TTAAGatgG A T 75%
M2 C C ACAAT T CGCCAatgT T G 37%
M3 C G AGTCG A AGATAatgG T A 56%
Figure 4.9 Southern blot analysis of genomic clone A3.
lp g  of A3 genomic DNA was digested as below and electrophoresed 
through a 0.8% agarose gel, Southern blotted and hybridised to a TaRl 
probe as detailed below. Panel A is probed with a 5 ’ probe (a 770bps 
Pstl/Xbal fragment). Panel B is probed with a 3 ’ probe (a 170bps Xhol/Xbal 
fragment). Below each is the ethidium stained gel before blotting.
Lane 1 A3 genomic DNA digested with BamHI
Lane 2 Hind III digest
Lane 3 EcoRI digest
Lane 4 N otl digest
Lane 5 SphI digest
Lane 6 BamHUHindlll digest
Lane 7 BamHUNotl digest
Lane 8 EcoRI/HindlH digest
Lane 9 BamHUEcoRI digest
Lane 10 SphUNotl digest
Lane 11 EcoRI/Notl digest
Lane 12 HindllHNotl digest
Lane 13 EcoRI I SphI digest
Lane 1: A3 genomic DNA digested with Xhol
Lane 2: SacI digest
Lane 3: K pnl digest
Lane 4: Sail digest
Lane 5: XhoHBamHI digest
Lane 6: Xhol/Notl digest
Lane 7: SacI/EcoRI digest
Lane 8: Sacl/Notl digest
Lane 9: Kpnl/EcoRI digest
Lane 10: KpnHBamHI digest
Lane 11: Sail/EcoRI digest
Lane 12: Sall/Notl digest
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Figure 4.10 Restriction map of the T aR l genomic clone (A,3)
This figure shows the restriction mapping of the genomic clone 
together with the regions hybridising with the 5 ’ and 3 ’ probes from the 
TaRl cDNA clone. A  2.7kB EcoRI/ BamHI fragment was subcloned into 
the pBluescript vector for sequencing and restriction analysis. The hatched 
lines show the regions of the X3 clone hybridising with TaRl cDNA clones. 
The 5’ sequence from the BamHI site is given below. The BamHI site is 
shown in bold.
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Xliol
Bam HI
N otl
BamHI
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G I G L A I H K I R A S G S Y I R G T N  
cDNA TGGGATAGGGCTCGCGATTCACAAGATCAGAGCCAGCGGCTCGTACATtCGAGGTACAAA
111111111II! 111111111111111111111111111111111111111111111111
gDNA TGGGATAGGGCTCGCGATTCACAAGATCAGAGCCAGCGGCTCGTACATTCGAGGTACAAA
G I S N G I V P M L K I F N S T A K Y V  
cDNA CGGCATCTCAAATGGGATTGTACCAATGCTAAAAATTTTTAACTCAACAGCCAAATATGT
I I 11111I I1111I I I I 111I I I I I I I I I I I  111 I! IIII11111 III 11! I! 1111111
gDNA CGGCATcTCAAATGGGATTGTACCAATGCTAAAAATTTTTAAcTCAACAGCCAAATATGT
D Q G G G K R K G S F A I Y L E P W H A  
cDNA AGACCAGGGAGGTGGAAAGCGCAAAGGCTCGTTTGCGATATACCTGGAGCCCTGGCATGC
II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I
gDNA AGACCAGGGAGGTGGAAAGCGCAAAGGCTCGTTTGCGATATACCTGGAGCCCTGGCATGC
D I  F K L L D L R K N H G S E D Q R A R  
cDNA TGACATTTTTAAGCTGCTGGACCTCAGGAAAAACCACGGCTCAGAAGACCAGCGCGCACG
II I II I I II I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I II I I I I I I II I I I
gDNA TGACATTTTTAAGCTGCTGGACCTCAGGAAAAACCACGGCTCAGAAGACCAGCGCGCACG
D L F Y A L W I  P D L F R K  
cDNA CGACCTATTTTACGCGCTTTGGATCCCCGACCTGTTCAGGAAA
I I I I I I !  I I M i l l  I I  l l l l l l l
gDNA CGACCTATTGTACGCCCTCTGGATCC
Figure 4.11 Northern blot analysis of TaR l expression in bovine life 
cycle stages.
lOpg of total RNA from BL20, D7@37 , D7@41(day7) cells and 
piroplasm were separated on a 1% formaldehyde agarose gel and blotted 
onto Hybond C membrane. Labelling of probe and hybridisations were as 
described in chapter 2.
Panel A shows the hybridisation signal with the 180bp PCR fragment used 
as a probe for TaRl.
Panel B shows the signal obtained with the T. annulata DNA polymerase 6 
subunit probe using a H indlll fragment from the coding region of the 
genomic clone.
Panel C shows the signal with the T. annulata tubulin probe.
Panel D shows the ethidium stained gel
Key:
Lane 1: BL20 total RNA
Lane 2: D7(37°C) total RNA
Lane 3: D7(41 °C) total RNA
Lane 4: Piroplasm total RNA
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Figure 4.12 Expression and purification of TaR l fusion protein.
Bacterial lysate was prepared by re-suspending cell pellets in SDS- 
sainple buffer and running lysate on a 12.5% SDS-PAGE gel (lanes 2 & 3). 
The purified protein was prepared by resuspension o f the bacterial pellet, 
sonication in non-denaturing buffer, centrifuging, then further purification 
from the supematent (lane 4)by GST affinity chromatography according to 
the manufacturer’s instructions (lane 5).
Key:
Lane 1 Protein molecular weight markers.
Lane 2 Clone containing expression plasmid prior to induction.
Lane 3 Clone after 2 hour induction.
Lane 4 Sonicate o f induced clone.
Lane 5 Purified fusion protein after elution from GST column.
Lane 6 Purified GST protein from vector only expression.
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Figure 4.13 T aR l sera recognises 2 proteins from piroplasm extracts 
only.
BL20 and piroplasm extracts were prepared as described in Section 
2.5 and separated on an 8% SDS-Page gel. The proteins were then 
transferred onto Hybond C membrane (Amersham) and stained with 0.3% 
Ponceau S to assess equal protein loadings. The blots were then incubated 
with block buffer prior to the primary antibody being applied. Development 
of signal was using the ECL system (Amersham).
Lane 1: BL20 extracts
Lane 2: Piroplasm extracts
Panel A shows the reactivity o f the CM82 pre-immune sera and sera from 
the final bleed. Sizes are as indicated next to panels. Both are at a 1/200 
dilution.
Panel B shows the reactivity o f the CM97 pre immune sera and sera from 
the final bleed at a 1/200 dilution. Lanes 1 and 2 are as above.
Panel C shows the reactivity o f CM97 sera after pre-incubation with either 
purified GST protein or fusion protein.
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Figure 4.14 Immunofluorescence shows both CM82 &CM97 sera to 
react with schizont nuclei in D7 cells.
BL20 and D7 cells were transferred onto lysine coated slides by 
centrifugation in a Cytospin (Shandon Instalments). The slides were then 
fixed in 4% formaldehyde at room temperature for 10 minutes, prior to 
permeabilisation in 0.25% Triton X100 for 10 minutes again at room 
temperature. The slides were then pre-incubated with TBL medium for 1 
hour in a humidified chamber then rinsed in PBS. The CM97 antibody was 
then applied at a dilution o f 1/100 and incubated for 2 hours at room 
temperature. The slides were then rinsed in PBS and the FITC conjugated 
secondary antibody was then applied for 1 hour. The slides were rinsed for a 
final time, mounted with a DAB CO/D APHI solution and a coverslip 
attached. Pictures were taken on a M CI00 spot camera attached to a Zeiss 
Axioplan microscope.
Panel A  shows DAPHE staining of D7 cells.
Panel B shows the same D7 cells stained with the FITC conjugated antibody 
detecting labelling with CM82 antibody
Panel C shows BL20 cells stained with DAPHI.
Panel D shows the same cells in Panel C stained with the CM82 antibody 
via the FITC staining.
Panel E shows D7 cells reacting with DAPHI stain
Panel F shows the same cells reacting with CM97 antibody detected by 
FITC staining
Panel G shows D7 cells DAPHI stained
Panel H shows D7 cells reactive to the pre-immune sera from CM97 
detected by anti-rabbit conjugated FITC anti-serum.
Magnification is at X I00 (scale bar is 2pm) save for panels C+D which are 
at X40 (scale bar is 5pm).
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Figure 4.15 Immunofluorescence shows Ab0223 mAb to react with 
bovine cytoplasm only.
BL20 and D7 slides were prepared as detailed in Figure 4.12. The 
antibodies used were a mouse monoclonal against an unmapped epitope of 
the mouse Rl subunit and an anti-mouse FITC conjugate. Fixation and 
permeabilisation is as detailed in Fig. 4.12.
Panel A shows DAPHI staining of BL20 cells.
Panel B shows the same BL20 cells stained with the FITC conjugated 
antibody.
Panel C shows D7 cells stained with DAPHI.
Panel D shows the same cells in Panel C stained with the monoclonal 
antibody via the FITC staining.
Magnification is at X40 with the scale bar representing 5pm.
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Table 4.1 Homologies at amino acid level of R l subunits from various 
organisms
This table shows the homologies at amino acid level between the 
various R l subunits isolated from different organisms present in the 
GenBank/EMBL database using the GAP analysis programme. For each 
comparative pair two values are given, the first is the % identity and the 
second is the % similarity. The %  identity is a measure of absolute amino 
acid conservation between the pair and the % similarity takes account of  
conservative amino acid changes. The pairwise comparisons were carried 
out using the complete coding sequence from each species.
Key:
Ta - Theileria annulata 
P f - Plasmodium falciparum 
Hs - Human 
Mm - Mouse
Sp - Schizosaccharomyces pombe 
Sc - Saccltaromyces cerevisiae 
Va - Vaccinia virus 
Ec - E. coli
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Ta Pf Hs Mm Sp Sc Va Ec
Ta - 72/84 70/82 70/82 66/84 67/83 66/80 28/46
Pf 72/84 - 66/79 66/79 65/84 69/86 66/82 28/44
Hs 70/82 66/79 - 97/98 72/87 68/84 76/89 33/48
Mm 70/82 66/79 97/98 - 72/87 68/84 76/89 33/48
Sp 66/84 65/84 72/87 72/87 - 76/88 66/83 27/45
Sc 67/83 69/86 68/84 68/84 76/88 - 66/81 22/41
Va 66/80 66/82 76/89 76/89 66/83 66/81 - 29/48
Ec 28/46 28/44 33/48 33/48 27/45 22/41 29/48 -
Chapter Five
Regulation of Expression 
of the 
Large Subunit 
of
Ribonucleotide Reductase 
from 
Theileria annulata
5.1.1 Introduction
This chapter considers possible mechanisms which could control expression of 
the TaRl gene and polypeptide product and intially considers the regulation of 
ribonucleotide reductase expression in other eukaryotes which has been reviewed by 
Greenberg & Hilfinger (1996).
RR activity varies greatly during the cell cycle and is highest when DNA 
synthesis occurs but hardly detectable in quiescent cells. In higher eukaryotic cells the 
variation in RR activity at different stages is due to the fluctuation in R2 protein levels 
whereas the levels of R1 protein remains constant. In mice, the half life of R1 is >24 
hours whereas for R2 it is only three hours. Activity is regulated by the S phase specific 
synthesis and breakdown of the R2 protein (Engstrom et al, 1984). The R1 protein is 
constitutively expressed, remains at a constant level and is in excess throughout the cell 
cycle. The mRNA levels of both subunits rise in parallel in G1 reaching a peak as the cell 
progresses into S phase then declining into the G2+M phases (Bjorklund et al, 1990).
The S phase expression of the R2 mRNA is regulated by a cell cycle specific release of a 
transcriptional block which has been mapped to the 1st intron of the R2 gene. In S phase, 
a nuclear protein then binds just upstream of the block allowing full length transcripts to 
be produced (Bjorklund et al, 1992). This protein may be M ETlal, a transcription factor 
which has been shown to play a role in transcription of the human complement protein 
C2 and c-myc (Ashfield et al, 1991). Promoter analysis of the R1 gene in mice shows it 
to be a TATA less promoter but contains the TF-II binding elements common in cell 
cycle regulated genes (Filatov et al, 1995).
In lower eukaryotes transcription of the large subunit also appears to be periodic 
over the cell cycle. Two R1 genes are present in S. cerevisiae. The transcription of one 
of these, RNR1, is cell cycle regulated as a result of an MCB box which contains a 
consensus Mlul restriction site (Elledge & Davis, 1990). The MCB sequence element 
binds a transcription factor complex known as MBF or DSCI which promotes 
transcription (Johnston & Lowndes, 1992). The other large subunit gene, RNR3 is 
induced by DNA damage and is apparently not controlled by the MCB promoter system 
under these circumstances (Johnston & Johnson, 1995). Transcription of the single 
cdc22+ gene present in S. pombe which encodes the large subunit of ribonucleotide
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reductase, also shows cell cycle specific regulation, being maximally expressed at the 
Gl/S boundary (Gordon & Fantes, 1986). The stic22+ gene encodes the small subunit 
but two transcripts have been shown to hybridise to suc22+ , a smaller 1.5kb transcript 
that is constitutively expressed and a larger 1.9kb transcript that is induced upon 
blocking DNA replication with hydroxyurea (Femandez-Sarabia et al, 1993). This size 
difference is due to different transcript start sites (Harris et al, 1996). Cell cycle 
expression of the larger transcript is under MCB control but is also induced by DNA 
damage and heat shock.
In E. colt, the two genes encoding ribonucleotide reductase are arranged in an 
operon and are transcribed as a polycistonic message in the order R1 then R2. The 
expression requires two proteins, dnaA and Fis binding to specific sites upstream of the 
mRNA start. Another AT rich site upstream of the start site is necessary for the coupling 
of expression to the replication cycle.
In the mouse, the R1 gene lies on chromosome 7. It lacks a TATA box but 
contains other sequence elements which link its expression to the cell cycle. There are 
several mRNA start sites and upstream of the first of these, there are two 23nt boxes 
which were shown to be important in gene expression using footprinting studies. Further 
work showed there to be three protein factors involved in binding to these two regions. 
One protein was an S phase specific protein, another was very similar to the Spl 
transcription factor while the identity of the third remains unknown. Although the level 
of mRNA is controlled at the level of transcription, there is evidence that there are 
further controls on the mRNA levels in addition to the transcriptional controls detailed 
above. There is a 49nt region in the 3’UTR which binds a 57kDa cytosolic protein. The 
binding of this protein increases the rate of degradation of the mRNA. Work with known 
PKC inhibitors such as staurosporine found that the PKC pathway exerts an influence on 
stability by decreasing the binding affinity of p57 for the 49nt sequence in the R1 3’
UTR.
The stability of the R2 message is also regulated and a protein (p45) has been 
shown to bind to the 3’ UTR with a resultant increase in the rate of degradation. This 
can be reversed by the action of TP A, a phorbol ester, in a similar manner to the PKC 
mediated stabilisation of R1 mRNA. Another protein, p75 binds further downstream in 
the 3’UTR but acts to stabilise the message. This protein is linked to the action of TGF-
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p i, which has been shown to increase the levels of R2 protein in stimulated cells, via an 
increase in the R2 mRNA levels and via p75 mediated stabilisation of the R2 message.
Significance of the 3’ UTR of human R1 and R2
It has been shown that the 3’UTR of the R1 and R2 mRNA contain sequences 
important in regulating gene expression through changes in message stability. It has been 
shown by transfection experiments that the R1 and R2 3’ UTR can suppress 
tumourigenic properties of malignant mouse cells (Fan et al., 1996). Cells expressing the 
R2 3’UTR had significantly reduced potential to disseminate in experimental metastasis 
assays. By some means the 3’UTR regions of R1 and R2 can modify tumour cell 
development and dissemination, possibly by the interaction of the mRNA with 
components involved in the regulation of cell growth. Thus, in conclusion, there are a 
wide range of means of controlling the transcription and translation of the R1 and R2 
genes in both prokaryotes and eukaryotes. These pathways are linked to other signalling 
pathways within the cell showing that the expression of RR is intrinsically and intimately 
linked to the cell cycle.
As discussed in chapter 4, there is an upstream region in the TaRl cDNA which 
contains two in frame ATG codons prior to the consensus start codon based on 
ribonucleotide reductase large subunit protein sequences from other eukaryotes. It is not 
known if there is an N-terminal extension in the mature polypeptide but it is possible that 
this sequence upstream of the eukaryotic consensus start methionine is not translated and 
serves a regulatory role in the expression of TaRl at the translational level, possibly by 
forming an ordered secondary structure in the mRNA 5’ region. This possibility will be 
considered in relation to what is understood about mechanisms for regulation of rate of 
translation in other eukaryotes. The P. falciparum RR has significant differences to the 
mammalian systems. The genes for PfRl and PfR2 are located on the same chromosome 
and these genes have a different temporal order of expression than their mammalian 
counterparts, in that the PfR2 transcript appears earlier and persists for longer than the 
PfRl transcript (Rubin et al, 1993) in the schizont stage. No data is available on the half 
life of the subunits in P. falciparum or the sequence of the promoter regions. Thus there 
is relatively limited information on the regulation of RR expression in Apicomplexan
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parasites. The aim of this chapter is to provide a preliminary analysis of the features that 
may determine the regulation of the Theileria RR. This chapter also considers the 
transcriptional regulation of TaRl using aphidicolin, a DNA synthesis inhibitor, to block 
the cell cycle with the aim of determining whether the parasite R1 subunit transcription is 
under cell cycle control as has been shown for the mammalian and yeast systems.
The Theileria mRNA has only a small 3’UTR and there is no evidence for either 
alternative transcription start sites or variable length 3’ UTR as there is only a single 
mRNA species detected by Northern blotting in different life cycle stages (Chapter 4). 
This is 2.8kb, very similar to the predicted size of the cDNA clone (2.79kb).
5.1.2 Mapping of the transcriptional start site of TaRl
As promoter sequence will be upstream of the transcription start site, it was 
decided to map the transcriptional start site of TaRl using a PCR based method known 
as 5’ Rapid Amplification of fiDNA Ends (5’RACE). A description is given in the 
materilas and methods section. Two primers were designed to specifically amplify the 5’ 
end of the TaRl mRNA. The first primer annealed to a region downstream of the ATG 
codon representing the consensus translational start (M3). The second primer annealed 
to a region upstream of the 2nd ATG codon (M2). These are shown on Figure 5.2.
cDNA was prepared from a template of total piroplasm RNA using the first 
primer. Figure 5.1 shows the results of the PCR of reverse transcribed cDNA from the 
nested PCR reaction with the second primer, together with the control reactions supplied 
with the kit. The product was ligated into the pTAG vector and the one positive 
transformant was sequenced using pTAG specific primers. The DNA sequence of the 
RACE fragment is shown in figure 5.1. As only one positive transformant was obtained 
from the cloning of the PCR fragment, this does not exclude the possibility that the PCR 
fragment contained representatives with small size differences. SI mapping would 
possibly enable finer mapping of the mRNA starting site and allow establishment of a 
conclusive transcriptional start site.
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However, the end of the 5’ RACE PCR fragment is 51 nucleotides further 
upstream from the end of the cDNA clone so it is likely that this is the true 
transcriptional start site. It is probable that the mRNA was not fully reverse transcribed 
during the library construction. The existence of this 5’ untranslated region may be useful 
in designing anti-sense oligonucleotide inhibitors specific for the parasite gene given the 
results on anti-sense inhibition in P. falciparum published by Barker et a l (1996).
5.1.3 Is the 5’ region of the TaRl mRNA a means of regulation?
Northern blotting of P. falciparum RNA showed that the PfRl mRNA was 
actually 5.4kb, with an ~ 2.9kb untranslated region (Rubin et al, 1994) and although this 
has not been sequenced in its entirety, it is quite common for mRNAs in P. falciparum to 
possess a 5’UTR longer than the coding sequence.
Rather interestingly, if the 229bp upstream to the consensus start methionine 
(M3) of TaRl is collapsed into a stable secondary structure using the FOLDRNA 
package of the GCG program, its free energy value (AG) is -52 kcal/mol which indicates 
a potentially very stable structure. The plot of the secondary structure is shown in Figure
5.3. The P. falciparum cDNA clone sequenced by Chakrabarti et al., (1993) contains an 
upstream region of 123 base pairs before the consensus start codon is reached. If this is 
collapsed then the (AG) is -5kJ which suggests would not to be a stable structure. The 
full length mouse R1 cDNA possesses an upstream region of some 170bps in length 
(Thelander & Berg, 1986). If collapsed into a stable secondary structure with the 
FOLDRNA programme then the free energy value (AG) is -49kJ which indicates that a 
highly stable secondary structure can form. This AG value is rather similar to the value 
obtained for the TaRl upstream sequence.
5.1.4 Analysis of the 5’non-coding sequence from A,3 genomic clone
The 2.7kb BamHI/EcoRI fragment was subcloned from the TaRl X genomic 
clone (chapter 4) containing the entire gene. This was sequenced using the same gene
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specific internal primers designed for mapping of the transcriptional start site on template 
cDNA by the 5’ RACE method (figure 4.1). Approximately 250bps of upstream 
sequence was obtained on one strand only and is shown in figure 5.4a. The sequence is 
identical to the cDNA clone and to the 5’RACE product which mapped the 
transcriptional start site except for a single bp deletion and two adjacent bp deletions in 
the 5’RACE PCR product (marked as gaps..). As the PCR product was sequenced on 
both strands, it is probable that these are artefacts of the amplification reaction. These 
three sequences are aligned in figure 5.4b for comparision. The genomic sequence 
upstream of the transcriptional start site was analysed for homology to known promoter 
sequences in the Eukaryotic Promoter Database (EPD) and the TFASTA transcription 
binding site server. Some homology to regions of vertebrate encoded transcription 
factors were found - namely OCT-1, GATA and TATA boxes. These are shown in figure
5.4. Next it was desirable to see if this region contained any of the Mlul boxes (MCB 
elements) found in the upstream region of the S. pombe R1 gene and if there was any 
homology to the upstream sequence of the mouse R1 gene. The Mlul boxes had been 
shown to be involved in the transcriptional regulation of the S. cerevisiae R1 gene at the 
Gl/S border (Lowndes et a l 1992). There was no significant homology between the 
Theileria R1 sequence and the mouse or yeast sequences. The best match to the 
consensus TATA sequence found in most eukaryotic promoters (TATAA/TA/T) is 
found at -33 from the transcription start site (figure 5.4b). This has the sequence 
TATTAGA and is not an optimum match though it is positioned at a typical point in 
eukaryotic promoters (usually ~ 25bps) upstream of the transcription initiation site. 
Interestingly there is no TATA box found in the mouse R1 promoter (Bjorklund et al, 
1993) or in the human R1 promoter (Parker et al, 1995). It has been found that many 
genes involved in the cell cycle are regulated by the E2F transcription factor and that the 
regulation of this factor itself is subject to cell cycle control by a variety of other factors 
such as the tumour suppressor gene product p53 (reviewed in Muller, 1995). TATA 
boxes are present in genes transcribed by RNA polymerase II and are present in the P. 
falciparum PCNA gene (Horrocks & Kilbey, 1996) which shows differential expression 
in life cycle stages. The report of a gene encoding a divergent TATA binding protein 
from P. falciparum (McAndrew et al, 1993) suggests that protozoan TATA box 
sequences may differ slightly from higher eukaryotes. With respect to other common
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binding sequences present in the upstream R1 sequence there is homology to an OCT 1 
box at -80 from the transcription start site and a perfect match to a GATA factor binding 
sequence at -70. GATA transcription factors are important in determining cellular 
differentiation patterns (Merika & Orkin, 1993; Orkin, 1995). There is also a GATA box 
present in the P. falciparum PCNA gene as well as a single match to the GATA 
consensus sequence found in the Theileria tubulin sequence. There is a partial match to 
the eukaryotic CAAT promoter sequence (consensus GGCCAATCT) at -110 
(AGACAATTG) with 5/9 residues conserved. This sequence is involved in binding 
factors which regulate promoter efficiency and although the match is not well conserved, 
the distance from the transcriptional start site is typical for eukaryotic CAAT sequences 
(—75). The fact that there are possible consensus sequences present in the upstream 
sequence of the TaRl gene suggests that undertaking band shift assays with competing 
oligonucleotides and DNAse I footprinting studies against these regions would be 
informative in terms of defining whether these sequences are involved in the transcription 
of this gene. These sequences are highlighted in the upstream region of the TaRl and 
tubulin genes as shown in figure 5.4.
5.1.5 Aphidicolin as a means of cell synchronisation
It is important to determine if the parasite genes coding for cell cycle related 
proteins are subject to cell cycle control of transcription in a manner similar to that found 
for some higher eukaryotic and yeast genes. For example, the human DNA polymerase a  
gene is expressed as cells enter the cell cycle from GO and is then down-regulated after 
exit from the cell cycle (Pearson et al, 1991). In budding yeasts the transcription of at 
least 17 genes encoding enzymes for DNA synthesis or precursor production are 
coordinately induced at the Gl/S boundary. This is due to the presence of a conserved 
DNA sequence known as the MCB element or Mlu I cell cycle box (it contains a Mlu I 
restriction site). In S. pombe the expression of the large subunit of ribonucleotide 
reductase is induced at the Gl/S boundary and also contains the Mlu I box. However, 
the transcript levels of the DNA ligase gene in fission yeast is expressed constitutively 
throughout the cell cycle as are the transcript levels of the DNA polymerase a  and 8
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genes (Park et al., 1993) suggesting that, in S. pombe, there are at least two different 
regulatory modes for the expression of genes involved in the DNA synthesis. In order to 
investigate the regulation of cell cycle related genes, aphidicolin was used as a blocking 
agent to arrest cells at the start of S phase by specifically binding to the DNA polymerase 
a  and 6 subunits of the DNA replication machinery. Cells outside of S phase at the time 
aphidicolin is added, accumulate in S phase when they pass through the Gl/S checkpoint 
(Johnson et al., 1993). Aphidicolin affects the elongation activity of DNA polymerase 
but not initiation activity as shown by experiments done using aphidicolin sensititive and 
resistant CHO cells (Singleton & Mishra, 1995).
In Theileria infected cells, several objectives might be achieved through the study 
of aphidicolin inhibition. It is not known if Theileria DNA replication is sensitive to 
aphidicolin and if this is found to be the case, it should be possible to examine 
transcription of cell cycle associated genes and to analyse the effects of artificial 
synchronisation of host and parasite cell cycles.
5.1.6 BrdU labelling of D7 cells
In order to examine the effects of aphidicolin treatment on host and parasite it 
was necessary to develop a simple system for assay of DNA synthesis. There is no simple 
way of distinguishing host and parasite DNA synthesis using assay methods based on 
analysis of total cell extracts such as thymidine incorporation. It was decided to base the 
assay on microscopic detection of DNA synthesis in individual cells combined with 
counting of labelled host and parasite nuclei. This was done using 5-bromo-2- 
deoxyuridine (BrdU) incorporation followed by incubation with a specific antibody 
coupled with an immunofluorescent FITC labelled secondary antibody. As a control and 
baseline for using aphidicolin as a means of synchronising D7 cells in S phase, 
incorporation of BrdU was initially assessed in D7 cells growing at 37°C under normal 
conditions. The incorporation of BrdU was detected by immunofluorescence as shown in 
figure 5.5 and the results of the quantitative analysis are given in figure 5.6. Those host 
cells with reactive nuclei are those undergoing DNA synthesis during the course of the 
BrdU incorporation period (15, 30 and 60 minute incorporations were tried and it was
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found that a one hour incubation was required to see parasite nuclear reactivity). As seen 
from figure 5.5 (Panel B), parasite nuclei rarely label in the absence of parallel host nuclei 
labelling. The numbers of cells containing labelled host nuclei only, labelled parasite 
nuclei only and both types of labelled nuclei were counted and then plotted as shown in 
figure 5.6. Macroschizonts with any degree or number of nuclei showing reactivity were 
scored as positive. In practice, it appears that parasite nuclei synthesise DNA 
synchronously within a macroschizont as most cells showing parasite BrdU incorporation 
have reactivity in all the nuclei based on comparison with the DAPHI staining pattern. 
However, it is not uncommon to see a cell where, compared to the DAPHI stain, there is 
a group or block of parasite nuclei showing reactivity and a group that does not (figure 
5.5). At any one time there are approximately 60% of host cells synthesising DNA but 
only 20% of parasites . Of the parasites undergoing DNA synthesis most (-80%) do so 
in the presence of host DNA synthesis with relatively few parasites labelling in the 
absence of host DNA synthesis. As seen in figure 5.5, parasite DNA synthesis cannot be 
correlated with any particular intensity of host reactivity suggesting that parasite DNA 
synthesis is not closely linked to a specific point in the host S phase.
5.1.7. Aphidicolin blocking of D7 cells
The cells were treated with 1.5 mg/ml of aphidicolin for a period of 18 hours at 
37°C, a concentration typically used for mammalian cells (Tobey et al, 1988). The drug 
was then washed out and the cells resuspended in fresh fresh pre-warmed medium and 
sampled at 1, 2,4, 5 and 6 hours post-release from aphidicolin for RNA preparation and 
BrdU incorporation. A sample of cells was also taken prior to resuspension in fresh 
media (time 0). For each time-point, a cytospin slide was prepared for BrdU 
incorporation counting and the remaining cells were used to prepare total RNA.
By counting the numbers of host and parasite nuclei with detectable BrdU 
incorporation, it was possible to achieve a measure of the efficiency of the aphidicolin 
treatment determining the frequency of positives. This should decrease as the cells move 
out of S phase and are no longer undergoing DNA replication. Figure 5.7 shows the 
incorporation of BrdU into D7 cells at time points 0 and 1 hour post release. At time 0,
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there is very little detectable labelling of the parasite nuclei and low host reactivity (Panel 
B). The reactivity increases strongly in both types of nuclei as the cells move into S 
phase after release from the drug. The results of the cell counts for each time point are 
shown in figure 5.8 and plotted in the same figure. From the graph, it can be seen that 
not all host cells are arrested in S phase as the number of cells staining with the BrdU 
antibody is <100% after release from drug. The peak is at 1 - 2 hours post release with 
76% of the host nuclei staining very brightly. This figure then decreases as the host cells 
move out of S phase. After 6 hours only 24% of the host nuclei are synthesising DNA. 
The degree of synchronisation is comparable to the 80 - 90% of S phase mammalian 
fibroblast cells cited in Tobey e ta l (1988). The % of parasites showing nuclear staining 
peaks at 50%, 1 hour after release, decreases to 3.5% by 4 hours before increasing again 
to some 15% by 6 hours after release. Early after release, the majority of parasites 
showing BrdU incorporation do so in the presence of host DNA synthesis (85%). 
However, by the end of the time course the parasite component showing incorporation in 
the absence of host increases considerably (72%). Examples of cells seen following 
release from the aphidicolin block are shown in figure 5.7. From Panel C it can be seen 
that all the individual parasite nuclei are labelling and the host nucleus labelling is very 
strong, following release from the block but in Panel E only a proportion of the parasite 
nuclei are labelling one hour after release from block in this cell. It would be interesting, 
albeit difficult, to score the numbers of nuclei labelling in each schizont to determine how 
synchronous the parasite nuclear population is within a given host cell following 
aphidicolin treatment. The host cell seen in Panel E is larger than those seen in Panels A 
& C and it is possible that aphidicolin treatment makes cells more fragile so that this cell 
has been distorted by the presence of the drug. There could be two explanations for only 
50% of the parasite nuclei being in S phase. The first being that the parasite may be less 
sensitive to the drug than the host; the increase to 50% from the 20% of parasites in S 
phase in the control culture suggesting S phase is slower or extended in the presence of 
this concentration of aphidicolin. This could be due to transportation of the drug into the 
macroschizont or the Theileria polymerase being insensitive to the drug, a situation 
found in Trypanosomes (Mutomba & Wang, 1996) and Toxoplasma (Makioka et al, 
1993). Secondly, the parasite may be sensitive to aphidicolin but because of the small 
size of the genome compared to the bovine (200 fold smaller), the time spent in S phase
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is likely to be shorter and during drug treatment which causes an accumulation of 
parasites in S phase, some may manage to complete and exit S phase over the time of 
treatment.
5.1.8. Northern blotting of RNA prepared from aphidicolin treated D7 cells
RNA samples were prepared for five of the timepoints sampled and was used to 
prepare Northern blots for probing with TaRl and parasite tubulin together with the 
ThaCRK2 and host cdc2 genes. Figure 5.9 shows the RNA time course Northern blot 
probed with the TaRl and tubulin probes (Panels A & B respectively).
With the TaRl probe the strength of the hybridisation signal increases following 
removal of the drug and peaks at the two hour time point, After this there is a small 
decrease in signal between four and six hours. Two - four hours post release is 
equivalent to the trough in parasite DNA synthesis as seen by BrdU incorporation 
(Figure 5.8, Panel A). Using a Theileria |3 tubulin cDNA clone as a probe, there is a 
similar increase in trancript levels immediately following removal of the drug. The 
hybridisation signal of 1.8kb reaches a maximum at 2hrs and does not decline 
significantly thereafter (Panel B). The blots were then stripped and re-probed with 
parasite ThaCRK2 and host cdc2 probes. Again, using the ThaCRK2 probe (Panel C), 
there is an increase in hybridisation signal 1 hour after removal of the drug which remains 
at a similar level over the rest of the time course,a pattern almost identical to that 
obtained with the (3 tubulin probe. The bovine cdc2 probe (Panel D) (Logan & Kinnaird, 
unpublished) hybridises to RNA species of 1.4 and 3.5 kb with the smaller of the two 
being the same size as the polyadenylated cDNA clone. The upper band is routinely 
present and may represent hybridisation to a closely related CDK RNA or an unspliced 
precursor of cdc2. The 1.4 kb transcript appears to show a marginal decrease 1 hour 
after removal of drug but then rises to a peak at 6 hours. This peak coincides with the 
exit from S phase of the majority of the host cell population. It has been shown that the 
human cdc2 promoter is activated in S phase (Dalton, 1992). As a control for 
synchronisation of the host, an attempt was made to hybridise the mouse R1 probe (a gift 
of L. Thelander) which is known to be transcriptionally regulated over the cell cycle
146
(Bjorklund et al, 1992) but the probe fragment did not cross-hybridise with bovine 
RNA. It is possible that this region is quite divergent between mouse and bovine Rls. 
The increase in RNA levels could be analysed for parallel changes in polypeptide levels 
by immunoblotting of protein extracts prepared from cells blocked and released from 
aphidicolin.
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5.2 Discussion and Conclusions
The 229bps sequence in the TaRl cDNA clone upstream of the consensus 
translational start codon (M3) has the potential to fold into an extremely stable 
secondary structure. While it is possible that this region could be translated and form an 
N-terminal extension to the typical eukaryotic R1 protein structure, it is equally possible 
that formation of a stable secondary structure at the 5’ end of the mRNA could provide a 
means of regulating the rate of translation of the TaRl RNA. This could occur either 
through preventing access to the ribosome or by binding of a protein factor to prevent 
translation. ATG burdened leader sequences are extremely rare on mRNAs encoding 
highly expressed proteins such as caseins, histone, immunoglobulins etc. Most of the 
mRNAs with a high ATG burden are also GC rich thereby reducing translation by virtue 
of a highly ordered secondary structure. Many vertebrate mRNAs can form sufficient 
secondary structure at the 5'end to repress translation which can become 'derepressed' 
upon a mitogenic signal inducing a specific protein binding to this region and thus 
changing the secondary structure or preventing the mRNA from maintaining the 
secondary structure. Whether this is an actual phenomenon used by Theileria as a means 
of translational regulation would need to be tested experimentally. This would require a 
Theileria based in vitro translational system using full length and truncated versions of 
the R1 mRNA.
The region of the DNA extending 225bps upstream of the transcription start site 
was sequenced and analysed for possible promoter sequences with homology to known 
eukaryotic promoter elements. It will also be interesting to determine if the various genes 
involved in the parasite cell cycle have a common promoter structure to enable co­
ordination of expression. From the results of the aphidicolin experiments TaRl may be 
subject to cell cycle regulation. It would be of interest to determine if the polymerase 5 
subunit shows the same pattern of expression in infected cells after exposure to 
aphidicolin. From the analysis of the upstream region of the genomic clone there is some 
homology to known promoter sequences found in higher eukaryotes such as the OCT1 
and the TATA box, although the relative AT richness of these regions may account for 
artefactual homologies which resemble known transcription factor binding sites. In 
higher eukaryotes, the OCT1 transcription factor is preferentially expressed in early S
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phase and up-regulates genes encoding enzymes involved in DNA replication. It has also 
been shown to be subject to regulation by phosphorylation during the cell cycle (Verrijer 
et al, 1990).There is a perfect match to the GATA box known to be important as a 
binding sequence for a class of DNA binding proteins important in differentiation, 
although multiple GATA binding sites are required for erythroid cell specific trans­
activation (Orkin, 1995). Interestingly the upstream region of the P. falciparum PCNA 
gene contains TATA boxes together with some regions showing strong homology to the 
OCT1 consensus sequence (Horrocks & Kilbey, 1996). There are also GC regions rich 
found in the promoter which are unusual given the AT richness of Plasmodium, 
however, the significance of these sequence elements is unknown. There is also a perfect 
GATA box found in the PCNA promoter but again, the significance of this is unknown. 
The P. falciparum PCNA promoter also contains a region with high homology to the 
initiator core promoter element consensus sequence (Javahery et al, 1994). This initiator 
functions to localise a transcriptional start site and can co-operate with the TATA 
element if both are found in the same core promoter and are approximately 25bps apart. 
The consensus sequence is (T/C)(T/C)AN(T/A)(T/C)(T/C) with the matching sequence 
in the P. falciparum PCNA promoter being TTATATA and a TATA box being 25bps 
further upstream. This may indicate that the initiator element has been conserved in the 
protozoa and that the basal mechanisms of transcription are similar to that found in the 
higher eukaryotes. Comparing the TaRl sequence (figure 5.4) there is a perfect initiator 
element TTAGACT found at the transcription start site but this could feasibly be a stand 
alone initiator element as they can operate in the absence of a TATA box. The Theileria 
tubulin gene contains a region with high homology to the TATA box about 25bps 
upstream of the transcriptional start site although this homology could be due to the high 
%AT found in intergenic regions. Earlier work by Horrocks et a l (1996) showed that 
PCNA and polymerase 6 proteins are found at similar levels in trophozoites and 
schizonts despite the transcripts probably only being present in trophozoites. The 
promoter activity of these two genes is different despite the fact that, in both cases, the 
transcript and protein levels rise in parallel. Pol5 is regulated at the level of transcription 
initiation whereas the PCNA transcript levels are regulated post-transcriptionally.
Looking for parallels with the Theileria R1 gene, it seems that the levels of 
protein and transcript rise in parallel throughout the course of differentiation with mRNA
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levels remaining high in the piroplasm stage. However, given that promoter regions in 
Theileria have not been well characterised, it is difficult to postulate specific mechanisms 
involved in transcriptional regulation in Theileria. As a result of the work presented, it 
would now be possible to perform a detailed analysis of the TaRl upstream region by 
deletion analysis and transient transfections to determine what sequences are necessary 
for promoter function once such techniques have been developed.
In order to investigate transcriptional regulation of cell cycle associated genes in 
Theileria and to investigate the relationship between host and parasite DNA synthesis, 
pilot experiments were carried out using the DNA synthesis inhibitor aphidicolin to block 
cells in S phase. In D7 cells growing at 37°C only -20% of parasites are seen to be 
undergoing DNA synthesis at any one time. Aphidicolin treatment increases this to 50% 
by one hour following removal of the drug. Thus there is clearly an effect of aphidicolin 
on parasite DNA synthesis. However, it is impossible to distinguish whether this is a 
direct effect of the drug on the parasite DNA replication machinery or an indirect effect 
via the effect of the drug on host DNA synthesis. Since, under normal growth conditions 
at 37°C, most of the parasites that are synthesising DNA do so in the presence of host 
DNA synthesis, there may be some link with the host and parasite S phases- hence the 
effect of aphidicolin allowing host cells to accumulate in S phase may be transmitted to 
the parasite. Another possibility is that the parasite is less sensitive to the drug. This 
could be due to the requirement for transport of aphidicolin into the macroschizont or to 
the Theileria DNA polymerases being less sensitive, a situation found in Toxoplasma 
gondii (Makioka et al, 1993). As Theileria species are in the same phylum, 
Apicomplexa, as Toxoplasma this may suggest that the Theileria polymerase subunits 
are aphidicolin insensitive. Conversely, work with the DNA polymerases from P. 
falciparum shows the activity to be aphidicolin sensitive (Inselberg & Banyal, 1984, 
Chavalitshewinkoon et al., 1993). It would be necessary to purify the DNA polymerase 
enzymes from the parasite to determine the exact sensitivity of the Theileria DNA 
polymerase to aphidicolin by biochemical assay. An effect of a reduced sensitivity of 
Theileria to aphidicolin may manifest itself as lengthening of the parasite S phase 
sufficiently to give an accumulation of parasites in S phase but, because of the small 
genome size (107 base pairs, 200 fold less than the host genome size), a proportion 
manage to complete and exit S phase over the time of treatment. It appears that
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aphidicolin may induce two peaks of parasite DNA synthesis within one host cell cycle. 
The evidence from nuclear counts (Shiels et al, 1992) and the control D7 experiment 
indicate that two rounds of replication do not normally occur. This may reflect the 
artificial disruption of synchrony caused by the presence of the drug. If differentiating D7 
cells are cultured in the presence of aphidicolin for 18 hours prior to the induction of 
differentiation at 41°C, the rate of differentiation is faster compared to control cells, 
lasting only four to six days (Shiels, pers. comm.).
For co-ordination of host nuclear division with parasite nuclear and schizont 
segregation to occur, the parasite gap phases may be elongated to allow for the 
completion of host S phase. How the parasite aligns itself with the host spindle for the 
division to occur is largely unknown though it has been suggested that attachment to 
host centrioles occurs (Carrington et al, 1995). It has previously been shown by 
immunofluorescent detection of a schizont surface antigen that some parasite infected 
cells contain two macroschizonts (Carrington et al, 1995). These observations suggest 
that DNA synthesis is synchronous in all the nuclei within a schizont but not between 
schizonts in a single host cell. Definitive proof of this would require double labelling with 
detection of both the schizont surface antigen and BrdU labelled nuclei.
From the aphidicolin blocking of the D7 cell lines it is possible to draw some 
conclusions regarding the lengths of the host and parasite cell cycles. The probable 
existence of two peaks of DNA synthesis in this experiment would suggest that the 
nuclear division cycle of the parasite only lasts 3-4 hours. For the host, S phase lasts 
longer than 6 hours, given that incorporation of BrdU is still measurable 6 hours post 
release from the block. This fits with the 18-22 hour cell cycles typical of higher 
eukaryotes. However, it is possible the peak of parasite BrdU incorporation may have 
occurred within the 1st hour post-release from block which would only be detectable if 
earlier time points had been taken.
The Northern blotting experiments undertaken with RNA prepared from the 
aphidicolin blocked and released cells suggests that the parasite ThaCRK2 and P-tubulin 
are not under cell cycle control as transcript levels are steady in the 1-6 hour period after 
removal of drug.
It is interesting to note that the human cdc2 gene is TATA-less and is negatively 
regulated by the retinoblastoma gene product pRb which only associates with the E2F
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transcription factor in G1 when transcription is blocked (Dalton, 1992) and a degree of 
transcriptional regulation of the bovine cdc2 gene was observed following release from 
the aphidicolin block. Here the peak transcript level was observed at 6hrs when most of 
the host cells were leaving S phase, a result identical to that obtained with human cdc2 
transcription in synchronised HeLa cells (Dalton, 1992). This would parallel a 
requirement for cdc2/cyclin B at the G2/M phase boundary in mammalian cells with 
CDK2/cyclin B acting at Gl/S phase. However, in fission yeast there is little if any cell 
cycle regulated transcriptional control of the cdc2 gene (Durkacz et a l , 1986). Relating 
this to the ThaCRK2 signal in the Northern blots of the aphidicolin blocked cells, it 
seems that there is again little regulation of transcription of this gene, a situation similar 
to that found in S. pombe and Paramecium tetraurelia (Tang et al., 1995).
The pattern of expression seen for TaRl following aphidicolin treatment may 
indicate that the transcript levels of TaRl are cell cycle regulated. The results indicate 
that there may be a degree of regulation of TaRl transcription over the nuclear division 
cycle in the macroschizont stage as there appears to be a peak in transcript level when 
DNA synthesis is low and just prior to the start of the next parasite DNA synthesis wave 
i.e. in preparation for the provision of dNTPs. As the peak is not striking, there may be 
several explanations as to why the effects of a transcriptional regulation may be masked: 
at one hour post release only ~50% of parasites were synthesising DNA which could 
contribute to a lack of sharpness of the peak. However, from a study of cell cycle 
regulation in S. pombe where a similar efficiency of synchronisation was obtained using 
an elutriation method (measured as 40% septated cells), there was a clear cell cycle 
regulation of histone 2A1 transcription (Park et al, 1993). Therefore, it seems that this 
level of synchronisation should have been adequate to detect transcriptional regulation of 
gene expression during the nuclear cell division cycle in Theileria. It should be pointed 
out that the TaRl transcript peak occurs after the first round of parasite DNA synthesis 
is complete and, as with all artificially induced synchronisation, it begins to break down 
after the first cycle. It might be expected that during the period of drug treatment, 
transcript levels of TaRl would be elevated as S phase is prolonged but as the later peak 
appears to occur at the lowest level of parasite DNA synthesis i.e. prior to S-phase, an 
accumulation of RNA may not occur during an S phase block. In fact as all parasite 
transcripts assayed were at their lowest levels in the presence of aphidicolin, the period
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of treatment needed to accommodate the long host cell cycle may have had a secondary 
effect on cell functions other than DNA synthesis such as protein synthesis. This has been 
found for some mammalian cell types following aphidicolin treatment (Schimke et 
al.,\99X). Although the promoter sequence ofR l from P. falciparum has not been 
analysed, work with synchronised parasite cultures showed that the transcript levels of 
R1 & R2 are co-ordinately regulated during the cell cycle with a peak of expression 
occurring just prior to the entry of S phase (Rubin et al, 1993). This is a similar situation 
to that found in mice where R1 & R2 transcripts increase in parallel correlating with 
DNA synthesis (Bjorklund et al, 1990). However, it is not known if the half life of the 
Plasmodium R1 protein is longer than the R2 protein, a situation found in higher 
eukaryotic cells. There is very little homology between the Theileria R1 promoter 
sequences and those from mouse and human sequences which are very similar to each 
other. If anything, there are parallels between the Theileria R1 and Plasmodium PCNA 
promoters which may reflect the fact that both proteins are vital for DNA replication. 
More work with this region in Theileria could shed light on the means of regulation of 
cell cycle related genes by this parasite and how these relate to other members of the 
Apicomplexa. Certainly, this area has not been well investigated in Theileria and with 
only a few genes sequenced so far, it is not possible to draw any major conclusions about 
the mechanisms of transcriptional regulation at work in this parasite.
It is probable that there is a high degree of control over nuclear division in 
Theileria and this could extend to transcriptional control of expression of some 
associated genes such as TaRl. The evidence for this comes from the analysis of BrdU 
incorporation under non-drug conditions. These results show that in the non­
differentiating macroschizont, DNA synthesis is synchronous between nuclei in a single 
schizont. This situation is found in higher eukaryotic syncytial cells eg in early 
Drosophila embryo development (Edgar et al, 1994). However, this contrasts with 
schizogony in P. falciparum where the nuclear divisions are known to be asynchronous 
(reviewed in context in Leete & Rubin 1996). This, in itself, argues that regulation of 
nuclear replication may be more complex in Theileria.
The analysis of the upstream region of the TaRl gene shows homology to some 
common motifs such as the TATA box and the GATA binding regions which may be 
important in the basal transcription apparatus of the parasite but further work is needed
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to show that this upstream region acts as a functional promoter. Recent work with the P. 
falciparum PfPK5 protein which is highly homologous to the ThaCRK2 has shed some 
light on its role in the malarial cell cycle (Graeser et al., 1996). Using aphidicolin treated 
cultures, it was shown that the immunoprecipitated PfPK5 kinase activity increased 
significantly in these blocked cells which suggests a role for this protein in the S phase of 
the cell cycle. The authors also showed that the PfPK5 is activated at the beginning of 
the nuclear division cycle and that the pool of cytoplasmic PfPK5 must be maintained for 
the newly formed nuclei. This may also hold true for the ThaCRK2 protein although 
further work needs to be done to confirm the role of ThaCRK2 in the division cycle in 
Theileria. This will be of interest if the DNA polymerases in Theileria are shown to be 
aphidicolin sensitive. Based on the results in this chapter it is not possible to state 
conclusively the effects of aphidicolin on the parasite DNA polymerases.
Work on the differentiation of neuroblastoma cells showed that addition of 
aphidicolin together with nerve growth factor acted to induce differentiation (Poluha et 
al., 1996). This is interesting since prior treatment with aphidicolin induces 
differentiation in D7 cells. Further experiments showed that the neuroblastoma cells 
continued to express p21wafl, a CDK inhibitor, after removal of aphidicolin and that the 
expression of p21 was required for the survival of these cells. This, perhaps, places 
control of differentiation in the context of negative regulators of the cell cycle which 
would be most interesting to look at from the view of parasite control of the host cell 
cycle and how the switch between proliferation and differentiation takes place. This is 
analysed in the next chapter.
To conclude, in T. anmilata the host and parasite cell cycles are closely linked 
with the parasite S phase occurring within the host S phase. The genes encoding 
ThaCRK2 and (3 tubulin do not appear to be transcriptionally regulated during the 
nuclear division cycle but TaRl may be subject to regulation. There is a partial degree of 
synchrony in the parasite induced by aphidicolin treatment but it is not clear from these 
experiments if the effect is mediated by a direct effect on the parasite DNA polymerase 
or indirectly as a result of the host cell cycle being blocked. Further experiments are 
necessary, particularly to define the sensitivity of the parasite to aphidicolin.
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Figure 5.1 5’ RACE with piroplasm RNA as template
Piroplasm total RNA was reverse transcribed according to the 
instructions supplied. The cDNA was then amplified using nested PCR with 
die second TaRl specific primer together with the anchor primer and cloned 
into die pTAG vector. The DNA sequence of die product is shown in figure 
5.2.
Panel A shows the RACE PCR reaction with the gene specific primer (5 
PRIME RACE 2).
Lane 1: PCR reaction with anchor primer and gene specific primer
Lane 2: PCR reaction widi anchor primer only
Lane 3: PCR reaction with gene specific primer only
Panel B shows the control reactions showing 538bp bands obtained with the 
control RNA supplied widi die kit.
M: DNA markers - lkb ladder (Gibco-BRL)
Lane 1: Control RNA with the first strand synthesis using GSP1
primer dien nested PCR with GSP2 and GSP3 primers.
Lane 2: Control RNA widi die first strand synthesis using oligo-dT
primer then nested PCR with GSP2 and GSP3 primers.
Primers
5PRIME RACE 1 - 5 ’ AGCGATAACTTCCTGATGCG 3 ’ (antisense to 
position 289 - 308 o f cDNA sequence.)
5PRIME RACE 2 - 5 ’ AAATCGTGGTCCTCATAGCC 3’ (antisense to 
position 127 - 146 o f cDNA sequence.)
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A B
M  1 2 3
226/200bps 
154/134bps
M  M  1 2
2kb ---► *  ¥
1 6kb---► •  ¥
l.Okb ---+ • •
500bps---►
-
538bps
Figure 5.2 5 ’ RACE PCR maps likely transcriptional start site
The sequence of the RACE PCR fragment is shown opposite.
Key:
AGGA - mRNA sequence upstream of cDNA clone
AGGA - sequence o f cDNA clone
AGGA - region o f primer 2 used for second round of PCR
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DNA Sequence from RACE fragment showing the upstream region from 
cDNA clone.
1 TTAGACTATA TATTGTTTAT CTTTCGCTAT ATTTTTAAAT TATGCTTCTT
Ml
5 1  CTGATACAAA CTCGTTATTT CCTTGATTGT TTTTAAAGTT AAGATGGATG
1 0 1  CATCAACAGG ATCATAACAA TACCACAAGT GGTTTTCCGC CTGAGGATGT 
1 5 1  GTCGGAAAGC TCACGTGGCT ATGAGGACCA CGATTT
Figure 5.3 FOLDRNA program shows upstream region of T aR l cDNA  
clone can form a stable secondary structure
The FOLDRNA program of the GCG package was used to collapse 
the229bp region upstream of the consensus start ATG codon of the cDNA 
clone into a secondary structure. The AG value of -52kJ shows that this 
structure is exceptionally stable.
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Figure 5.4a Alignment of genomic, RACE and cDNA T aR l clone
This figure shows the alignment o f the genomic, RACE PCR and 
cDNA clones of TaRl. The location o f the first in frame ATG codon is 
marked in bold.
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1 60
TaRlgen AAAACCGAAA GTTCTATTTG GCAGAAAGAA TGCAGCTATT ACACACAAAA TAGGCAAGAT
RTPCR ---------- ----------- ----------- ----------- ----------- -----------
TaRlcDNA---------- ----------- ----------- ----------- ----------- -----------
6 1  1 2 0
TaRlgen CTGTGATTAC AGTTGAAATG TAAAAAAgAT TAACANACAA TTGTTGAaAT AAAATTAGAC
RTPCR ---------- ----------- ----------- ----------- ----------- -----------
TaRlcDNA---------- ----------- ----------- ----------- ----------- -----------
1 2 1  1 8 0
TaRlgen TCAAATTTAA GTGCAATGAT AGGAGTTAAC TAAGGGGTTT GGTACTGCCT GAATTaTTAG
RTPCR ---------- ----------- ----------- ----------- ----------- -----------
TaRlcDNA---------- ----------- ----------- ----------- ----------- -----------
1 8 1   y 2 4 0
TaRlgen ATTTGGATTG TGTGGCACGA TCACAAATTA GACTATATAT TGTTTATCTT TCGCTATATT
RTPCR --------------------- -------- TTA GACTATATAT TGTTTATCTT TCGCTATATT
TaRlcDNA---------- ----------- ----------- ----------- ----------- -----------
2 4 1  3 0 0
TaRlgen TTTAAATTAT GCTTCCTTCT GATACAAACT CGTTATTTCC TTGATTGTTT TTAAAGTTAA
RTPCR TTTAAATTAT GCTT.CTTCT GATACAAACT CGTTATTTCC TTGATTGTTT TTAAAGTTAA
TaRlcDNA --------- T GCTTCCTTCT GATACAAACT CGTTATTTCC TTGATTGTTT TTAAAGTTAA
★
3 0 1  3 6 0
TaRlgen GATGGATGCA CATCAACAGG ATCATAACAA TACCACAAGT G---------  ----------
RTPCR GATGGATG.. CATCAACAGG ATCATAACAA TACCACAAGT GGTTTTCCGC CTGAGGATGT
TaRlcDNA GATGGATGCA CATCAACAGG ATCATAACAA TACCACAAGT GGTTTTYCGC CTGAGGATGT
Ml
3 6 1  3 9 6
TaRlgen ----------- ------ ---- ----------- -------
RTPCR GTCGGAAAGC TCACGTGGCT ATGAGGACCA CGATTT
TaRlcDNA GTCGGAAAGC TCACGTGGCT ATGAGGACCA CGATTT
Figure 5.4b Upstream sequence of T aR l genomic clone
This figure shows the upstream sequence of the TaRl gene derived 
from the RACE primer of the A3 clone together with the upstream sequence 
from the tubulin gene (courtesy of M. Logan). Sequences of interest within 
this region are shown below:
Key:
TTAG  start of mRNA
TATTAG TATA box and close match to consensus sequence of
TATA(A/T)(A/T)
TGATAG GAT A boxes - matches to consensus sequence of 
(T/A)GATAR where R is a purine base (A or G)
ACTCAAAT Oct-1 box - consensus sequence of ATGCAAAT 
AGACAATTG CAAT box - consensus sequence of GGCCAATCT
Consensus binding sequences are as listed in Faisst & Meyer, 1992.
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Large subunit of Ribonucleotide Reductase
1 AAAC GATATT TTGAGGGGAA AACCGAAAGT TCTATTTGGC AGAAAGAATG
50 CAGCTATTAC ACACAAAATA GGCAAGATCT GTCATTACAG TTGAAATGTA
100 AAAAAGATTA ACAGACAATT GTTGAAATAA AATTAGA CTC AAA TTTAAGT
200 GCAATGATAG GAGTTAACTA AGGGGTTTGG TACTGCCTGA ATTATTAGAT
250 TTGGATTGTG TGGCACGATC ACAAATTAG
Tubulin iupstream intergenic region
1 TGAAAATTTG CTGATCTTTT TTTCCACCGA TGCGTCTCAC CTTTTTTTAC
51 TGTACTAACT GTAGCATACA TTTTAATTGA TCAAATATCT AAATAAATTT
101 TACATTATAA TTAATTATAA AAATTATTAA CTTGCACAAT CAAGGATAAT
151 TTTTAGCATC AACATACAAG AAAAGCTCGA TCCTACACTA AGGAATCATA
201 AACAATTTTA AAATCCTTCG AATCGTAATC AAAATTAGAA TTCGAAGTAA
251 GTATTAACTA GAGTTATATA TACAACGTCG TAAGTATGTC GTGAAAAGTG
301 AAAGTACAAG TGTTTAAAAG TAATATGGGA ACCTTTGATA TTATAAACCC
351 ATTTTAAAAC TAAAATATTT TACTTTCATT TAAAAGGGGG CGTAACGATT
401 TTACTTATTT AGTGTTGTCT GTGTGTGGTA TAATTTGTAA TATATGTGAT
451 TGTAAATCAG TAAT
Figure 5.5 D7 cells stained with DAPHI and BrdU.
This figure shows D7 cells growing at 37°C stained with BrdU and 
DAPHI. Arrows indicates the location o f a cell consisting o f parasite nuclei 
staining in the absence o f host staining (1), parasite and host nuclei both 
staining (2) and host nuclei staining alone (3).
Panel A  shows the cells stained with DAPHI stain.
Panel B shows the same cells reactive against the anti-BrdU antibody.
Magnification is X20 and the scale bar represents 10pm.
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Figure 5.6 BrdU incorporation into D7 cells growing at 37°C
The table lists values for the total numbers o f cells counted (as 
assessed by DAPHI staining) with the numbers o f host nuclei and numbers 
o f parasites with nuclei showing BrdU incorporation in D7 cells growing at 
37°C. The data from the table is plotted below. This illustrates that parasite 
nuclear labelling rarely occurs in the absence of parallel host nuclear 
labelling. The y-axis shows the number of nuclei staining with BrdU 
expressed as a % of the total number o f cells counted by DAPHI staining. 
The x -axis shows the host, parasite, parasite + host and parasite - host 
categories o f nuclei staining.
Key to table:
In each row two figures are given, the first is the number o f cells showing 
BrdU incorporation. The second is the first figure expressed as a % o f the 
total number o f cells counted.
Host nuclei Host nuclei showing any detectable BrdU incorporation
Parasite nuclei Parasite macroschizont showing any detectable degree of
BrdU incorporation
Host + Parasite Cells showing incorporation in both host and parasite
Host - parasite Cells where parasite shows incorporation in absence o f
host labelling.
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Table of BrdU incorporation into D7 cells growing at 37°C 
Total number of cells counted - 222 by DAPHI staining.
host nuclei parasite nuclei Host + parasite Parasite - Host
131 42 35 7
(59%) (19%) (16%) (3%)
Nuclei staining with BrdU as a % of the total number 
of cells counted by DAPHI staining
%Brdll
staining
% Host % Parasite %H+P %P-H
Nuclei staining with BrdU
Figure 5.7 BrdU staining with D7 cells subjected to aphidicolin block
This figure shows the typical staining patterns encountered pre and 
post release from the aphidicolin block.
Panel A  shows D7 cells prior to release from block stained with DAPHI. 
Panel B shows the same cells reactive with the anti-BrdU antibody.
Panels C & E show D7 cells sampled one hour post release from block, 
stained with DAPHI.
Panels D & F show the cells in panels C & E staining with the anti-BrdU 
antibody.
Magnification is X I00 and the scale bar is 2pm.
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Figure 5.8 Bromo-deoxyuridine incorporation into D7 cells in the 
presence of aphidicolin
The table lists the values for the cell counts done at each o f the 6 time 
points for the D7 cells blocked with aphidicolin for 18 hours at a 
concentration o f 1.5pg/ml then released. The values for the host and parasite 
incorporations o f BrdU are then plotted as %  incorporating BrdU o f total 
numbers o f cells counted.
Key to Table:
DAPHI Number of cells counted as stained by DAPHI
BrdU Host Number of host nuclei staining with BrdU
% DAPHI BrdU staining of host nuclei expressed as a % of the
number o f cells counted
BrdU P+H BrdU staining of both parasite and host nuclei
BrdU P-H BrdU staining of parasite in absence o f host nuclei
staining
Total P % of DAPHI Total % of parasite nuclei staining with BrdU
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Table of cell counts after release from aphidicolin block.
Time
(h)
DAPHI BrdU
Host
% of
DAPHI
BrdU
P+H
BrdU
P-H
Total P 
as %  of 
DAPHI
P+H as
% of
positives
P-H as
% of
positives
0 284 132 45.0 10 0 3.5 100 0
1 235 179 76.0 100 18 50.2 85 15
2 483 367 76.0 18 7 5.0 72 28
4 1317 469 35.6 40 7 3.5 85 15
5 1091 433 39.6 54 38 8.4 59 41
6 416 100 24.0 18 46 15.3 28 72
Incorporation of BrdU into host and parasite nuclei after 
release from aphidicolin block
0 1 2 4 5 6
Hours post re lease  from block
Figure 5.9 Northern blotting of RNA prepared from aphidicolin 
blocked D7 cells.
RNA from each sample was separated on a 0.8% denaturing 
formaldehyde gel and blotted onto Hybond N  membrane (Amersham). The 
blots were then cross-linked and hybridised as described chapter 2.
Panel A  shows the reactivity profile obtained with the TaRl probe - a 
0.75kb XhoI/PstI fragment excised from the pBluescript cDNA clone.
Panel B shows the profile with the parasite |3-tubulin probe - a 1 .Okb BamHI 
fragment excised from the pBluescript cDNA clone.
Panel C shows the profile with the ThaCRK2 probe - a 0.8kb KpnI-Xhol 
fragment from the pBluescript cDNA clone.
Panel D shows the profile with the host cdc2 probe - a 0.7kb Bglll/PstI 
fragment excised from the pBluescript cDNA clone
Sizes are as indicated to the right of the panels.
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Time post release of aphidcolin block 
tO tl t2 t4 t6
Time post release of aphidcolin block
tO tl  t2 t4 t6
Time post release of aphidcolin block 
tO tl t2 t4 t6
Time post release of aphidcolin block 
tO tl t2 t4 t6
Chapter Six
Expression of Cell Cycle 
Related Proteins 
during 
Differentiation
6.1.1 Introduction
Using a T. annulata infected cloned cell line D7 which has an enhanced 
differentiation phenotype, previous work had shown that during intra-cellular 
differentiation to the merozoite stage there is a point reached after which the parasite is 
committed to differentiation (Shiels et al, 1992). The number of parasite nuclei per 
infected cell increases typically by up to 300% within 96 hours of the culture being 
shifted to 41°C and continues to increase until merozoites are formed prior to host cell 
lysis. During the early stages at increased temperature, the infected host cells continue to 
undergo a parasite induced proliferation with a concomitant increase in infected cell 
number of approximately four fold over the first 48 hours, then the rate of increase slows 
down as the parasite differentiates within the enlarged macroschizont, while the number 
of parasite nuclei continues to increase as the rate of infected cell division decreases. 
Thus the synchrony between the parasite and host cell cycles breaks down after 
approximately 2-4 days at 41°C. The rate of parasite nuclear division must continually be 
greater than that of host cell division after the breakdown of synchrony to account for 
the increase in parasite nuclei per infected cell. It is possible that in the final stages of 
differentiation, the host cell cycle may be shut down completely.
The unique ability of Theileria to induce immortalisation of the host cell has 
stimulated research into the mechanisms responsible for this. The gene encoding host 
casein kinase II, a component of the signal transduction pathway, has been cloned 
(oleMoiYoi et al., 1993) as well as a gene coding for metalloproteinase MM9 (Baylis et 
al, 1995). Both of these have elevated levels in infected cell lines but it is difficult to 
distinguish a specific effect, at this level, by the parasite from a general result of 
stimulated proliferation. It is extremely difficult to single out candidates for the ‘factor’ 
which stimulates proliferation. However, it seems probable that the ‘factor’ is a 
component of the external surface of the schizont or is a molecule that is actively 
transported out of the schizont into the host cytoplasm. Carrington et al. (1996) showed 
that by specifically blocking host protein synthesis with ricin some, as yet unidentified, 
parasite proteins are exported into the host cell. Many changes in gene expression take 
place in the differentiating cell (Glascodine et al., 1990, Shiels et al., 1993, Swan et al, 
manuscript in preparation), some of which could be involved in effecting a change in
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parasite induced host cell proliferation. It is not known if the reduction in host cell 
division during differentiation is due to the removal of parasite stimulation or to a 
physical or metabolic effect of the enlarged macroschizont. The aim of the work in this 
chapter was to characterise the decline in host cell division rate and the interaction 
between host and parasite cell cycles at the molecular level during differentiation at 41°C 
with a view to establishing if and when a specific down regulation of the host cell cycle 
occurs during differentiation.
The intial approach was to use anti-sera directed against components of the host 
and parasite cell cycles to determine alterations in the reactivity profiles of these proteins 
(by Western blotting) during differentiation.
6.1.2 Analysis of host /parasite cell cycle proteins during parasite differentiation.
A differentiation time course of D7 infected cells was prepared by placing a 
culture at 41°C. The culture was maintained by diluting into fresh medium every second 
day to 1.2-1.4x105 cells/ml until the growth rate had decreased at day 8. The fold 
increase in cell number at each time point is shown in figure 6.2 and the cell counts for 
each time point in Table 6.1. In this time course the growth of the population is 
maintained up to a slightly later time point than was observed in Shiels et a l (1992) (day 
6). Samples were taken for preparation of protein extracts after 0, 2,4, 6, 8, and 10 days 
at 41°C and Giesma stained slides were made from each of the D7 samples to assess the 
stage of differentiation. These are shown in figure 6.1.
Each sample was standardised to equal cell numbers (1.8xl06 cells/track) by 
adjusting the resuspension volume of the cell pellet after centrifugation. The protein 
extracts from each time point were analysed by SDS-PAGE and Western blotting using a 
range of anti-sera. Standardisation on the basis of equivalent cell numbers rather than 
total protein was chosen as it should take account of possible alterations in the protein 
content of cells during the differentiation process. In practice, total protein content did 
not vary greatly as assessed by Ponceau S staining of Western blots. The anti-sera were 
selected to distinguish cell cycle events of both host and parasite. The sera used were 
higher eukaryote specific anti-cdc2 and ribonucleotide reductase (large subunit) and
166
Theileria specific ThaCRK2 and TaRl. In addition, control antisera for both host and 
parasite were used. These were a mammalian specific anti- HSP 60 antibody and the 
45kDa parasite protein which cross-reacts with the TaRl antisera (Chapter 4). The 
function of both of these proteins are thought to be unrelated to the cell cycle, and 
expression may, therefore, be differently regulated or unchanged during the 
differentiation time course. The reactivity profiles are as shown in figure 6.3.
Using the parasite specific anti-ThaCRK2 anti-serum (Panel A) the reactivity 
increases markedly after 4 days at the higher temperature (Lanes 4 - 7 )  and correlates 
with the most active period in terms of increase in numbers of parasite nuclei. Assuming 
that this protein is necessary for completion of the parasite cell cycle, it is present at a 
low concentration in non-differentiating cells and does not increase significantly during 
the early stages of exposure to the higher temperature (Lanes 3-4). From day 4 onwards, 
the size of the parasite macroschizont and nuclear content increase considerably (figure 
6.1) and the increase in anti-ThaCRK2 signal may reflect this. However, after peaking at 
day 8 (Lane 6) the reactivity significantly decreases. This could reflect arrest of the 
parasite cell cycle prior to the rupture of the host cell and release of the mature 
merozoite stage which are non-dividing and do not react with anti-ThaCRK2 antibody by 
immunofluorescence (Kinnaird, unpublished). It is important to note that individual 
parasites in the cell population will be at various stages of differentiation, thus the 
process is not synchronous. These results indicate the trend of the population as a whole 
at a particular point in time. Hence at day 10, for example, the reduction in anti- 
ThaCRK2 signal largely represents the cells where merogony is complete but also 
includes some cells at earlier stages of differentiation. Similarity, it is difficult to 
determine if the apparently sharp rise in reactivity over days 6-8 reflects an upregulation 
in expression of ThaCRK2 or merely an increase in the size and nuclear content of the 
macroschizont. If it were possible to synchronise cell differentiation, this could be 
clarified.
An opposite effect is seen with the anti-cdc2 anti-serum which specifically 
recognises bovine cdc2 only (Panel B). During the early stages (days 2-4) of 
differentiation (Lanes 3-4) there is a gradual decrease in reactivity compared to that 
found in the D7 infected cells when maintained at 37°C (Lane 2), and by 6 days into 
differentiation the levels of host cdc2 protein are very low (Lanes 5 -7). At day 4-6 the
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host cell division rate decreases (Shiels et al, 1992) and this is reflected in the profile of 
host cdc2 and R1 reactivity.
The trends shown by the host cdc2 and parasite ThaCRK2 are mirrored almost 
exactly if the sera specific for the host and parasite large subunit of ribonucleotide 
reductase are used. Panel C shows the profile of the anti-TaRl anti-serum (Chapter 4).
As mentioned before there are two reactive bands seen with this antibody. It can be seen 
that for the 97kDa polypeptide, the predicted size of the T. annulata large subunit of 
ribonucleotide reductase, the reactivity increases most markedly over the later stages of 
the time-course (Lanes 5-7) though there is a small gradual increase over the early 
stages. This parallels the rise in ThaCRK2 reactivity over the same stage (Panel A Lanes 
5-7), again with reactivity peaking after 8 days at the higher temperature (Lane 6). There 
is proportionally much weaker reactivity seen with piroplasm extracts (Lane 8) when 
compared to differentiating cells at day 8 (lane 6) than there is between the same two 
time points with the anti ThaCRK2 antiserum. However, the cross-reactive polypeptide 
of ~45kDa recognised by this sera exhibits a different profile of reactivity, remaining 
relatively constant throughout the experiment (Lanes 2-8). With the anti-mouse R1 
antibody the situation is reversed (Panel D), there is a clear decrease in reactivity by 2 
days after the shift to the higher temperature (Lane 3-7). This profile parallels that seen 
with the anti bovine cdc2 reactivity (Panel B), linking both these together. Panel E shows 
the reactivity of an anti-mammalian HSP60 antibody which was selected as a control (see
6.1.3 below) to show that the levels of host protein unconnected with the cell cycle 
remained similar throughout the time-course (Lanes 1-7). There is no cross-reactivity 
observed with this antibody against any parasite protein present in piroplasms (Lane 8).
6.1.3 Induction of host HSP60 upon heat shock
In order to establish the validity of the specific changes in cell cycle proteins 
during differentiation it was necessary to relate these results to control proteins which 
are known not to be involved in the cell cycle. Several antibodies were tested which 
might specifically react with bovine proteins. These included antibodies against HSP-90 
and histone both of which cross-reacted with piroplasms and therefore would also
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probably react with the parasite component of infected lymphocytes. An antibody raised 
against human glucose-6-phosphate dehydrogenase (a gift of P. Mason) was also tried 
but did not react against the bovine homologue. A commercial antibody against HSP-60 
which was found to react exclusively with a bovine polypeptide of the expected size and 
showed no cross reactivity with piroplasms, was eventually selected. Of course it cannot 
be ruled out that a cross-reactive parasite HSP-60 protein is expressed in differentiating 
cells and not in piroplasms but this seems unlikely. HSP proteins are generally induced 
under stress conditions such as heat shock and previous work had shown that parasite 
HSP-70 RNA increased approximately three fold after the first 4 hours following heat 
shock at 41°C and thereafter remained at a stable level (Kinnaird etal., unpublished). It 
was decided to test reactivity of the bovine HSP-60 antibody over a similar period to 
ensure that the reactivity did not change over the major part of the differentiation time 
course.
Equal numbers of cells were harvested from a culture at 0, 8, 32 and 48 hours at 
41°C and analysed by SDS-PAGE and immunoblotting (Figure 6.4). By 32 hours there 
was an approximately 4-5 fold increase in HSP-60 protein which did not change by 48 
hours. This shows that the reactivity increases once the cells are exposed to the higher 
temperature but that the reactivity remains relatively constant over the later stages of the 
heat shock. This validates the use of the antibody as a control in the experiments 
described in section 6.1.2. It would be ideal if another host specific antibody could be 
used in addition to the HSP60 as a means of measuring host protein contribution over 
the course of differentiation.
6.1.4 Densitometer scanning of reactivity profiles confirms decrease in host cell 
cycle related proteins.
The autoradiographs showing the reactivity profiles of the antisera in section
6.1.2 were scanned using a BioRad Densitometer II scanner and the results used to 
calculate relative ratios for each anti-body as a % of the day 0 value after the background 
value had been subtracted (Table 6.2). The values were then plotted on a graph over the 
period of days at the higher temperature, as shown in figure 6.5.
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This qualitative analysis confirms the qualitative observations made in section
6.1.2 which showed that two host cell cycle related proteins decreased very early in the 
time course of differentiation. The host cdc2 protein falls to less than 50% of its inital 
value after 2 days at 41°C but appears to increase between this point and the next 
sampling point (Day 4). This is probably a track loading artefact in the gel as the same 
Western blot when probed with the anti-ThaCRK2 serum, gave an unexpectedly low 
signal in this track. This is not mirrored with the bovine R1 or TaRl signals at the same 
time point as these results were obtained from a second gel. However, it is clear that 
between days 2- 4 ,  there is an approximately 50% decrease in reactivity of bovine cdc2 
and R1 antibodies which appears to occur slightly earlier than the sharp rise in the two 
corresponding parasite polypeptides which remains at low levels until day 4 - 6. By day 
8, both the host cdc2 and R1 signals have fallen to less than 20% of their initial values.
With the parasite ThaCRK2 and TaRl signals, both show similar trends over the 
course of differentiation with a peak of reactivity at day 8 prior to a fall of >40% by day 
10 when many of the cells are producing mature merozoites and the host cells are 
disintegrating. The values obtained from the HSP60 antibody reactivity showed little 
variation over the time course.
6.1.5 Kinase activity over D7 differentiation
Using another D7 time course, extracts were prepared every 48 hours over a 
period of 10 days from D7 cells incubated at 41°C. The cell extracts were standardised 
for equal protein concentrations and each incubated with a constant volume of pi 3- 
sepharose beads then washed as described in chapter 3. The eluate from each time point 
was then assayed for kinase activity using histone HI as the exogenous substrate. The 
activity profile is shown in figure 6.5. It can be seen that the phosphorylation of histone 
HI remains quite constant throughout the time course. There is an additional polypeptide 
of 45 kDa present in the piroplasm extracts (marked as X, Lane 7) which also becomes 
apparent in the D7 extracts after 6 days at the higher temperature (Lane 4). This is not 
present in uninfected lymphocytes, only faintly in D7 infected or early stage 
differentiating cells. It was not detectable in purified schizonts. The profile of this
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polypeptide parallels the Western blot data shown in section 6.1.2 where the levels of the 
ThaCRK2 protein are seen to increase over the course of differentiation. It has 
previously been shown that ThaCRK2 binds, albeit very weakly, to p i3 sepharose 
(chapter 3). It follows, therefore, that phosphorylation of the histone HI substrate may 
be as a result of the parasite proteins kinases expressed during the later stages of 
differentiation assuming that at this late stage of differentiation, the host protein 
contribution is minimal. The Western time course data indicates that the levels of the 
bovine cdc2 protein drops to between 5-10% of its day 0 value by day 6-8. As the 
mammalian cdc2 protein is present in excess and only a small porportion is complexed 
(Draetta & Beach, 1988; McGowan etal., 1990) to give an active kinase in vivo, it is 
possible that the histone HI kinase activity is due to host CDK’s. It is difficult to 
extrapolate between extracts prepared from different time-course experiments but it is 
possible to draw trends in activity profiles that could form the basis for future 
experimental work.
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6.2 Discussion and Conclusions
The work presented in this chapter deals with the differentiating parasitised cell. 
The immunoblotting shows that the switch between proliferation and differentiation 
could be related to levels of host CDK and other proteins involved in the cell cycle. The 
parasite proteins involved in proliferation rise quite spectacularly after 96 hours (around 
the point of commitment to differentiation (Shiels et al, 1992)) in culture at 41°C when 
the host proteins have dropped to less than 50% of their initial levels. The parasite 
proteins remain relatively constant over the first 96 hours whilst the host cdc2 and R1 
levels fall. Due to the cultures not being synchronous the rises may be staggered in that 
each individual cell will be at a different point in its differentiation at the sampling points. 
If the cultures could be synchronised in terms of the cell cycle then this could only be 
maintained over a short period at 41°C before the synchrony of division of host and 
parasite would break down, so that the trends seen in figure 6.3 would be similar.
This indicates that there is an early change in the expression pattern of host cell 
cycle genes measured at the protein level. While this could be due to changes in the rate 
of protein turnover or in the rate of translation, the most likely explanation is that there is 
a down regulation in the transcription of these genes. Future experiments should include 
an analysis of RNA levels by Northern blotting and nuclear run-on studies during the 
time course. The fact that there is still some host cdc2 reactivity after 10 days (Lane 7) 
suggests that the protein is still being synthesised by some intact host cells and/or the 
protein is quite stable as host R1 is not detectable at this stage. Previous work had 
shown that host cell division rate slows down around the commitment point of the 
parasite to differentiation at day 4 (Shiels et al, 1992). In fact, these experiments 
(confirming and expanding on previous preliminary experiments, J. Kinnaird, unpublished 
results) showed a rather earlier decline in levels of host cdc2 and in host R1 suggesting 
that there is a change in the regulation of expression of some or all of the host cell cycle 
associated proteins as early as the first 24-48 hours at the elevated temperature. There 
was little change in a control bovine HSP-60 protein over the time course indicating that 
this effect could be specific to cell cycle proteins. However, this conclusion could be 
strengthened if at least one other reactive bovine antibody was available as a standard. It 
is not known if the reduction in the amount of the two host proteins is caused by an
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equal reduction in all cells in the population or whether it is restricted to a certain class of 
cells. If the latter is the case, it would point to an alteration in the parasite control of the 
host cell division associated with entry into the asynchronous differentiation pathway. It 
should be possible to show this by quantitative immunofluorescence assay of individual 
cells in a population.
However, reduction of these molecules in all cells would perhaps suggest an 
effect of stress i.e. heat shock on the host cell cycle. In S. cerevisiae it has been 
demonstrated that heat shock causes a temporary cell cycle block (Rowley etal., 1993). 
In response to elevated temperature cells accumulate in G1 prior to ‘START’ and that 
this is probably due to an effect of heat shock on the transcription of some cyclin genes. 
As the transcription of the transcriptional activator, SW14, required for the expression of 
these cyclin genes, is also transiently affected by heat shock they proposed that this may 
partially explain the effects. Therefore, a primary effect of heat shock on the host cell 
cycle could be sufficient to cause an imbalance between host and parasite growth and 
division leading to initiation and eventual commitment to the differentiation pathway.
The latter hypothesis is attractive in that it does not rule out a second phase where 
differentiation of the parasite and division of the host cell become mutually exclusive i.e. 
the parasite has no further need for an actively dividing host cell for its proliferation 
hence the control over host cell division is shut down.
It is not possible to standardise the piroplasm track loading in terms of equal cell 
number as was done with the differentiating cells but protein loadings were equivalent as 
assessed by Ponceau S staining. It is possible, however, to obtain comparative ratios of 
protein levels in the piroplasm stage from reactivities of different antisera. Hence in the 
piroplasm stage, reactivity with anti-ThaCRK2 is at a similar level to day 8 differentiating 
cells and much greater than day 10. With TaRl antisera the piroplasm reactivity is much 
less than that observed at day 8 or 10. As ThaCRK2 is not detectable in merozoites by 
immunofluorescence, it suggests that the gene is actively transcribed in the piroplasm 
stage and this conclusion is supported by the detection of high levels of specific mRNA 
and protein (Kinnaird et cil, 1996). The comparatively low reactivity of the TaRl anti­
sera in the piroplasm stage compared to the actively dividing stages of differentiation 
suggests that division is not a major feature of the asynchronous piroplasm population. 
This provides further evidence for the conclusions, made by Conrad et al., (1985) based
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on microscopic evidence, that T. anmdata piroplasms only divide twice in the 
erythrocyte stage. The low levels of TaRl reactivity, an essential enzyme of DNA 
synthesis, also tend to disprove the theory that T. annulata piroplasms can form 
merozoites which continually re-invade erythrocytes and develop into piroplasms, This is 
known to happen in T. sergenti (Uilenberg et ah, 1985) and it would be interesting to 
compare the relative levels of R1 protein in the piroplasm stage of the two species.
Certainly the parasite increases its rate of nuclear division during differentiation 
which would account for the rise in ThaCRK2 and TaRl levels between day 4 and day 8. 
If this is the case, it raises the question as to why ThaCRK2 is highly expressed in 
piroplasms if it functions in the regulation of division. This points to an additional role 
for ThaCRK2, possibly directed by a different cyclin partner and, although it is 
premature to speculate, ThaCRK2 could play a role in organisation of the piroplasm 
nuclear structure in preparation for the tick vector stage or perhaps in gametocytogenesis 
which is likely to occur at this stage.
The histone HI phosphorylation profile does not change greatly over the course 
of differentiation using proteins bound to pi 3 sepharose. It was previously shown 
(chapter 3) that bovine CDKs and, at least, two parasite kinases can bind to yeast pl3. 
The amount of bovine cdc2 in the differentiating cell population has been shown to 
decrease considerably from early in differentiation. However, as cdc2 is always present in 
considerable excess in cells (Draetta & Beach, 1988, McGowan et al., 1990) even a 
reduced amount of polypeptide may still show little reduction in activity, if other 
important proteins such as cyclins are still being expressed. It has also been shown that 
parasite ThaCRK2, a putative cdc2 homologue, rises greatly during differentiation and 
this also binds to pl3 albeit weakly (chapter 3). Thus, ThaCRK2 may contribute to the 
pi 3 bound kinase activity seen here in the later stages of differentiation. However, 
immunodepletion of ThaCRK2 from piroplasm extracts (chapter 3) did not greatly alter 
the casein phosphorylation profile but did change the histone HI phosphorylation profile. 
It was concluded that a second pl3 bound kinase may be largely responsible for casein 
phosphorylation. As this parasite kinase is unidentified, its expression profile during 
differentiation is unknown. Clearly, p i3 purification of cdc2 related kinases cannot 
distinguish clearly between host and parasite activities, especially as bovine cdc2/CDK2 
may have a much higher affinity for p i3. Therefore, this experiment does not clarify the
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obvious decrease in amount of host cdc2 protein in terms of a parallel decrease in 
activity. A future approach would be to assay the different kinase activities over a time 
course using specific antisera for immunoprecipitation. Human cdc2 C terminal antibody 
will immunoprecipitate bovine cdc2 from native extracts to give a histone HI kinase 
activity but it has not yet been possible to immunoprecipitate kinase activity for parasite 
CRK2 (J. Kinnaird, pers.comm.).
A polypeptide of 45 kDa was strongly phosphorylated in the p i3 bound complex 
from piroplasm extracts and also in later stage differentiating cells. This polypeptide has 
the same molecular weight as the polypeptide identified as being specifically 
phosphorylated by a pl3 bound complex from piroplasm extracts (chapter 3). 
Phosphorylation of this polypeptide was found to be considerably reduced in ThaCRK2 
immunodepleted extracts and it was concluded that it may represent a component of the 
active ThaCRK2 kinase complex that is phosphorylated by ThaCRK2 or perhaps the 
second kinase bound to pl3 could be a substrate for ThaCRK2.
The recent publication of Graeser et al (1996) found that the PfPK5 kinase, 
which is likely to be the P. falciparum homologue of ThaCRK2 because of the degree of 
identity, was possibly associated with S phase as activity was high in aphidicolin blocked 
cells. In the time course reported here, TaRl antibody reactivity increases in parallel with 
ThaCRK2 again indicating that DNA synthesis is a major feature in post commitment 
differentiating cells.
With respect to the p i3 bound kinase assays, there are other parasite proteins 
binding which seem to increase over the differentiation and are still present in the 
piroplasm stage. One of these may be the recently identified ThaCRK3 which could be 
assayed for p 13 binding properties once a good anti-serum is produced. This could also 
be used to probe immunoblots of the pl3 eluate fractions from D7 cells and piroplasms 
to determine if it is expressed at the protein level during differentiation.
To conclude, there is a very early decrease in two proteins associated with the 
host cell cycle. This occurs before a decrease in division rate and before commitment of 
the parasite to differentiation. It may suggest that the parasite derived mechanism which 
controls host cell proliferation is altered during the early stages of differentiation.
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Figure 6.1 Giesma staining of D7 infected cell differentiation time 
course at 41°C used to prepare protein samples.
For each time point sample, lOOpl o f cells were centrifuged onto glass 
microscope slides using a cyto-spin (Shandon). The slides were then dried 
and fixed in methanol prior to staining in Giesma stain. The slides were then 
viewed and photographed at a X I00 magnification.
Scale bar is 10pm.
Key:
Print 1 D7 @ 37°C
Print 2 D7 cells after 2 days at 41°C
Print 3 D7 cells after 4 days at 41°C
Print 4 D7 cells after 6 days at 41°C
Print 5 D7 cells after 8 days at 41°C
Print 6 D7 cells after 10 days at 41°C
hn Host nucleus
chc Condensed host chromosomes
ms Macroschizont
ems Enlarged macroschizont
m Merozoites
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Figure 6.2 Graph showing fold increase in cell numbers over course of 
differentiation
The values for the fold increase in cell number relative to day 2 were 
plotted against number o f days at 41°C. The values are as in Table 6.1.
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Figure 6.3 Reactivity Profile of anti-sera against cell cycle proteins 
during infected cell differentiation.
A time course of D7 infected cells were placed at 41°C and samples taken 
after 2, 4, 6, 8, and 10 days at 41°C. Samples were standardised for equal 
cell numbers at each of the sampling points. Samples of uninfected cells and 
D7 cells grown under standard conditions were also taken (BL20 and 
D7@37°C).
Samples from each sample were lysed in SDS-PAGE sample buffer 
and separated on 12.5% and 8% SDS-PAGE gels and immunoblotted 
Protein loadings were assessed by Ponceau S staining and samples are 
standardised for equal cell numbers at each time point.
Panel A  shows the reactivity profile of the anti-ThaCRK2 anti-serum.
Panel B shows the same gel probed with the higher eukaryote anti-cdc2 anti­
serum.
Panel C shows reactivity profile with the anti-TaRl anti-serum.
Panel D shows the profile with the higher eukaryote specific anti-Rl 
antibody.
Panel E shows the profile with the higher eukaryotic specific anti-Heat 
Shock Protein (HSP-60) anti-serum (Sigma).
Key:
Lane 1 BL20 total cell extracts.
Lane 2 D7 infected cell extracts @ 37°C.
Lane 3 D7 cell extracts after 2 days at 41°C.
Lane 4 D7 cell extracts after 4 days at 41°C.
Lane 5 D7 cell extracts after 6 days at 41°C.
Lane 6 D7 cell extracts after 8 days at 41°C.
Lane 7 D7 cell extracts after 10 days at 41°C.
Lane 8 Piroplasm cell extracts.
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Figure 6.4 HSP-60 reactivity increases upon heat shock of D7 cells
The HSP-60 monoclonal antibody used in section 5.1 was shown to 
react specifically with host HSP-60 only. An immunoblot was done to assess 
the reactivity profile after the D7 cells had been placed at 41°C. Extracts 
were prepared from equal cell number samples o f a D7 cell culture after 8,
32 and 48 hours at the higher temperature, separated on an 8% SDS-PAGE 
gel and immunoblotted. Equal protein loadings were assessed by Ponceau S 
staining after transfer.
This figure shows the profile obtained with the antibody over these 
sampling points. Sizes are as indicated on the left o f the figure.
Panel A  shows a 60 second exposure.
Panel B shows the same blot exposed for 5 minutes.
Key:
Lane 1 D7 cells at 37°C
Lane 2 D7 cells after 8 hours at 41°C
Lane 3 D7 cells after 32 hours at 41°C
Lane 4 D7 cells after 48 hours at 41°C
Lane 5 Piroplasm extracts
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Figure 6.5 Densitometry results show decrease in host cell cycle 
proteins over differentiation
The values o f the densitometry scanning analysis are plotted for 
both the parasite and host proteins.
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Figure 6.6 Kinase assay of differentiating cell extracts after p l3  
binding.
This figure shows differentiating D7 cell extracts assayed for kinase 
activity after binding to p i3. Kinase assays were done using Histone HI as 
the exogenous substrate as detailed in chapter 3. Two specific bands 
referred to in the text are labelled as X and Y.
Key:
Lane 1: D7 extracts @37°C
Lane 2: D7 extracts after 2 days at 41 °C
Lane 3: D7 extracts after 4 days at 41 °C
Lane 4: D7 extracts after 6 days at 41 °C
Lane 5: D7 extracts after 8 days at 41 °C
Lane 6: Schizont extracts
Lane 7: Piroplasm extracts
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Table 6.1 Cell counts for the D7 time course
The cell counts for each sampling point are listed below together with 
the dilution used.
2 7 .4x l05 1.48 xlO5 -
4 5.9 xlO5 1.2 xlO5 4.0
6 5.0 x10s 1.4 x10s 4.2
8 2.1 xlO5 - 1.5
10 2.8 xlO5 - 1.3
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Table 6.2 Densitometer Scanning of Time course immunoblots
The immunoblots described in section 6.1.2 were scanned using a 
BioRad densitometer and the absorbance values for each antibody were 
used to plot a graph showing change of reactivity o f the antisera over die 
course of differentiation.
For each antibody the values are calculated as a relative value compared to 
the Day 0 figure. For host antibodies the Day 0 value was normalised to 10 
and for parasite antibodies this figure was normalised to 1.
Background absorbance was subtracted from each absorbance value (Abs) 
to give the true absorbance (Abs-B/gr.)
For plotting the graph (figure 6.4) only the D7 day 0 to day 10 values were 
used. The BL20 and piroplasm reactivity values were not used.
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D. Anti-Rl anti-serum specific for host R l. 
Background -16.199
BL20 20.508 4.309 -
Day 0 20.586 4.387 10.0
Day 2 18.398 2.199 5.1
Day 4 17.394 1.195 2.8
Day 6 17.131 0.932 2.2
Day 8 16.554 0.355 0.8
Day 10 16.243 0.044 0.1
Piroplasm 0.000 0.000 -
E. Anti-HSP-60 antibody.
Background - 20.236
BL20 20.756 0.520 -
Day 0 20.805 0.569 10.0
Day 2 20.873 0.637 11.2
Day 4 20.815 0.576 10.1
Day 6 20.909 0.673 11.8
Day 8 20.826 0.590 10.4
Day 10 20.915 0.679 11.8
Piroplasm - -
Chapter Seven
Summary
and
Future Perspectives
7. Summary and Future Perspectives
The Theilerici life cycle is characterised by alternating phases of proliferation and 
arrest and the proliferative stages are associated with much of the pathogenic features of 
the disease. A detailed understanding of how parasite growth and division cycles are 
controlled will lead, ultimately, to the development of highly specific reagents for 
treatment of the disease. The work presented here attempts to address these issues.
The first stage of the work focussed on the use of yeast pl3 sepharose as a means 
of affinity purification of pl3 binding kinases from T. anmdata. At least two different 
pl3 binding kinase activities were demonstrated from the piroplasm stage of T. annulata. 
The substrate preferences of these kinases differs with the ThaCRK2 kinase showing a 
preference for histone. The other kinase whose existence was first inferred from the prior 
immunodepletion of ThaCRK2 binding studies exhibited stronger phosphorylation of 
casein and can possibly bind pl3 with a stronger specific affinity than ThaCRK2. This 
other kinase may be encoded by the ThaCRK3 gene which was recently isolated. This 
will be confirmed once the anti-sera is available against this protein. Results presented 
here suggest that the binding of T. annulata kinases to yeast p i3 was not optimal. It was 
not possible to isolate a Theilerici homologue in this study but certainly, if a pl3sucl 
homologue could be isolated from T. anmdata then this would be expected to show 
maximal affinity for T. annulata CRKs. It is possible that bovine CRK’s would have a 
reduced affinity for a Theileria p i3 homologue and this may provide a means for a more 
specific detection of parasite cdc2-related kinase activity from the intra-lymphocytic 
stage. Future attempts to clone this parasite homologue may include design of more 
suitable degenerate oligonucleotide primers for PCR amplification or using a Theileria 
CRK cDNA cloned in a suitable yeast expression vector as a trap in the yeast two hybrid 
system screen for interacting polypeptides. An alternative approach might be to screen a 
cDNA expression library with recombinant histidine tagged ThaCRK2 followed by 
specific detection of the histidine tag by a specific antiserum. However, this would 
depend upon correct folding of the proteins in bacterial expression systems.
Further refinement of the pi 3 sepharose purification system for CRK’s and/or 
development of specific antibodies against parasite and host CRK’s for
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immunoprecipitation would allow comparartive assay systems to be established for 
testing different kinase inhibitors for differential effects on parasite and host.
Two cdc2-related kinases have been isolated so far from T. anmdata and this 
shows that there is a family of cdc2-related kinases present in this parasite. This mirrors 
the situation in Leishmania, Trypanosoma and Plasmodium. It may be that there still 
remains a cdc2 homologue to be isolated from these parasites and the genes isolated so 
far may be related to other aspects of the parasite life cycle and may not be involved in 
the cell cycle. Gene knockouts with the Leishmania CRKs shows them to be essential (J. 
Mottram, pers. comm.) for parasite survival. Once the binding partners for these CRKs 
have been isolated and characterised, it may be possible to determine precise functional 
roles for these polypeptides in the individual parasite. Regarding cyclins, one has been 
cloned from P. falciparum and two from T. brucei (P. Neuville, pers. comm.). It is 
feasible that there will be significant differences in the regulation of parasite CRKs given 
the evolutionary distance between them and the higher eukaryotes. Although all the data 
so far suggests that the mechanisms of kinase regulation are conserved, the molecules 
involved may be different. It will be interesting to compare phylogenetic relationships 
between the CRKs and other genes involved in the cell cycle to assess how these differ 
compared to the classical phylogenetic relationships derived from rRNA genes (Gajadhar 
et al, 1991). If rRNA genes are used to predict evolutionary relationships between the 
protozoa then T. anmdata is close to Sarcocystis muris, a related Apicomplexan, but 
there is considerable divergence between T. annulata and Plasmodium which is 
surprising given the similarities between this pair in morphology and life cycles. The 
apicomplexans form a group with dinoflagellates and with ciliates which is separate from 
the other protist groups.
More information regarding the cellular localisation of the CRKs would point to 
possible functions of these proteins especially since work with PfPK5 (which is likely to 
be the homologue of ThaCRK2) suggests it to have a role in the nuclear division cycle in 
P. falciparum (Graeser et al, 1996b). The authors immunolocalised PfPK5 to the edge 
of the parasite nuclei, possibly close to the centrosomes. Based on the knowledge of the 
localisation of cdc2/cyclin B to the mitotic spindles in HeLa cells, they postulated PfPK5 
to have a role in mitosis, possibly in organisation of the spindle. Because of a higher 
activity of PfPK5 in aphidicolin blocked parasites, the authors speculated that PfPK5
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may also have a role in DNA synthesis suggesting, as is the situation with cdc2 in higher 
eukaryotes, that PfPK5 may act at both Gl/S and G2/M phases of the nuclear division 
cycle. In agreement with this, PfPK5 localised diffusely with DNA staining during S 
phase rather than as the discrete points at the sides of nuclei found later in the cycle. 
ThaCRK2 localises predominantly to the schizont cytoplasm, a situation found for PfPK5 
by other workers (Ross-MacDonald et al, 1994). This suggests that different fixation 
methods might bias localisation results, a situation found in HeLa cells (Bailly et al,
1989; Riabowol et al, 1989). It is possible that ThaCRK2 could also have a nuclear 
localisation which is beyond the limits of detection by the anti-serum. BrdU 
incorporation studies showed that very few parasites were synthesising DNA at any one 
point during growth at 37°C (10-20%). Hence, if transport of ThaCRK2 into the nucleus 
likewise only occured in a small percentage of parasites at any one time this would 
render detection in the nuclei even more difficult.
The isolation and characterisation of the large subunit of ribonucleotide reductase 
raises the possibility that this can be used as a target for a species specific therapeutic. 
The Theileria R1 subunit possibly possesses an N - terminal extension which is not 
present in the higher eukaryotes. This is interesting in terms of why is it present? Does it 
exist in the mature protein? If so, how would it affect the folding of the large subunit, its 
dimerisation and its interaction with the small subunit? Does this region have a role in the 
allosteric regulation of the parasite enzyme? If so, how does this regulation differ? Since 
the P. falciparum gene also contains an upstream region from the consensus eukaryotic 
start codon, it is possible that an N-terminal extension could be a feature of all 
Apicomplexan R1 subunits. It is interesting to speculate how the ribonucleotide 
reductase enzyme of P. falciparum may differ in terms of its allosteric regulation given 
the AT richness of the Plasmodium genome. Certainly if it were shown that this region is 
present in the mature protein, as is likely based on the most 5’ translational start 
sequence having the best fit to the protozoan consensus start sequence, then it may be 
worthwhile testing anti-sense oligonucleotides and peptidomimetic inhibitors against this 
region as they shouldn’t affect the host enzyme. As a first step in this latter direction it is 
necessary to show that the N-terminal extension is present in the mature protein either by 
purification of sufficient quantities of R1 for N-terminal sequencing or by generation of a 
specific antiserum. It would also be necessary to model the N-terminal extension on a 3-
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dimensional structure prediction of the R1 subunit, in order to assess its effects on the 
tertiary and quaternary structure of the enzyme. Given the success of the peptidomimetic 
inhibitors against the Herpes simplex virus in vivo (Liuzzi et al, 1994) then it may well 
be possible to use these against a range of intracellular parasites. If anything, Theileria 
could be the best in vitro system to use for this since there are easily maintained cloned 
cell lines available. As most peptidomimetic inhibitors are based on the sequence of the 
site of interaction in the small (R2) subunit, future work should center on isolation of this 
gene from T. annulata. Production of both recombinant subunits may allow an in vitro 
assay to be established for rapid testing of different inhibitors.
The localisation of the TaRl subunit to the nucleus differs from the R1 subunit 
localisation in the host which is strictly cytoplasmic. Given this result, it is feasible that 
the DNA replication cycle of each nucleus is partly under individual control in that a 
supply of dNTP’s does not come from a common pool but is synthesised within each 
nucleus. It is possible that the small subunit in Theileria plays a role in the regulation of 
ribonucleotide reductase activity as is found in the mouse, by the S phase specific 
synthesis and breakdown of the R2 protein (Engstrom et al., 1984). The R1 protein in 
mice is constitutively expressed and remains at a constant level and is in excess 
throughout the cell cycle. It is possible that this situation occurs in Theileria as all nuclei 
were seen to label with the anti-TaRl antisera by immunofluoresence. It is possible that 
the R2 subunit is synthesised in the cytoplasm every cell cycle and transported into the 
nucleus to combine with the large subunit, producing an active enzyme. If the small 
subunit is successfully cloned and specific antiserum raised to a fusion protein, it will be 
possible to carry out immunolocalisation studies which could test this hypothesis.
Northern blotting of RNA prepared from the aphidicolin treated cells showed that 
there was little change in the levels of the ThaCRK2 mRNA after release from block. 
However, there was a small but noticable peak in the amount of TaRl mRNA after 
release from block. This coincided with the end of parasite S phase. The inference from 
this is that these ThaCRK2 gene is not under cell cycle control but the TaRl gene may 
be subject to some form of transcriptional regulation. The sequencing of the upstream 
sequence from TaRl shows there to be some common motifs but further experiments are 
needed to map which regions are important in expression and if these regions are capable 
of binding transcription factors.
187
Attempts made to synchronise D7 cells growing at 37°C using aphidicolin 
resulted in only 50% of the parasites being synchronised. The figure for synchrony of the 
host cell was higher given that mammalian DNA polymerases are known to be inhibited 
by aphidicolin. The situation in protozoa is different. Some such as the P. falciparum are 
known to be sensitive whilst others such as T. gondii and T. brucei are known to be 
insensitive. It was not possible to determine if the T. annulata polymerase is sensitive but 
there was a partial effect observed in the D7 cells used where drug treatment led to 50% 
of parasites entering S phase as opposed to the non-drug treated situation of 10-20%. 
This suggests that aphidicolin probably inhibits the parasite DNA replication. Parasite 
nuclei rarely labelled in the absence of parallel host nuclei labelling.
In the light of analysis of cell cycle protein levels in differentiating cells (Chapter 
6) it is interesting how the levels of ThaCRK2 and TaRl change over this period. The 
levels rise dramatically after 4 days at 41°C. This would just precede the reduction in 
host cell division and the massive enlargement of the macroschizont stage. This would 
provide pools of ThaCRK2 and TaRl proteins needed for division and a higher rate of 
DNA synthesis occuring in the parasite nuclei. The levels of both drop at day 10 which 
would reflect the cell population completing differentiation into the merozoite stage 
which is non-dividing. The levels of the two host cell cycle markers, cdc2 and the large 
subunit of ribonucleotide reductase drop very early after the cells are shifted to the 
higher temperature. This is interesting as it indicates that synthesis of some of the host 
proteins essential for the cell cycle may be down-regulated before the commitment to 
differentiation. It is known that the stress of heat shock in yeast can cause a transitory 
arrest of the cell cycle in G1 and has an effect on transcription of genes such as Rl. It is 
possible that this could be sufficient to provide the initial stimulus for a switch to a 
differential pathway by the parasite leading to a decline in the parasite induced host cell 
proliferation. A cell line, derived from the enhanced differentiating cloned cell line D7, 
has been isolated and does not differentiate to a significant extent at 41°C. The nature of 
the change is not known (Shiels et al., unpublished). However, such a cell line would 
provide an ideal control for a parallel set of experiments to analyse the polypeptide 
changes in host and parasite cell cycle proteins over a time course at 41°C.
The experiments using BrdU incorporation to measure DNA synthesis showed 
this synthesis to be synchronous between nuclei in a macroschizont. The implications of
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this would be that the division of each nucleus would only be synchronous if it were to 
rely on a common cytoplasmic pool of molecules needed for the intiation of replication. 
This allows for the speculation that the localisation of the ThaCRK2 to the cytoplasm is 
indictive of its role in the division of the nuclei in a manner similar to that postulated for 
PfPK5 (Graeser et al., 1996b). Although there would need to be a control mechanism for 
the regulation of ThaCRK2 to ensure its activation at the correct stage. This could be 
achieved by specific cell cycle expression of cyclins and other regulatory molecules as 
found in higher eukaryotes. A possible theory for the control of parasite nuclear division 
can be made based on the results in this thesis. In D7 cells, BrdU incorporation showed 
that parasite nuclei within a macroschizont undergo synchronous DNA synthesis. R1 was 
localised to parasite nuclei and ThaCRK2 was already known to be predominantly in the 
cytoplasm. It is possible that control of RR activity may be due to cyclical synthesis and 
breakdown of the R2 subunit which would be relocated to the nucleus at each nuclear 
division cycle to allow for provision of dNTP’s for DNA synthesis. Transcription of R1 
and R2 may ultimately be under the control of a CDK such as ThCRK2 which could be 
activated in the cytoplasm, perhaps by a threshold concentration of cyclin binding 
partners. Activated ThaCRK2 would be transported to the nucleus to act on its 
substrate. Such a theory would accommodate the need for a common pool of a 
regulatory molecule to achieve co-ordination of DNA synthesis between nuclei. This may 
be a cyclin binding partner although other possibilities cannot be ruled out.
. This raises a question about how the timing mechanisms of S and M phase are 
then integrated. There may be a relative timing mechanism in that all the parasite nuclei 
undergo replication at the same time then mitosis would occur at a set time afterwards. 
There is a G2 size control phase operating under rapid growth conditions in fission yeast 
which integrates mitosis with cell size. The size at mitosis was found to be dependent on 
the weel:cdc25 ratio. As the cells grow during G2 the levels of cdc25 mRNA and 
protein rise until mitosis is triggered which may mean that size control is a relative timing 
mechanism whereby mitosis occurs after a threshold level of Cdc25 is reached, activating 
cdc2 (reviewed in Lew & Kombluth, 1996).
To conclude, this work has shown the existence of at least two kinases which are 
capable of binding to p l3sucl. These kinases, one of which is ThaCRK2, are likely to play 
a role in the cell cycle of T.annulata. The large subunit of ribonucleotide reductase has
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also been isolated and gives optimism for use as a possible therapeutic target. It also has 
significant differences in its molecular and structural biology from that of the higher 
eukaryotic homologues which make a case for the further study of this molecule. The use 
of specific antisera has given an insight into the interplay between host and parasite cell 
cycle associated proteins during the intracellular differentiation of the parasite to the 
merozoite stage and raised questions about what means of control the parasite is using in 
its division cycle. Attempts with aphidicolin to synchronise infected cell populations 
merit further study.
More is known now about the proliferation and differentiation process in 
Theileria annulata and progress on the gene expression patterns within the 
macroschizont and the proof of exchange of polypeptides between host and parasite hint 
that the mechanism of transformation may soon be deduced.
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